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ABSTRACT
Understanding the Variable Drivers of Toxicity for the Broad Class of Carbon Nanotubes and
Nanofibers from U.S. Facilities
Kelly E. Fraser
Pulmonary exposure to carbon nanotubes or nanofibers (CNT/F) is known to induce inflammation,
toxicity, or tumorigenesis, and is a concern in the occupational setting. U. S. facility employees are at risk
of inhalation exposure of multi-walled carbon nanotubes and carbon nanofibers during primary and
secondary manufacturing. To date, only one MWCNT, Mitsui-7 has been classified as possibly
carcinogenic to humans (Group 2B), while all other materials were subsequently categorized as
unclassifiable (Group 3). This class of material has recently been listed as a high priority to the
International Agency for Research on Cancer due to this significant knowledge gap. Furthermore,
expressed desire to better understand the toxicity profiles of these materials has emerged from the National
Institute for Occupational Safety and Health. While human research to date is limited, the use of in in vivo
and in vitro model systems can be implemented for the assessment of toxicity outcomes following
respiratory exposure to CNT/F. The goal of this study was to generate an accurate an effective safety
profile of MWCNT and CNFs from U. S. facilities, and to adapt a multi-disciplinary approach using
machine learning to identify pertinent physicochemical characteristics that act as drivers of these toxicity
outcomes.
This study established toxicity profiles from male C57BL6/J mice aged 8-10 weeks exposed to
either 4 or 40 µg of one of nine different CNT/F via oropharyngeal aspiration as well as human epithelial
BEAS-2B cells (0-24 µg/ml), differentiated THP-1 cells (0-120 µg/ml), and human fibroblasts (0-2 µg/ml)
for four primary outcomes of genotoxicity, inflammation, pathology, and translocation. The nine materials
used in this study had a wide range of characteristics including diameter (6-397 nm), length (0.1-50 µm),
surface area (18-238 m2/g), aspect ratio (2-1396), residual metal catalyst (0.3-6.2 %), density (0.007-0.220
g/cm3), etc., to consider.
Toxicity profiles were generated regarding these four primary toxicity outcomes, and both
supervised and unsupervised machine learning was used to identify the key drivers of these adverse health
effects. While some physicochemical characteristics were determined to be key drivers of specific toxicity
outcomes, different characteristics were essential when considering other toxicity endpoints. No single
characteristic could be used as a toxicity predictor, therefore, multifactorial processes, or combination of
characteristics, were necessary for an accurate and effective prediction model for responses. The study
identified physicochemical drivers of CNT/F toxicity using an integrated approach, combining
experimental evidence with computational modeling, with potential for broad application. This study
provides necessary information for the consideration of the potential human health effects that can result
from CNT/F exposure. The safety profiles and identified drivers of toxicity may be useful for future
predictive risk assessment studies and translational studies as well as contributing to safety-by-design for
future material designs.
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CHAPTER 1:
Introduction and Literature Review

1

1.1. Introduction
The unique physicochemical properties of carbon nanotubes and nanofibers (CNT/F) make them
a diverse class of immensely useful engineered nanomaterials with a multitude of applications. These
applications are consistently growing resulting in the development of new materials, each with specialized
properties suited for their intended use. Many properties of CNT/F are consistent and conserved between
classes. For example, CNT/Fs have high tensile strength that is comparable to stainless steel yet have only
a third of the density [1]. These properties, combined with being thermally and electrically conductive,
make them ideal for use in composites, electronics, energy storage, and medical applications such as
lenses, batteries, biosensors, and drug delivery systems. Of note, MWCNT and CNF are primarily used in
composites. The addition of MWCNT and CNF to polymers, resins, and construction materials can
generate composites that are stronger and more resilient without adding excess weight, allowing for
applications in automotive, aerospace, and construction designs.
Beyond these universal properties, CNT/F can also be altered to have unique physicochemical
properties to serve specialized functions. For example, CNT/F s can be coated or functionalized to alter
surface chemistry resulting in differing dispersions, reactivity, durability, or application and uses [2-4].
However, these unique properties that make CNT/F s into such valuable materials may also be the same
properties that drive their toxicities and adverse health outcomes following human exposure, primarily
dermal and pulmonary exposures.
In the 1970s, Mearl F. Stanton led his research team and inspired subsequent studies to generate
the fiber hypothesis. In his own words, “Precise parameters need not be defined to appreciate that
carcinogenicity can depend on the structure rather than the physicochemical composition of a particle,”
[5]. This hypothesis stated that a fiber’s toxicity is dependent on its physical characteristics of size, shape,
dimension, and biopersistence. While these studies primarily focused on asbestos and glass fibers, this
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hypothesis can be expanded to all fibrous nanomaterials including CNTs, CNFs, nanowires, nanoribbons,
and similarly high aspect ratio nanoparticles (HARNs).

1.2. Key Physicochemical Characteristics
Several key physicochemical characteristics must be well understood to address questions
regarding CNT/F toxicities including length, diameter, agglomeration state, dustiness, metal content, and
functionalization. These factors are all considered to be potential drivers of toxicities and will be explored
further in the following sections.

1.2.1. Length
Historically, length has been a key characteristic in nanoparticle toxicities. Dating back through
asbestos literature as well as nanowires, metallic nanofibers, and other HARNs, length has often been
associated as being a key driving factor in nanofiber toxicity. These same assumptions have been applied
to CNT toxicities. Numerous studies have linked CNT/F length to an increase in adverse health outcomes.
Dating back to early 2010s, Donaldson and his collaborators published a series of publications
investigating the link between particle length and toxicities in the lung and pleura of rodents. When
directly exposed to peritoneal mesothelium, longer fibers, compared to shorter, tangled fibers, were more
likely to induce greater inflammation and fibrosis in the pleural viscera, similar to previous asbestos
findings [6, 7]. Like Stanton, this research suggested that increased particle length can result in more
severe outcomes, likely due to diminished clearance capabilities. CNTs and CNFs can often be too large
for macrophage uptake resulting in incomplete or “frustrated” phagocytosis. This frustrated phagocytosis
acts as a driver for chronic inflammation and subsequent progressive pathologies and are often of note in
determining the carcinogenicity of the material [8]. Donaldson et al. investigated pathological changes in
the pleural viscera while groups such as Mercer et al. investigated changes in the lung tissue, also in rodent
3

models [6, 9, 10]. Both concluded that diminished particle uptake can be linked to the development of
fibrosis as well as lead to the formation of granulomas. Overall, particle length is an important
characteristic responsible for the progression of adverse outcomes in the lung and can be linked to
carcinogenicity, inflammation, and histopathology changes.

1.2.2. Diameter
While length is often considered to be a greater consideration regarding CNT/F aspect ratio,
diameter is still a critical factor. Thinner materials, and therefore greater aspect ratio, must be specially
considered under the fiber hypothesis. In comparison to length, the role of diameter as a driver of toxicity
outcomes in previously published literature has been less understood. In a series of publications from the
National Research Centre for the Working Environment (NRCWE) (Denmark), carbon nanotubes of
greater diameter were less likely to induce inflammation, genotoxicity, and histopathology changes
including fibrosis and the granulomatous response [11, 12]. Similarly, when comparing single-walled
carbon nanotubes (SWCNT) to MWCNTs, Mercer et al, found that SWCNTs were more fibrotic than
MWCNTs, though this difference was linked to potential changes in macrophage uptake and particle
accumulation in the alveolar interstitium [9, 10]. Macrophages had a greater capability to clear MWCNTs,
therefore reducing interstitial accumulation and associated fibrosis. Furthermore, in a paper published in
2012 by Fenoglio et al. investigated two CNTs of different diameters, 9.4 and 70 nm, and found that
thinner particles induced greater lactase dehydrogenase release, a classic marker of cell damage, increased
reactive oxygen species (ROS) production, linked to oxidative stress, and greater inflammatory cell
infiltration to the lung [13]. However, the in vivo study findings were reported 24 hours post-exposure by
aspiration to a high dose of 2 mg, which may have induced artificial bolus responses. In contrast to these
findings, Nagai et al. (2011) completed a study in which rats were exposed via intraperitoneal (i.p.)
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injection. Thinner, less rigid particles were more likely to induce a greater frequency and malignancy of
mesothelioma, as well as a lower survival rate than thicker CNTs [14].
These studies indicate that the diameter may play a role in determining toxicity outcomes, but a
lack of cohesive study design as well as the range of size differences included in the study can lead to
conflicting or unclear conclusions. A comparative study inclusive of a wide representation of particle sizes
as well as ensuring translational relevance is necessary to fully understand the role of diameter and its
influence on toxicity outcomes.

1.2.3. Agglomeration
Agglomeration of a particle can be a critical determinant in the type of response induced within
exposed tissue. CNT/Fs can form agglomerates depending on their rigidity, size, production process, and
surface chemistry. For assay purposes, both in vivo and in vitro, the preparation of the particle for dosing
can also impact particle agglomeration as a secondary, artificial effect [15].
To simplify agglomeration, two general types of agglomerates can be formed, though these
agglomerates can vary widely in shape and size. First, are spherical agglomerates. These agglomerates are
often referred to as “cotton ball-like,” “bird’s nest,” or “cooked spaghetti” in shape and their extent of
entanglement [13]. As these particles are tightly tangled together into small clusters of particle, they are
more difficult to disperse and can be as large as several microns in diameter. The second type of
agglomerates are referred to as “bundles,” “rope-like,” or “rod-like” and can also contain tangles
containing as few as just a couple of tubes together, or several together, often in parallel with one another.
These agglomerates have a distinctly measurable length and diameter, compared to spherical agglomerates
that generally only have a diameter. These can range anywhere from less than a dimeter in length, to tens
of microns in length.
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Agglomeration is of special concern when considering pulmonary deposition. Su and Cheng
completed a study using a human nasal replica and both SWCNTs and CNFs (stacked cups CNT) [16]. In
this study, the aerodynamic diameter of the particle was quantified, and the respiratory deposition of the
particle was assessed. All particles in this study were able to reach beyond the nasal passages and deposit
in at least the bronchioles of the lung, though it was indicated to be more likely that deposition of the
particles could reach the alveolar regions of the lung. Other studies have indicated that CNTs can be
deposited in the alveolar space and can be found within the alveolar interstitium [9]. Some studies have
attempted computer modeling of agglomerate sizes as a means of predicting regions of pulmonary
deposition related to agglomerate size and shape [17, 18]. Other experimental studies have also shown
evidence that agglomerate size can alter the region of deposition within the lung as well as how those
aggregates can accumulate and “stack” with one another to form aggregates of deposited particle. In an
earlier study in 2017, particle deposition related to agglomerate size had been investigated and evidence
suggested that particles of larger agglomerate size may be more likely to be deposited in the bronchi and
bronchioles prior to the broncho-alveolar duct, limiting tissue injury to airways excluding the alveolar
region [19]. For this reason, it is necessary to develop methodology to properly quantify particle
agglomeration as a means to predict regional pulmonary deposition and the associated toxicity outcomes.

1.2.4. Dustiness
Dustiness is a measurement that confers the likelihood of aerosolization of a particle, or the ability
to become airborne, and the subsequent ability for that particle, when inhaled, to bypass the nasal passages
and reach the deeper airways of the lung. Two values can be quantified per the methodology established
by Evans et al. in 2013 [20]. First, the total dustiness is fraction of the particle that can be aerosolized and
is often considered the inhalable fraction, while the respirable fraction is the portion of the total dustiness
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capable of reaching the alveolar region of the lung. Factors such as density, particle size, dimensions, and
agglomeration are all factors that contribute to particle dustiness.
Dustiness is an essential consideration when determining the likelihood of particle exposure.
Particles with decreased dustiness, and therefore less propensity for aerosolization, have a reduced
possibility of inhalation. Overall, this can reduce the likelihood of human exposures by reducing the
quantity of inhaled and respired particle both by number of particles and the mass of total particle
exposure. Furthermore, dustiness, when considered in pair with aerodynamic diameter, may be important
in determining the biokinetics of particle respiration.
Previous studies have attempted to investigate the relationship between particle dustiness and
toxicity outcomes. In the previous study by Bishop et al. (2017), two particles, both as produced and
coated with a proprietary coating (four total particles), were characterized and extensively investigated for
toxicity outcomes including genotoxicity, inflammation, and histopathology [19]. In one instance, the
coating decreased the dustiness by an order of magnitude, while the second company’s coated particle had
an increase in dustiness, also by an order of magnitude. While the coating of these particle may have
altered some outcomes such as histopathology changes, these changes were more likely to be a result of
changes in recognition by immune cells including macrophages. The region of deposition was not
significantly different regardless of dustiness, and histopathology outcomes were suspected to be due to
changes in clearance, independently of dustiness. Therefore, dustiness may not alter outcomes once
exposure has occurred, but reduction of the overall likelihood of exposure can still be beneficial to
reducing human adverse outcomes.

1.2.5. Metal Content
Several methods of CNT/F production exist, including laser ablation, arc discharge, and chemical
vapor deposition. While these methods remain useful, chemical vapor deposition methods for CNT/F
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production are most applicable for large scale, or large quantities of particle production. This method for
production allows for several adaptable parameters during production stages to alter the physicochemical
properties of CNT/F end products, including nominal diameter, nominal length, and morphology. Altering
the catalyst chemicals present, the size and shape of the catalyst, reaction times, and temperature can all
contribute to variations in generated CNT/F end products [21]. Metals are the most commonly used
catalyst in these reactions, and their use is referred to as metal loading [21]. The most commonly used
metals include cobalt, iron, nickel, and molybdenum, though metals such as aluminum, cadmium,
magnesium, manganese, and more can be employed [15, 22-24]. Due to the nature of CNT/F growth
during production, these metals often remain in the final product in detectable quantities through methods
including inductively coupled plasma atomic emission spectroscopy (ICP-AES) and thermogravimetric
analysis (TGA) to analyze residual ash [22]. Removal of these metals from the final product often requires
acid washing or other extensive measures, though this purification process comes with the less desired
result of particle surface defects, so metals typically are not fully removed to balance preservation of
particle structure with particle purity [24].
Residual metal content is of interest in several studies as these metals, particularly iron, are
hypothesized to be drivers of toxicity through oxidative stress pathways. The Fenton reaction is often
suggested as the generator of these free radicals and occurs when an iron particle is oxidized in the
presence of hydrogen peroxide to produce superoxide or hydroxyl free radicals. Free radicals are then
available to interact and interfere in numerous cell signaling cascades and have been associated with
mitochondrial dysfunction, cancer and genotoxicity, disruption of macrophage activity and phagocytosis,
and more [25-28].
One key study by Kagan et al. in 2006 investigated the potential for toxicity outcomes associated
with residual iron catalyst in SWCNTs [26]. Two materials were tested. First was the as-produced
SWCNT with an iron content of 26% by weight, and the second was the same material following acid
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washing to purify the product with an iron content of only 0.23% by weight remaining. This study
demonstrated that higher iron content did induce greater hydroxyl free radicals in an acellular model,
though when applied within a RAW 264.7 macrophage in vitro model, no superoxide radicals could be
induced by neither the purified nor the as-produced particle suggesting limited interaction of the metals
with macrophages. In another study by Pacurari et al. (2012), MWCNTs were capable of inducing
epithelial cell permeability, macrophage activation and migration, and actin filament remodeling though
mechanisms dependent upon oxidative stress responses [28].
In a recent study by Lee et al. (2020), MWCNTs with various metal content, including Mitsui-7,
were assessed for their iron content, other metal impurities, and their ROS generating abilities [29]. This
was followed with an assessment of inflammation in rat lungs at one day post-intratracheal exposure to
MWCNTs. This study found that the soluble iron content alone, nor the ROS generating potential of the
materials correlated with inflammation, the total transition metal content may serve as a predictor of
MWCNT induced inflammation. However, this study also noted that particle size may be more important
as a predictor than metal content, though together these characteristics may be useful in predicting toxicity
outcomes.
Other studies have also demonstrated limited evidence of CNTs inducing free radical production
or oxidative stress in both in vitro and in vivo systems, and even suggest that CNTs can act as free radical
scavengers [30-32]. Further research may be necessary to clarify the role of CNT/Fs in the generation of
oxidative stress and the possible mechanisms involved.

1.2.6. Functionalization
Functionalization is an alteration to the surface chemistry of CNT/Fs in order to alter their
reactivity or dispersion to optimize performance for a particularly intended application. Often, this
functionalization is designed to improve dispersion within a matrix to produce a final, cohesive composite
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product. Furthermore, this change in surface chemistry can modify its interactions with other molecules
to improve adherence and incorporation into its intended matrix or system of application. While these
modifications are often made in consideration of their intended final product, this functionalization may
also alter their interactions with biological systems following exposure.
Several key studies have attempted to investigate the role of CNT/F functionalization in relation
to toxicity outcomes. In a series of studies by the NRCWE (Denmark), CNTs with various surface
functionalization were tested including hydroxylation and carboxylation [11, 12]. However, the
functionalization was found to not always be present as reported by the production facility, suggesting
that certain modifications may have a limited time before deterioration of this surface modification. For
this reason, minimal conclusions could be drawn linking surface functionalization to toxicity outcomes.
Of note, one key question yet to be fully addressing within the literature is the stability of
functionalization over time. This functionalization may degrade during a product’s “shelf life” which may
result in interlaboratory variations depending on experimental time-dependent factors. Additionally, once
within the body or biological system, the stability of functionalization cannot be accurately determined.
Functionalization may be quickly altered or degraded within bodily fluids with various levels of acidity
or protein compositions. Overall, conflicting evidence for the role of functionalization in determining
toxicity outcomes creates the need for further research.
Other studies have been more successful in linking functionalization to toxicity outcomes. In a
study by Hussain et al. (2016), MWCNTs functionalized with hyaluronic acid were found to induce less
pulmonary inflammation, less fibrosis, and less mucosal cell metaplasia than non-functionalized
MWCNTs using both in vivo and in vitro models, suggesting that the interactions of CNTs within
biological systems can be altered with various surface modifications [33]. One other key study by Landry
et al. (2016) investigated whether surface functionalization can alter their degradation, and therefore
biopersistence, of MWCNTs in an in vitro model. This study found that particle length may also be an
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important contributing characteristic to biopersistence, though functionalization may be protective against
macrophage degradation, therefore increasing the particle’s biodurability [34]. Also, in a study by Wang
et al. 2014, as-produced MWCNTs and MWCNTs functionalized with -COOH groups were assessed for
their fibrogenic potential. This study reported that functionalization resulted in less activation of TGFβ
activation and less fibrosis in both a C57 mouse model and in vitro in a human epithelial cell line [35].
Other studies highlight that functionalization alone is insufficient and other factors must be considered
such as purification [36].
These findings suggest that functionalization with hyaluronic acid or carboxylation may play a
role in predicting toxicity outcomes, and that functionalization with carboxylation may reduce toxicity
outcomes and demonstrate that surface functionalization may both increase or decrease a particle’s
biopersistence and therefore toxicity outcomes depending on the state of altered biological interactions.

1.2.7. Summary
These physicochemical characteristics have been highlighted due to their historically noted impact
in influencing toxicity outcomes. Additional characteristics can also be considered including surface area,
density, rigidity, polyaromatic hydrocarbon contamination, and surface charge. The subsequent studies
included in later chapters include an in-depth characterization for all materials investigated in order to
elucidate the potential link between physicochemical outcomes and their ability to provoke specific
toxicity outcomes.

1.3. Four Primary Toxicity Outcome Categories
Four categories of toxicity outcomes can be highlighted in consideration of CNT/F toxicities and
include genotoxicity, inflammation, pathology, and systemic translocation. While these outcomes are
often interlinked with one another, each one stands as an individual consideration regarding adverse health
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effects. Since the early 2000s, researchers have investigated these outcomes in both in vivo and in vitro
modeling systems with a wide variety of experimental approaches, and a selection of highlighted studies
can be found in the following discussion below.

1.3.1 Genotoxicity
The genotoxic potential and carcinogenic properties of CNT/Fs are still greatly unexplored. In
2014, the International Agency for Research on Cancer (IARC) classified one material in particular,
Mitsui-7, as possibly carcinogen to humans (Group 2B), while all other CNT/Fs were categorized as not
classifiable (Group 3), indicating that there is not enough evidence to make a definitive conclusion
regarding their carcinogenicity. In the 2020-2024 Report of the Advisory Group to Recommended
Priorities for the IARC Monographs, MWCNT were listed as a high priority to be ready for evaluation
within five years [37]. This report identified a key knowledge gap in understanding the toxicities of
CNT/Fs and encouraged research teams to further investigate CNT/Fs for their genotoxic potential in order
to more accurately assess and categorize these materials.
To date, the carcinogenicity of CNT/Fs has been minimally investigated, however, several key
studies can be noted. Takagi et al. in 2008, and again later in 2012, exposed p53(+/-) mice to Mitsui-7 via
intraperitoneal injection (i.p) and quantified tumor occurrence and mortality[38, 39]. These studies found
that mice exposed to Mitsui-7 developed mesothelioma in a dose and time dependent manner.
Furthermore, several studies using rat models, including F344, Wistar, and F334/ Brown Norway hybrid
rats, found that i.p injections or intra-scrotal injections of MWCNTs, including Mitsui-7 and other
MWCNTs of various sizes and physicochemical properties, could also induce mesothelioma [14, 40, 41].
While these studies demonstrated the capabilities of MWCNTs to be carcinogenic, one key limitation was
the method of dosing. It was not until 2014 and later that several studies specifically linked inhalation
exposure to lung cancers. These studies found that inhalation exposure to MWCNTs, often using the
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aforementioned Mitsui-7, could result in increased tumor incidence and tumor burden compared to
controls in both mice (B6C3F1) and rats (F344 and F344/Crj) [42-44]. Overall, these studies demonstrated
the carcinogenic potential of MWCNTs, though most of these studies used the same infamous material.
While several of these studies linked exposure to tumor incidence, mechanisms of carcinogenicity
are also under investigation. Several key mechanistic events have been highlighted as necessary for
carcinogenicity and include disruption of the cell cycle, increased signaling for cell proliferation, oxidative
stress, changes to the tumor microenvironment, and genotoxicity [7, 28, 45-47]. Genotoxicity is of
particular interest in the following chapter. Genotoxicity is DNA damage resulting from direct and indirect
mechanisms and includes mitosis disruption, chromosomal damage, and impaired DNA repair processes.
Several studies have noted these mechanisms following CNT exposure. In 2014, Siegrist et al. reported
that exposure to MWCNTs resulting in damage to the mitotic spindle as well as increase in aneuploidy,
or abnormal chromosomal numbers, which are markers of disrupted mitosis [46]. Furthermore, this study
reported cell cycle arrest, another marker for carcinogenicity. Another hallmark of genotoxicity,
micronuclei formation (fragmentation of nuclear material), was reported by Muller et. al as early as 2008
and reported by others including Bishop et al. in 2017 [19, 48].
Together, these reports suggest that MWCNTs may be capable of inducing genotoxicity through
various mechanisms, but additional studies are necessary to elucidate these critical pathways and to
determine if all CNTs induce genotoxicity and carcinogenicity through the same mechanisms. Additional
exploration of these potential pathways as well as studies comparing more CNT/Fs within the same study
paradigm will be needed to fully understand the carcinogenic potential of CNT/Fs and properly classify
the risks associated with particle exposure.
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1.3.2. Inflammation
Inflammation is one of the most well understood outcomes of CNT/F exposure. Many studies have
demonstrated that pulmonary exposure to CNT/Fs can result in cellular injury and activation of
inflammatory cascades. Endpoints such as lactate dehydrogenase (LDH) release, inflammatory cell
infiltration, cytokine, and chemokine release, and inflammasome activation, as well as functional
outcomes such as changes in macrophage phagocytic abilities, and changes in cell proliferation and
transformation can be assessed. Several hallmark studies of CNT/F inflammation have been completed to
date and are discussed below.
The first of these studies was completed in 2005 by Muller et al. in which Sprague-Dawley rats
were intratracheally dosed with MWCNTs and subsequently underwent bronchoalveolar lavage (BAL) at
3- and 15-days post-exposure [49]. A dose dependent increase in LDH was observed. This classic marker
of cellular injury can be found when cell membrane damage results in the release of this cytoplasmic
enzyme into the extracellular space. Additionally, granulocyte accumulation as well as infiltration of
eosinophils and neutrophils was observed. The infiltration of inflammatory cells including macrophages,
eosinophils, neutrophils, and lymphocytes are also classic markers of inflammation. This study was one
of the first to compare the pulmonary toxicities of MWCNT to that of asbestos and carbon black, as well
as to consider the role of particle size in determining toxicity outcomes.
The second key study was completed in 2009 by Ma-Hock et al. and was a 90-day inhalation
toxicity study using Wistar rats [50]. The particle used in this study was the Nanocyl 7000 MWCNT, and
the authors reported increases in neutrophil infiltration and total protein content in bronchoalveolar lavage
fluid (BALF). Furthermore, pathology assessments at 24 days following the last exposure reported
inflammatory cell infiltration. This novel study was the first to implement inhalation dosing methodology
to improve translation to human studies, and to investigate the effects of MWCNTs on various regions of
the respiratory tract.
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Porter et al. (2010) is the third hallmark study of MWCNT inflammation [51]. C57 mice were
exposed to Mitsui-7 via oropharyngeal aspiration. This was also the first study to complete a thorough
dose (10, 20, 40, 80 µg) and time course (1, 7, 28, and 56 days post-exposure) study of MWCNT induced
inflammation. This study reported that while inflammation seems to peak around 7 days post-exposure as
measured in inflammatory cell infiltration, cell counts remained consistently elevated compared to
controls at the latest time point. Similar trends were also reported for LDH and albumin in the BALF.
Furthermore, dose-dependent effects were also observed at all time points in which greater doses of
MWCNT resulted in greater inflammation. This study was one of the first to report the pulmonary
toxicities of Mitsui-7, as well as to investigate inflammation in relation to dose and time.
Mercer et al. in 2013 published a 12-day inhalation study that investigated the long-term effects of
MWCNT inhalation [10]. C57 mice were exposed to Mitsui-7 and inflammation, as well as a thorough
investigation of fibrosis, was assessed at 1, 14, 84, 168, and 336 days post-inhalation, This study reported
that inflammatory BALF cell infiltration and LDH was significantly elevated at 168 days post-exposure,
with slight, but not statistically significant, elevation at 336 days post exposure. This was one of the first
to highlight the chronic inflammatory activation of MWCNTs, but to also demonstrate that inflammation
will subside over time when exposures cease.
In 2014, Sweeney et al. published a study investigating the effects of MWCNT on alveolar
macrophages [52]. Primary human alveolar macrophages were exposed to 10 µg/ml long and short
MWCNTs in vitro for 24 hours. Inflammatory cytokine release was investigated, and the authors report
that IL-6 release was significantly increased following treatment with the longer of the two MWCNTs.
Furthermore, functional changes in phagocytic capacity were assessed and found that both long and short
MWCNTs could significantly reduce the phagocytic abilities of macrophages, which has implications for
altered biopersistence of particle in the lung, as well as clearance and extrapulmonary translocation of
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tubes. This study is also notable for its contributions of linking physicochemical characteristics to toxicity
outcomes.
A couple notable papers have been published regarding the toxicities induced by carbon nanofiber
exposure. First is the study by Delorme et al. in 2012 in which Sprague Dawley rats were exposed to CNF
by inhalation for up to 90 days [53]. Cell damage, inflammation, and histopathology were assessed. This
study reported sub-chronic inflammation as well as notable histopathological changes including
pulmonary fibrosis that persisted through later time points in a dose-dependent manner.
A second CNF hallmark study was published in 2018 by Hamilton et al. which investigated the
role of CNFs in inflammation and the activation of the inflammasome [54]. Alveolar macrophages, both
mouse and human, were exposed to up to 50 µg/ml CNF and evaluated for various markers of
inflammasome activation including LDH, IL-1β, IL-18, and cell viability and proliferation. Additionally,
C57BL/6 mice were exposed to 40 µg CNF via aspiration. Markers for inflammasome activation including
LDH and cathepsin B were assessed in BALF. This study found that NLRP3 inflammasome activation
was present in all models used. This study is important for its notable use of CNF and for the investigation
of mechanisms behind the previously observed inflammatory responses, including the activation of the
inflammasome.
In conclusion, these studies through the years have shown that CNT/F are capable of inducing
potent activation of pulmonary inflammation. Cellular injury, activation of the inflammasome and other
cellular signaling cascades, and changes in phagocytic abilities can have persistent impacts and can serve
as drivers in relation to other toxicity outcomes including, histopathology alterations and translocation
and particle biopersistence. The question still remains if all CNT/F have the same inflammatory potential
as all other CNT/F, or if the cross-linked outcomes are all equally affected by changes in inflammation.
Future studies are still necessary to answer overarching questions regarding the toxicities of the broad
class of materials.]
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1.3.3. Pathology
Numerous histopathology changes can be observed in the lung following exposure to nanoparticles
that can be associated with changes in morphology of the tissue, inflammation, and changes in functional
respiratory outcomes. Several of these outcomes are discussed in detail.

1.3.3.1. Granulomatous Inflammation
Pulmonary exposure to MWCNT is known to induce granulomatous inflammation or granuloma
formation with associated fibrosis. This granulomatous response is predicted to be the result of frustrated
phagocytosis or inability to clear the particle from tissue. In order to prevent persistent tissue injury and
activation of an inflammatory response, CNT/Fs and CNT/F agglomerates are enclosed in a granuloma.
A granuloma is an encapsulating wall composed of immune cells, such as macrophages, neutrophils, and
lymphocytes, which serve as a barrier between the particle and healthy lung tissue thereby preventing
further cellular injury. Macrophages involved in these lesions are often giant, or multinucleated, or are
observed to have granular cytoplasm [55]. Granulomas often contain collagen deposits for the long-term
stability of the encapsulation and are generally considered to be permanent.
Minimal presence of granulomas can have little to no adverse health effects. However, with
increasing severity, number, and size of granulomas, diminished respiration and elasticity of lung tissue
can occur. While granulomatous lung disease if often associated with both infectious and non-infectious
causes including tuberculosis and sarcoidosis, nanoparticle driven granulomatous response has been
observed. Few studies have attempted to quantify functional changes in respiration following CNT/F
exposure in rodents, though histopathological outcomes often consider granuloma formation.
Furthermore, to date, no human studies have reported functional changes in respiration as an adverse
health outcome nor have histopathological outcomes been assessed to observe changes including fibrosis
as the latency for these changes has not yet been achieved.
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While granulomatous inflammation is often seen following CNT/F exposure, a particular note
should be made considering the route of exposure. Well-dispersed CNT/Fs dosed via inhalation methods
may not result in heavy particle or large agglomerate deposition in the lung and may not induce a
granulomatous response compared to other methods of bolus-type dosing such as oropharyngeal aspiration
[10]. The translational aspect of bolus-type dosing should be considered when extrapolating rodent
findings to human health outcomes [15].

1.3.3.2. Small airway disease and pathology
Particle induced small airway disease has been previously characterized following exposure to
mineral dusts, air pollution, and other fine particulates such as silicates and metal oxides. As these particles
are frequently deposited in the bronchi and bronchioles, pathological changes are frequently observed
including hypertrophy and hyperplasia, bronchiolitis obliterans-like changes, and fibrosis. Hypertrophy
and hyperplasia of the bronchial epithelium is a thickening of the epithelial layer of cells as both the
number of cells and cell layers present increase and the size of the epithelial cells themselves increases
[55]. This thickening occurs as a response to cellular damage and can occur with and without the activation
of inflammatory cascades and may also be linked to oxidative stress. Furthermore, bronchiolitis obliterans
like changes have been previously observed and are known to occur when a combination of pathology
changes in the bronchi and bronchioles results in a constriction of the small airways leading to potential
respiratory difficulties.
In a previous study investigating MWCNT exposure in rodents, MWCNTs that heavily deposited
in the small airways resulted in the occurrence of bronchiolitis obliterans-like changes, suggesting that the
particles themselves may serve as a direct driver of these pathologies [19]. Future research into these exact
mechanisms are still necessary. While the latency for human studies of pathology changes has not been
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reached, the additional use of rodent models can be an acceptable system for investigating these potential
outcomes.

1.3.3.3. Pathology of the alveoli and gas exchange regions
Similar to the pathology changes in the small airways, changes in the alveoli region of the lung
have also been observed following exposure to particulates, and several studies have investigated the
potential effects of CNT/Fs. Additionally, similar to observations in the bronchi, hyperplasia has been
observed in the alveoli. This hyperplasia is recognized as an increase in alveolar epithelial type II cells
and increased cell number, or hypercellularity [55]. Furthermore, alveolar histiocytosis, or an
accumulation of macrophages often presenting with foamy cytoplasm within the alveolar region, may also
occur following CNT/F exposure and is a hallmark of inflammation [19, 55]. These lesions are classic
indications of persistent cellular damage and inflammation.

1.3.3.4. Pulmonary Fibrosis
Studies have shown that exposure to MWCNT can result in fibrosis. Stimulation of resident
fibroblasts will result in increased collagen production and will be readily observed as excessive or
abnormal deposition of collagen with special stains such as Masson’s trichrome stain or picrosirius red
can result in stiffening and decreased elasticity of lung tissue and the increased thickness can increase the
distance across where gas exchange occurs resulting in difficulty expanding and contracting the lungs and
diminished gas exchange, respectively[9, 55]. Additionally, highly affected regions may also result in
atelectasis, or focal alveolar collapse.
Two distinct regions for pulmonary fibrosis are of interest for CNT/F exposure. First, bronchi and
bronchiolar fibrosis can occur the bronchi and bronchiolar epithelium. This thickening can occur when
particle deposits in these regions and stimulates fibroblast activity. Due to the branching structure of the
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terminal bronchioles and the broncho-alveolar duct, combined with their narrowing diameters, particle is
likely to deposit within this region leading to fibrosis. Bronchiolitis obliterans-like obstructions are also
commonly seen in conjunction with this fibrosis leading to the obstruction and impaired respiration in
downstream airways and alveoli. Duke et al. published a study in 2017 noting that MWCNTs that
deposited in the bronchiolar region induced a potent fibrotic response in the small airways of mice exposed
to rod-like MWCNTs at 21 days post-exposure that resulted in airway constriction [56]. Similar findings
were reported in 2017 by Bishop et al. in which mice exposed to large tangles of MWCNTs that deposited
in the small airways resulted in bronchiolitis obliterans-like pathologic alterations [19].
Furthermore, the respirable fraction of CNT/Fs can reach the alveolar ducts. As previously
mentioned, these particles can readily diffuse into the alveolar interstitium resulting in fibroblast
stimulation and subsequent collagen deposition. This thickening of the alveolar interstitium can increase
the thickness of tissue, resulting in a greater distance across where gas exchange must occur. Severe
alveolar fibrosis can lead to poor respiration. Several studies have noted the occurrence of alveolar
fibrosis. In 2010 Porter et al. completed a dose and time response study to measure pulmonary injury
following exposure to MWCNT and determined that the fibrotic response was measurable as early as 7
days post-exposure that persists through chronic time points [51].
Overall, pulmonary fibrosis is of particular concern following CNT/F exposure. Additionally,
fibrosis was of importance in the determination of the NIOSH recommended exposure limit (REL). This
REL was based upon the likelihood of developing fibrosis (early stage lung disease) as an adverse health
effect at a likelihood of 0.5-16% [57]. This outcome, in combination with genotoxicity outcomes, are of
key consideration in any future re-evaluations of the REL as well as establishing safe workplace handling
procedures.
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1.3.3.5. Pleural penetrations
Pleural penetrations are a hallmark of tissue injury often associated with asbestos exposures and
have been linked to mesothelioma outcomes. Previous studies have shown that particle dosing directly to
the pleural space can result in mesothelioma due to injury to the mesothelial cells present [14, 38, 39, 41].
Therefore, particle penetrations into the pleural space are a linked as a potential driver of particle induced
lung cancers and inflammation.
Several studies have also noted pleural penetrations following exposure to MWCNTs, particularly
following inhalation of the well-known Mitsui-7 MWCNT. Porter et al. in 2010 were the first to report
pleural penetrations as early as 12 days post exposure in mice [51]. In 2010, an additional study by Mercer
et al. used a pharyngeal aspiration model in mice to quantify the pleural penetrative capabilities of Mitsui7 [58]. This study found that penetrations occurred quickly and were seen at one day post exposure, though
these penetrations may have been subsequently cleared via macrophage mediated clearance. However,
increasing deposition of tubes in the pleural and subpleural tissue increased and accumulated as early as
28 days post-exposure.

1.3.4. Translocation
Extrapulmonary translocation to other organs including lymph nodes, liver, spleen, and kidneys
have been noted in various studies [59-61]. As previously indicated in the lung, the location of particle
deposition is important as many adverse health effects are related to the direct presence and interaction
between particle and tissue. While systemic outcomes may or may not be related to the physical presence
of tissue, the accumulation of particle in extrapulmonary tissue is an important consideration for systemic
toxicity outcomes [62, 63]. Due to possible mechanisms driven by the “systemic spill-over” effect in
which inflammation signals from the lung reach systemic circulation, extra-pulmonary inflammatory
cascades may be activated even in distant tissues, without the presence of accumulated particle [62].
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This translocation can occur through two keys mechanisms. First, independent, passive particle
translocation can occur without intervention of the immune or lymphatics system. Due to the hydrophobic
nature of CNT/Fs as well as their pointed ends, these particles can pierce and diffuse through cell
membranes allowing particles to passively enter into systemic blood circulation. Once within systemic
circulation, these tubes can eventually migrate to other organs, particularly the liver due to its high
perfusion, where particles can deposit and accumulate over time. Minimal translocation has been
previously reported to extrapulmonary tissues, those these percentages are often minimal ranging from
tenths to hundredths of a percentage of the original lung burden [64].
Second, macrophage mediated translocation occurs when macrophages and monocytes are capable
of phagocytosing particles and subsequently migrating to other regions of the body, primarily through the
lymphatic system. Within the lung, two notable regions for lymphatics flow can be identified. Lymphatic
flow can be easily found intermingling at the bronchoalveolar duct region and terminal bronchioles. This
area is also identified as a location of large blood vessels and vascularization. Second, the pleural space,
or the region between the outer wall of the lung and the inner wall of the thoracic cavity is also a region
of high lymphatic flow. Macrophage mediated translocation to the pleura was first reported by RymanRasmussen et al. in 2009 following inhalation of CNTs in mice [65]. Each of these regions will continue
flow to the local lymph nodes. Once in the lymph nodes, these particles can often be ensnared and migrate
from encapsulation in the macrophages to within resident cells of the lymph nodes. Like other organs,
these particles are likely to accumulate over time with recurrent exposures.
Several studies of note demonstrate this particle migration and extrapulmonary accumulation
following inhalation or pulmonary exposure to CNT/Fs. In 2010, Reddy et al. dosed male Wistar rats with
CNTs via intratracheal instillation [66]. This study reported extrapulmonary translocation to the kidney
and liver with associated toxicities. In 2013, Mercer et al. published two studies investigating the fate of
inhaled MWCNTs in a mouse model [10, 64]. The first study found that a significant portion of MWCNTs
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could be phagocytosed by macrophages in attempted particle clearance. The second study specifically
investigated extrapulmonary translocation of MWCNTs. Translocation to the lymph nodes was common
and accounted for over 7% of the initial lung burden of particles at one-year post-exposure. To a lesser
extent, particle was also found in the liver, kidneys, heart, brain, chest wall, and diaphragm. This study
also notes that particle accumulates in tissue over time. In an inhalation study using mice by Ingle et al,
also in 2013, Raman spectroscopy was used to follow particle translocation and found that particle can
translocate via the bloodstream where it can deposit in extrapulmonary tissues [67]. These three studies
together demonstrate that particle can translocate to extrapulmonary tissues via macrophage-mediated
transport and independent flow via the bloodstream where the particle can deposit and accumulate in
numerous other tissues. Further research is still necessary to elucidate the role of these particles directly
on systemic outcomes and to differentiate these direct effects from potential indirect effects of particle
exposure.

1.3.5. Summary
Overall, these four outcomes highlight the range and extent of health outcomes that can be altered
by pulmonary exposure to CNT/Fs. These outcomes can be readily assessed using in vitro and in vivo
model systems, though human data of these four outcomes is lacking. The latency for human research has
not yet been achieved for the assessment of most outcomes such as genotoxicity and fibrosis, and, to date,
few human studies have been completed.

1.4. Risk, Exposure, and Current Human Studies
1.4.1. Current Occupational risks, guidelines, and exposure prevention methods
Risk is the likelihood of detrimental effects to occur in a given scenario or event, and the present
study is critical to understanding the risk of harmful effects following exposure to nanomaterials,
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particularly CNT/F. Risk is a combination of two factors, the likelihood of exposure and the severity of
the potential adverse outcome. Minimizing the risk associated with CNT/F exposure is primarily
dependent upon reducing exposure to particles. During production of CNT/F, facility employees can be
exposed to dry powder materials that can be aerosolized and respired. Once in the lung, these materials
may induce the toxic outcomes previously discussed. These effects can cause irreversible pulmonary and
systemic effects that can lead to diseases such as cancer or pulmonary fibrosis.
In 2013, NIOSH published the Current Intelligence Bulletin 65: Occupational Exposure to Carbon
Nanotubes and Carbon Nanofibers in which they established a recommended exposure limit of 1 µg/m3
elemental carbon as a time weighted average for an 8-hour workday [57]. While there is no policy
enforcement of this recommendation, this limit is strongly urged to be upheld by primary and secondary
manufacturing facilities in the United States. In a recent assessment of U.S. facilities, 93% of respirable
measures across 12 facilities were below the REL of facilities maintained exposures at or below the
NIOSH REL [68]. These standards are derived from risk assessment studies that link studies of human
exposures with non-human studies including rodent studies in order to predict the threshold at which
human adverse outcomes are likely to occur.
In order to minimize risk, several steps can be taken to protect workers. The first step is elimination
and substitution to nullify the possibility of exposure. However, emerging nanomaterials, including
CNT/F, are often on the cutting edge of technology and substitutions or eliminations are not feasible. The
second step is the use of engineering controls to reduce exposure. These engineering controls include the
use of personal protective equipment such as respirators, protective eyewear, and gloves to minimize
respiration as well as alternative exposure routes such as dermal exposure. Engineering controls such as
air filtration can also be used to minimize exposures. Lastly, secondary prevention measures can be taken
to assess outcomes and consequences of exposures. Investigations including epidemiological studies and
medical surveillance can be used to detect human health consequences early. These methods together can
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be used to minimize worker exposures as well as monitor those who are exposed for adverse health
outcomes allowing for early intervention if necessary. These steps are critical for the safety and protection
of CNT/F facility workers.

1.4.2. Collaborative exposure assessments
Exposure assessments are studies completed to quantify human exposures in the workplace as well
as identify critical means or methods by which workers are most likely to be exposed. These studies can
determine if workers are exposed to levels below recommended exposure limits and determine the
respirable and inhalable fractions of CNT/F. Additionally, these studies can be used to determine which
steps in the manufacturing process are most likely to lead to exposure.
Several human exposure assessments have been completed. In one key study and follow up study,
14 U. S. facilities were assessed including companies that produce CNT/F, use CNT/F in secondary
production such as the production of composites that contain CNT/F, or a hybrid company that produces
both CNT/F and the secondary product [68, 69]. In these studies, samples of the personal breathing zones
(PBZ) for facility employees were collected to measure employee exposure to CNT/F. It was determined
that these facility employees were exposure to levels below the NIOSH REL for the respirable fraction,
but not the inhalable fraction, and PBZ samples primarily contained particle agglomerates greater than
2µm in diameter. This study raised concerns about the toxic effects of these particles as agglomerates as
well as the importance of distinguishing the respirable and inhalable fractions. Of note, these studies have
been paired with the final series of human health effects studies discussed below, and with the studies to
follow in subsequent chapters.

1.4.3. Human health effect studies
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Only twelve key studies have been published to date that attempted to directly detect or quantify
health effects following exposure to MWCNT/F in humans and have been generally completed by five
main groups. The first of these were completed by Liou et. al in 2012, and a second follow up study, also
by Liou et al. (2014) was subsequently published[70, 71]. This study investigated human health effects
from employees of Taiwanese facilities that produce various nanomaterials, and of note, only 23% of the
total exposed employees in this study were exposed to CNT/F. Blood, urine, and exhaled breather
condensates were collected from a total of 227 particle exposed employees and 137 control employees
from fourteen difference facilities. This study noted significant decreases in superoxide dismutase (SOD)
and glutathione peroxidase (GPx), in addition to increases in vascular cell adhesion molecule 1 (VCAM1) from baseline at a six-month follow-up. In the second publication reporting a four year follow up study,
similar findings were reported in addition to an increase in cardiovascular biomarkers fibrinogen, IL-6,
and intracellular adhesion molecule 1 (ICAM-1). No other significant findings were reported, including
spirometry and functional outputs.
The second of these groups was published in 2015 by Lee et al. who competed a health surveillance
study to quantify changes in blood and exhaled breath condensates of manufacturing employees [72]. This
study was able to identify three biomarkers present in exhaled breath condensates: malondialdehyde, 4hydroxy-2-hexenal, and n-hexanal levels. However, no functional changes in the respiratory abilities of
the employees were detected, and this study was limited by the number of participants (N=9 exposed
employees, and N=4 non-exposed).
The third series of publications were completed in 2016 by Fatkhutdinova et al. and Shvedova et
al. [73, 74]. The first study published quantified inflammatory markers in the blood and sputum of
MWCNT manufacturing facility employees and found an increase in markers including IL-1B, IL-4, and
TGF-β in both blood and sputum and additional increases in IL-5, IL-6, Il-8, and KL-6 in sputum. The
second publication assessed changes in non-coding RNA (ncRNA) and messenger RNA (mRNA) in the
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blood of exposed facility employees and found significant changes in pathways related to cell signaling,
proliferation, apoptosis, as well as cardiovascular regulation. These findings suggested possible
inflammatory, carcinogenic, and systemic adverse effects may occur. However, these studies were also
limited by small sample numbers (N=8-10 exposed, N=7-12 non-exposed employees).
The fourth series of publications were published between 2016 and 2018 by Vlaanderen et al.,
Ghosh et al., and Kuijpers et.al. [75-77]. These studies also relied on a relatively smaller sample number
(N=22-24 exposed workers and N=39-42 non-exposed employees). These studies also attempted to
complete follow-up assessments of the same workers to identify changes over time, though this group was
much smaller, and included ten-thirteen exposed and four-six non-exposed employees. In these studies,
immunological, respiratory, and circulating blood factors were analyzed for potential biomarkers and
changes in lung function as a consequence of respiratory exposure to MWCNTs. In the first, Vlaanderen
et al., inflammatory markers in the blood, lung function tests, and fractional exhaled nitric oxide (FENO)
were assessed [77]. Only a few markers assessed had any significant changes and included c-c motif ligand
20 (CCL20), soluble interleukin-1 receptor type II (sIL-1RII), and basic fibroblast growth factor were
increased, though control levels were quite variable. These markers also exhibited further changes in the
follow up study, though again, this was limited by small sample numbers. No functional respiratory
(spirometry) changes were observed, though FENO levels were significantly decreased in exposed
workers. Lastly, some other hematological changes were observed including decreased neutrophil counts
and increased monocyte counts in the exposed workers. Increased immature platelet counts and
reticulocyte fractions were also observed in exposed workers, though no other significant changes in the
blood samples were found.
The second publication by Ghosh et al. attempted to detect epigenetic changes in works exposed
to MWCNTs by investigating global DNA methylation and hydroxymethylation [75]. While numerous
genes were assessed for these changes, only a few sites had significant changes in methylation compared
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to non-exposed controls. These significant changes included DNA methyltransferase 1 (DNMT1), ataxia
telangiectasia mutated (ATM), SKI proto-oncogene (SKI), and histone deacetylase 4 (HDAC4) promoter,
which are genes that serve a role in the regulation of cell replication and proliferation, with potential links
to carcinogenicity.
Last in this series is a publication by Kuijpers et al., that intended to investigate cardiovascular
biomarkers associated with MWCNT exposure [76]. Of the twelve markers assessed, one marker, ICAM1, had significant changes in exposed workers in both the initial assessment and the follow-up assessment,
similar to previously reported publications. Overall, these three publications attempted to investigate
various outcomes of MWCNT exposure to consider inflammation, cardiovascular effects, and even links
to cancer. While the sample number also remains quite small, particularly in the follow-up phase of the
study, some interesting findings have emerged for consideration of human health effects.
The fifth human health effects study series was completed by close collaborators and are paired
with the previously discussed exposure assessments and the studies found in the following chapters. In
this series, over 100 exposed employees from 12 work sites were assessed, the largest sample number in
any of the human health effects studies, and four publications have been made. The first study, Beard et
al. 2018, exposed and non-exposed workers provided samples for biomarker analysis for a total of 37
blood and 36 sputum markers related to oxidative stress, fibrosis, inflammation, and cardiovascular
responses [78]. Several sputum biomarkers were of note including matrixmetalloproteinase-2 (MMP-2),
interleukin 18 (IL-18), GPx, SOD, and myeloperoxidase, and in blood, MMP-2, MMP-9,
metalloproteinase inhibitor 1, GPx, SOD, fibrinogen, endothelin-1, ICAM-1, and VCAM-1, were noted.
The second study is the previously discussed exposure assessment from Dahm et al. (2018) in
which it was reported that 18% of workers had CNTs within sputum samples, and 70% presented with
dermal exposures [68]. The third study by Schubauer-Berigan et al. (2018) investigated functional
respiratory and cardiovascular changes, allergic responses, and blood analytes [79]. Allergy responses
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were found to positively correlate with increasing years of employment in the facility as well as inhalable
elemental carbon fractions. Additionally, systolic blood pressure and resting heart rate, as well as blood
hematocrit, were noted to correlate to fine particulate matter, elemental carbon, and the number of CNT/F
structures, respectively. However, most other factors analyzed, including spirometry measurements, had
no significant outcomes, and the authors suggest the need for additional studies.
The most recent publication, also by Schubauer-Berigan et al. (2020), is the fourth publication in
this series [80]. In this study, ex vivo methodology, a TruCulture assay was used to detect biomarkers from
blood samples in response to stimuli. Regression modeling and pathway analysis was also used to
determine the relationships between other contributing factors and the identify key signaling pathways
that may have been affected or predictive of downstream health effects. Significant changes were observed
for haptoglobin, IL-1b, IL-1ra, IL-3, IL-10, IL-12p40, IL-15, IL-18, IL-23, MMP-9, stem cell factor
(SCF), tissue inhibitor of metalloproteinases 1 (TIMP1), vascular endothelial growth factor (VEGF), and
von Willebrand factor. Furthermore, pathway analysis identified several cellular and molecular processes
that may be influenced including cell-to-cell signaling and interaction, cellular growth and proliferation,
cellular development, cellular movement, inflammatory response, immune cell trafficking and
hematological system development and function. Overall, this study was able to highlight potential
changes in human health effects that may not be readily detectable by simple biomarker analysis,
suggesting undiscovered or currently unknown potential adverse human health outcomes.

1.4.4. Summary
Human studies have been limited by small sample sizes and minimal follow-up studies to assess
changes over time, though some factors such as biomarkers of oxidative stress and inflammation have
been identified. As previously mentioned, the latency for human exposures to present with adverse human
health effects has not yet been reached, and many studies have attempted to identify predictive biomarkers
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and early changes in cellular and molecular pathways that may indicate potential outcomes. However,
these limitations have resulted in a wide variety of outcomes between studies which may be influenced by
other lifestyle factors that vary between cultures and geographic locations. Future research and continued
monitoring are necessary to fully understand human health outcomes from CNT/F exposure. With
improvements in safe handling practices and minimizing human exposure risk, the likelihood of
significant and widespread effects can be minimized, though it remains critical to understand these
possible effects through advancing in vitro, in vivo, and human studies.

1.5. Conclusions and Justification of the Current Study
While the toxicities associated with pulmonary exposure to MWCNTs and CNFs have been
extensively studied, many questions are still prevalent. Are all CNT/Fs equally toxic, or should they all
have the same risk classifications? In a recent call to revise the NIOSH CIB, attention has been drawn to
the still prevalent knowledge gaps in the current understanding of the risks and adverse outcomes that may
result from MWCNT/CNF exposure. Furthermore, the recent classification of CNTs as a high priority
highlights the need for additional studies.
Current studies are often limited by their narrow focus on only a few materials such as the infamous
Mitsui-7 MWCNT. Studies that do investigate other materials with the intention to compare them directly
typically are limited to only a couple of particles. Even studies that attempt to compare a large variety of
MWCNTs side-by-side still often fail to include a diverse enough representation of the whole class of
MWCNT/CNFs such as size limitations. For example, the series of studies published by the NRCWE do
include Mitsui-7 particle, though this particle is the largest included in the study, and at only ~50-70 nm
in diameter, a significant population of particle sizes were not considered. For this reason, future studies
that are more representative of the large ranges of sizes and other characteristics are still needed.
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In addition to expanding the range of materials investigated, a multi-disciplinary approach may be
necessary to elevate these studies to answer more complex questions regarding the relationships between
physicochemical properties and the toxicity outcomes they may induce. This approach requires novel
contributions from the fields of artificial intelligence and machine learning to elucidate relationships and
meld the fields of engineering and biomedical sciences.
The expansive study in the following chapters attempts this more elegant and multi-disciplinary
approach to further understand CNT/F toxicity outcomes and their potential drivers. This study
hypothesizes that while all MWCNT/CNF are toxic, not all materials may induce the same toxicity
outcomes, and these outcomes may be dependent upon the physicochemical characteristics of the material
including, but not limited to, size dimensions, impurities and contaminants, density, dustiness and
respirability, and agglomeration. Nine materials, seven MWCNTs and two CNF, were included in this
study and encompass a large range of materials with diameters ranging from 9-150nm in diameter as
reported by their respective production facility. This study also included Mistui-7 as a benchmark material.
Eight of these materials are produced in U.S. facilities, the same facilities included in exposure
assessments and human health effects studies previously discussed as completed by collaborators,
therefore maximizing the potential for translational studies and conclusions.
In the first part of this study, these nine materials are extensively characterized and are assessed
for their genotoxic potential in human bronchial epithelial cells (BEAS-2B). The second part of the study
includes an in-depth investigation of the inflammation induced by these particles in vivo (C57 mouse
model) at both acute and chronic time points ranging from 1-84 days post exposure. Additionally,
mechanisms of inflammation are assessed in vitro (THP-1 macrophage) at a variety of doses at an acute
time point. The third part of this study is a thorough assessment of the histopathological changes that can
be induced in vivo at 84 days post-exposure as well as investigating the extrapulmonary translocation of
these particle to tissues such as the trachea-bronchial lymph node and liver. In vitro assessments using
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human fibroblasts also attempt to investigate the implementation of the fibroblast model for the
assessment of fibrosis and its possible mechanisms.
Within all three of these parts of the study, there is an additional assessment completed using
machine learning to discover the relationships between the physicochemical characteristics and the
toxicity outcomes. These correlations add additional layers to the conclusions to be drawn regarding the
classification of particles, the relationship between in vivo and in vitro models, and the links between
characteristics and outcomes. This multi-disciplinary approach expands upon the current understanding
of CNT/F toxicities and aims to eliminate the current unknowns within the field to improve knowledge of
occupational risks, health outcomes, and contribute to safety-by-design.
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2.1. Abstract:
Background: Carbon nanotubes and nanofibers (CNT/F) have known toxicity but simultaneous
comparative studies of the broad material class, especially those with a larger diameter, with
computational analyses linking toxicity to their fundamental material characteristics was lacking. It was
unclear if all CNT/F confer similar toxicity, in particular, genotoxicity. Nine CNT/F (MW #1-7 and CNF
#1-2), commonly found in exposure assessment studies of U.S. facilities, were evaluated with reported
diameters ranging from 6-150 nm. All materials were extensively characterized to include distributions of
physical dimensions and prevalence of bundled agglomerates. Human bronchial epithelial cells were
exposed to the nine CNT/F (0-24 µg/ml) to determine cell viability, inflammation, cellular oxidative stress,
micronuclei formation, and DNA double-strand breakage. Computational modeling was used to
understand various permutations of physicochemical characteristics and toxicity outcomes.
Results: Analyses of the CNT/F physicochemical characteristics illustrate that using detailed distributions
of physical dimensions provided a more consistent grouping of CNT/F compared to using particle
dimension means alone. In fact, analysis of binning of nominal tube physical dimensions alone produced
a similar grouping as all characterization parameters together. All materials induced epithelial cell toxicity
and micronuclei formation within the dose range tested. Cellular oxidative stress, DNA double strand
breaks, and micronuclei formation consistently clustered together and with larger physical CNT/F
dimensions and agglomerate characteristics but were distinct from inflammatory protein changes. Larger
nominal tube diameters, greater lengths, and bundled agglomerate characteristics were associated with
greater severity of effect. The portion of tubes with greater nominal length and larger diameters within a
sample was not the majority in number, meaning a smaller percentage of tubes with these characteristics
was sufficient to increase toxicity. Many of the traditional physicochemical characteristics including
surface area, density, impurities, and dustiness did not cluster with the toxicity outcomes.
Conclusion: Distributions of physical dimensions provided more consistent grouping of CNT/F with
respect to toxicity outcomes compared to means only. All CNT/F induced some level of genotoxicity in
human epithelial cells. The severity of toxicity was dependent on the sample containing a proportion of
tubes with greater nominal lengths and diameters.
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2.2. Introduction
The evaluation of the potential toxicity of carbon nanotubes and nanofibers (CNT/F) began in the
early 2000’s [30, 49, 81, 82]. The general outcomes of toxicity studies to date indicated that pulmonary
exposure to CNT/F was capable of inducing inflammation, fibrosis, cancer, immunosuppression, and
adverse cardiovascular and neurological outcomes in vivo [15, 42, 51, 53, 63, 83-88]. Studies of key
importance also confirmed that certain CNT/F were able to translocate from the lung to lung-associated
lymph nodes as well as systemic tissues [9, 10, 15, 64, 65]. These results raised justifiable concerns
regarding potential human health effects, especially in the occupational workforce, and prompted the need
to design and conduct epidemiological studies. While the latency needed for clinical symptoms has not
ended based upon other fiber toxicity models, as the average worker handling CNT/F has had just short
of a decade of cumulative exposure, evidence suggests exposure-related effects primarily consisting of
measures of inflammation, oxidative stress, and immunosuppression [70-73, 77-79, 89, 90]. The outcomes
were generally mild with no consistent pattern of effect among studies. Evidence of CNT/F in the sputum
was observed and a considerable number of workers, approximately 70 %, were subjected to dermal
exposure [68, 79]. The National Institute for Occupational Safety and Health (NIOSH) established a
recommended exposure limit (REL) of 1 µg/m3 as an 8-hour time-weighted average of respirable
elemental carbon, a surrogate for CNT/F, following background correction for ambient elemental carbon
[57]. Dahm et al. (2018) found that U.S. companies can, in fact, maintain the 1 µg/m3 REL, as 93 % of
respirable measures were below the REL from 214 collected samples at 12 different facilities [68],
although historically, and globally, this has not always been the case [91]. More recently, potential adverse
effects of the inhalable fraction, including airway fibrosis and bronchiolitis obliterans [19, 56], have been
recognized. The inhalable fraction was often significantly greater than the respirable fraction by 4 times
and 29% of the inhalable samples in U.S. facilities were greater than 1 µg/m 3 [68]. Recently, the
International Agency for Research on Cancer (IARC) classified one multi-walled carbon nanotube
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(MWCNT), the Mitsui-7 or MWCNT-7, as possibly carcinogenic to humans (Group 2B) [44]. There was
insufficient evidence to classify all other CNT/F. The 2020-2024 Report of the Advisory Group to
Recommended Priorities for the IARC Monographs indicates MWCNT as a high priority to be ready for
evaluation within five years [37]. In summary, 1) in vivo studies indicated a significant hazard potential
of CNT/F, 2) evidence exists of human exposure and health effect, 3) exposure can be controlled at
recommended levels, 4) reevaluation for carcinogenicity is imminent, and 5) recommendations to fill
toxicity knowledge gaps by examination of a broader class of CNT/F was warranted.
Our group recently conducted a cross-sectional study to evaluate exposure and potential associated
health effects in workers handling CNT/F [68, 78, 79, 89]. From these studies, which evaluated 12
different facilities, and the years of ongoing exposure assessment of more than 20 facilities [69, 92], it
was clear that a wide variety of CNT/F were being produced or utilized by primary and secondary
manufacturers. The production of CNT/F continues to increase, and new high-volume applications are
being evaluated, especially in the construction sector. The global CNT market is expected to grow from
approximately USD 4.5 billion to USD 10 billion by 2023 and USD 15 billion by 2026 with a compound
annual growth rate of 16 %. The primary question arising from a commercialization, industrial hygiene,
and research perspective was whether all as-produced CNT/F materials confer similar toxicity. In
controlled studies, differing physicochemical characteristics of CNT, such as length, diameter,
functionalization, or surface coating in turn altered the in vivo pulmonary toxicity profile [6, 12, 14, 19,
33, 93-100]. To date, very few studies simultaneously compared a broad class of as-manufactured CNT
and linked the relationship between physicochemical characteristics and toxicity endpoints.
In this current series of studies, with guidance from extensive facility exposure assessment [68,
69, 92], we selected six MWCNT and two carbon nanofibers (CNF), collectively termed CNT/F, either
manufactured or handled by U.S. companies, to evaluate four primary parameters of toxicity using in vitro
and in vivo studies. Specific CNT/F types were selected to be broadly representative of those to which
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U.S. workers may be commonly exposed. The parameters included genotoxicity, inflammation,
pathology, and extrapulmonary translocation. CNT/F selection was initially based on provided company
diameter. Nominal tube diameter was the simplest way to delineate samples for testing and previous
studies indicate a changing toxicity profile with increasing diameter (or rigidity) [9, 12, 93, 101]. The
selected materials ranged from 6-150 nm in diameter according to company specifications. Determining
the materials to test according to diameter, other key physicochemical characteristics also were expected
to vary, such as length (5-200 µm), thus providing a proper representation of the CNT/F material class. A
seventh MWCNT, Mitsui-7/MWCNT-7, was added as a benchmark material given the IARC
carcinogenicity classification and the large amount of historical toxicity data available for the four
parameters of interest. Of the materials selected, four MWCNT had reported company diameters smaller
than the benchmark material, and two MWCNT and two CNF had diameters larger than the benchmark
material. In the few comparative studies that examined multiple different materials, the larger diameter
materials were not evaluated [12, 93, 94].
For this section of the evaluation of CNT/F toxicities, all materials were extensively characterized,
and genotoxicity, one of the four primary parameters of toxicity, was evaluated in vitro. Analyses included
physical dimension, residual metal catalysts, dustiness, density, charge, acellular reactivity, surface area,
endotoxin and PAH impurities, thermogravimetric analysis, and hydrodynamic diameter in suspension.
Prevalence and forms of bundled agglomerates were also characterized as exposure assessment indicated
that agglomerates, not singlets or individual fibers, represent the majority of particles in personal breathing
zone samples in workplaces [92]. Human bronchial epithelial cells were treated with CNT/F to determine
cell viability, inflammation, oxidative stress, micronuclei formation, and DNA double-strand breakage.
Computational modeling was applied to physicochemical characteristics alone, and in conjunction with
toxicity outcomes. The modeling created clustering by material, as well as response, to evaluate the
relationship between physicochemical characteristic(s) and various toxicity endpoints.
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2.3. Results and Discussion:
2.3.1. Physicochemical Characterization
Seven MWCNT and two CNF (CNT/F), were arranged according to their diameter as reported by
the production facility and are referred to as MW #1-7 and CNF #1-2 (Figures 1 and 2). The arrangement
was designed as the information was readily available from the company and selecting a wide diameter
range was necessary to ensure representation of this large class of materials. Furthermore, one material,
MW #5, also known as Mitsui-7/MWCNT-7, has been commonly studied and was used as a benchmark
material for comparison. All CNT/F were extensively characterized as detailed in Tables 1-3 and Figures
1-5.
The typical representation of bundled agglomerates containing tubes/fibers with smaller diameters
materials and transitioning to more elongated bundles with tubes/fibers of increasing diameter was readily
observed (Figure 1). Also observed was the range in dimensions that could be present in each sample. For
example, MW #2 was a unique material containing two main populations, one with singlets or
agglomerates of discrete tubes and the other having highly entangled, cross-linked MWCNT with an
average diameter of 7 µm and length of 48 µm as measured by electron microscopy. In contrast, MW #7
had a highly mixed population of diameters that ranged from very thin to very thick with diameters ranging
from 9-425 nm (Table 1). All CNT/F were extensively characterized and detailed in Tables 1-3 and
Figures 1-5. Of the studies that have simultaneously examined a broad class of CNT/F, a greater proportion
of those materials were of diameters at or below MWCNT-7 (mean = 67 nm) [12, 93, 94]. We aimed to
extend those studies by encompassing MWCNT with larger diameter tubes and, additionally, by including
CNF.
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2.3.1.1. Nominal tube physical dimensions
The classic fiber paradigm links fiber dimensions and biopersistence with toxicity outcomes.
Fibers have been defined by an aspect ratio, or the ratio of particle length to diameter (or width), greater
than 3:1 with a length greater than 5 µm and a diameter less than 3 µm [15, 102]. Historically, length,
more so than diameter, has been the key consideration in understanding the toxicities induced by high
aspect ratio materials. In comparative studies, longer fiber lengths were often associated with greater
toxicities of naturally occurring or synthetic fibers [41, 103-112]. Often, materials greater than 5 µm in
length were associated with the development of mesothelioma, greater pulmonary biopersistence and
particle retention, and greater inflammatory and fibrotic responses. While longer fibers generally confer
greater toxicity, short fibers, those less than 5 µm in length, are not without toxicity [113].
The comparison of high aspect ratio CNT/F to asbestos was a natural progression [7, 15, 114, 115].
Several comparative studies assessing the effects of length and development of mesothelioma indicated
that CNT/F may have similar capabilities to induce adverse effects. General consensus among the
literature indicates that longer CNT/F particles were more likely to activate downstream inflammatory
cascades, induce fibrogenesis, interrupt macrophage clearance, and were generally more bioactive than
short or tightly bundled CNT/F [6, 7, 12, 23, 52, 54, 93, 96, 116-120]. Specific studies on CNT/F diameter,
with consistent length, have not been as extensively investigated as a determinant from toxicity outcomes
of CNT/F exposure. These studies, sometimes as a comparison of MWCNT to SWCNT, found that
increasing diameter can be associated with less toxicity than thinner fibers in terms of inflammation,
histopathology changes, alveolar fibrosis, disrupting membrane integrity, and genotoxicity, while other
studies link greater diameter to enhanced macrophage interactions, as well as greater apoptosis and
inflammation [9-14, 87, 100, 121].
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2.3.1.2. Nominal tube diameter
As previously noted, company-provided diameter was the initial segregator for deciding which
CNT/F to evaluate for toxicity to ensure broad representation of particle sizes. Preliminary evaluations by
electron microscopy of the samples also suggested that length was likely to vary with diameter, thereby
creating a good representation of the CNT/F class of materials produced and used in U.S. facilities.
To confirm the nominal tube diameters (6-150 nm) reported by the company (Table 1), the CNT/F
materials were dispersed in isopropanol and analyzed using scanning transmission electron microscopy
(STEM). Two hundred individual tubes for each material were measured and the following parameters
were determined: geometric mean, arithmetic mean, range, and median of diameters (Table 1). The
samples were further characterized by binning into specific diameter ranges (Figure 3). From STEM, MW
#1-4 had geometric means ranging from 12-20 nm (arithmetic means of 13-26 nm) (Table 1). These values
were similar to the range of company reported diameters of 6-30 nm. There was a range of 6-275 nm in
diameters but very few tubes of MW #1-4 had nominal tube diameters above 50 nm. The geometric mean
diameter of the benchmark material, MW #5, was found to be 63±1 nm (arithmetic mean of 67±2 nm)
with a range of 21-168 nm, slightly larger than previous reports of a mean of 49 nm [51] but in agreement
with other studies [38, 40, 43, 94]. MW #6-7 were larger in diameter than MW #1-4 but, on average,
smaller than MW #5 (Table 1). Interestingly, while the mean suggests materials smaller in diameter than
MW #5, the range and distribution of particles was greatest in the larger size bins (> 150 nm) for MW #67 compared to all other MWCNT (Figure 3). CNF #1 and 2 had diameter geometric means that were
similar to each other at 102±1 nm (arithmetic mean 110±3 nm) and 103±1 nm (arithmetic mean 110±3
nm), respectively (Table 1).
It was clear that the central tendency to only include the mean of the distribution of particle
dimensions, especially when evaluating MW #6 and #7, did not have enough resolution to fully
characterize and distinguish one material from another, a critical factor to understand and model toxicity
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outcomes based on material properties. The heterogeneity in diameter size distributions of the CNT/F was
assessed from the histograms in Figure 3. The 50% accumulation or cut-off point was determined by curve
fitting using the sigmoidal function and is represented by the dashed line with the nominal size value
represented by the upper x-axis. The point of 50% accumulation was rapidly achieved for MW #1-4 within
the first two bins indicating most particles were less than 25 nm in diameter. Beginning with MW #5, a
right shift can be seen, reflecting an increase in diameter. While MW #5 had a significantly larger
population of tubes around 64 nm in diameter, the distribution had a smaller range of particle widths;
virtually all particles were contained in three bins, compared to MW #6 and 7. While not large in absolute
number, subpopulations of larger diameter tubes were found in MW #6 and 7 that were not observed for
other MWCNT. CNF #1 and 2 had a similar profile and distribution. Compared to the MWCNT, the shift
in 50% accumulation towards larger size bins was more distinguished for the CNF and provided a clear
distinction from MW #1-4.

2.3.1.3. Nominal tube length
Lengths were not reported by all companies, and those reported had a range of 0.1-200 µm (Table
1). As with diameter, the nominal tube length was determined on tubes/fibers in parallel with diameter to
create paired STEM measurements. Two hundred individual tubes or fibers for each material were
measured. The summary of length measurements was presented as arithmetic mean, geometric mean,
range, median, and binning by specific diameter ranges (Table 1, Figure 4). MW #1-4 had geometric mean
lengths ranging from 0.67 – 1.41 µm (arithmetic means of 0.80-1.84 µm) (Table 1). MW #1 was the
shortest by average length followed by MW #3, with virtually all length values being segregated in the
initial bin (0-2 µm) (Figure 4). MW #5 measured much longer than MW #1-4 at 4.39±2.07 µm (arithmetic
mean of 5.62±0.29 µm) with a range of 1.2-25.8 µm. The measured length is consistent with previous
reports of MW#5/MWCNT-7 [51]. On average, MW #6-7 were shorter than MW #5 but longer than MW
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#1-4 (Table 1). The distribution of longer nominal tubes for MW #5-7 was greater than MW #1-4. CNF
#1 measured 3.64±2.36 µm (arithmetic mean of 5.23±0.36 µm) in length and CNF #2 was 2.16±2.31 µm
(arithmetic mean of 3.20±0.28 µm). The length differences between CNF #1 and 2 was notable as CNF
#2 was 40% shorter on average with virtually identical diameters. The arithmetic means of MW #5, #7
and CNF #1 crossed the threshold set by Schinwald et al. (2012) (5µm) for causing acute pleural
inflammation [110].
Nominal tube lengths were binned and depicted in histograms found in Figure 4 with the cut-off
points at 50% accumulation indicated in each case. For MW #1-4, almost all (96 %) nominal tube lengths
were concentrated in the first two size bins. The cumulative distribution of particles and the 50 % length
accumulation cut-off were shifted to the right for MW #5-7 and CNF #1-2. Overall, bulk samples
containing tubes of greater nominal length were more common in MW #5-7, and CNF #1-2, with notably
greater length particle populations in MW #5, 7, and CNF #1.

2.3.1.4. Aspect ratio
Aspect ratio was a critical measurement considered in the original fiber paradigm. In the 1970s
and 1980s, Stanton published his early work linking high aspect ratio materials, particularly glass fibers
and asbestos with increased toxicities including lung cancer incidences and mortality [111, 112]. A reanalysis of the research completed in 1980 by Bertrand and Pezerat used multiple regression analysis to
conclude that the carcinogenicity of fibers was a continuous spectrum that must include both length and
diameter, as a greater aspect ratio can be indicative of greater carcinogenicity [103]. While aspect ratio is
an inherent description of length to diameter, the values for each material, including the distribution, were
considered for toxicity outcomes.
Individual tube aspect ratio was quantified from STEM measurements as the diameter and length
measurements were paired. These measurements were as follows (Geometric Mean ± Geometric standard
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deviation, GM±GSD): 53±2, 96±2, 50±2, 76±2, 69±2, 73±2, 78±2, 36±2 and 21±2 for MW #1-7 and CNF
#1-2, respectively. MW #4-7 had a slightly higher aspect ratio compared to MW #1 and #3. CNF #1 had
a lower aspect ratio compared to all MW due to the notably larger diameter, which was even less for CNF
#2 given a similar diameter, but shorter length compared to CNF #1. As with length and diameter, aspect
ratios were binned and histograms with corresponding accumulation curves were generated and can be
found in Figure 5. All materials had a wide distribution of aspect ratios. There was a trend for the peak
aspect ratio to be from 50-100 for all materials except CNF #2. The CNF had a greater leftward distribution
with CNF #2 having a significant population of fibers with an aspect ratio of approximately 20. Due to
the differences in length, CNF #1 and 2 had notably different distributions of aspect ratios.

2.3.1.5. Two-dimensional sizing of agglomerates
Previous studies have considered the role of CNT agglomeration as a determinant of toxicity
outcome, particularly within the context of genotoxicity, macrophage recognition, the activation of
downstream inflammatory cascades, and pulmonary fibrosis [15, 56, 64, 122-124]. Rod-like and less
tangled particles, including singlets, were more likely to influence inflammation histopathology outcomes
by inducing more pulmonary fibrosis, and impact extrapulmonary translocation [10, 56, 122].
Furthermore, agglomeration patterns and size are relevant factors in human occupational exposures and
respirability [68, 69].
Using SEM images, size measurements of particle agglomerates were completed following
dispersion in our physiologic dosing medium, commonly referred to as dispersion medium (DM). We
have previously described how the sample preparation mimics collected personal breathing zone samples
of workers [19]. Representative SEM images can be found in Figure 2. Based on the dimensions, particles
in this study were categorized into two distinct groups, spherical or bundled agglomerates. Spherical
agglomerates were defined as tangles of tubes/fibers that had an aspect ratio of less than 3:1; this
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convention was adapted from earlier workplace exposure assessment studies [68]. The second category of
agglomerates was referred to as “bundles.” These bundled agglomerates were tangles of particle with an
aspect ratio greater than 3:1. These bundles varied in the number of tubes/fibers, with some having only a
couple. In sizing these structures, the major and minor axes of the bundles were reported as length and
diameter, respectively.
MW #1 and #3 were similar with spherical agglomerates composing the bulk (87% and 83%,
respectively). A second subpopulation of bundled agglomerates was present, but not dominant. Spherical
agglomerates of MW #1 averaged 0.96±2.01 µm (arithmetic mean of 1.28±0.16 µm) in diameter and MW
#3 has spherical agglomerates averaging 0.66±1.84 µm (arithmetic mean of 0.81±0.10 µm) in diameter.
Bundled agglomerates of MW #1 and #3, which represented less than 20 % of the total sample exceeding
a 3:1 dimension, had lengths under 2 µm and diameters under 0.4 µm on average.
MW #2 was a unique material that formed quite large agglomerates that were not spherical, but
rather interconnected ‘rivers’ of highly entangled cross-linked MWCNT (Figure 2). These agglomerates
were “bundled” agglomerates with a high aspect ratio and two subpopulations were distinguished (Table
2). The large bundled agglomerates averaged 49.55±3.58 µm in length and had an average diameter just
under 10 µm. The second subpopulation was found as more loosely bundled, smaller structures, likely
agglomerates of singlet tubes as compared to the entangled cross-linked MWCNT. This subpopulation
had arithmetic averages of 3.80±0.38 µm in length and 30 nm in diameter. The two populations also
highlight that the singlet nominal tube diameter and length of MW #2 was not entirely representative of
the material as it did not account for the large bundled agglomerates.
Beginning with MW #4, there was a rather dramatic transition from spherical agglomerates to
bundled agglomerates (Table 2). In fact, less than 0-4 % of any of MW #4-7 or CNF #1-2 were categorized
as spherical agglomerates using our criteria. As the materials increase in diameter, the materials become
almost exclusively small bundles and singlets that assume a more classic fiber-like appearance (Figure 2).
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The bundled agglomerates, more representative of a fiber-like appearance, were representative of the
physical dimensions. Specifically, the length of the bundled agglomerates for MW #4 and CNF #2 were
on average 50-75 % shorter compared to MW # 5-7 and CNF #1.

2.3.1.6. Hydrodynamic diameter and zeta potential
The hydrodynamic diameter, which qualitatively reflects the agglomerated state of the CNT in
aqueous solution, was evaluated using dynamic light scattering (DLS). The hydrodynamic diameter
ranged between 478 – 771 nm (Table 2). MW #4 was found to have the smallest hydrodynamic diameter,
followed by MW #5. Similar values were found for MW #1, 3, 7, and CNF #1 and 2, and MW #2 and
MW #6 had the largest hydrodynamic diameters.
Zeta potential, the electrokinetic potential at the interface of the particle surface and aqueous
solution, was evaluated by measuring the electrophoretic mobility of the particles in solution by phase
analysis light scattering. Zeta potential of a nanomaterial is indicative of its stability in a solution. Minimal
differences in zeta potential were observed between these materials (Table 2).

2.3.1.7. Surface area
Surface area has been a central measurement for ultrafine particle characterization [125]. Studies
have focused on how surface area was a primary determinant of toxicity, especially with metal oxides
[126-129]. While surface area is inversely related to nominal tube diameter and decreases with
agglomeration, the quantification of the surface area of CNT/F can pose some limitations due to their
physical structure [22, 130, 131]. For example, the interior space of variable concentric layers paired with
porosity, grooves, and other surface topography can lead to variation in measurements of surface area. A
few studies have linked increased surface area of CNT/F to more pronounced toxicity outcomes, including
genotoxicity and inflammation [12, 122, 132]. In this study, all CNT/F were analyzed using the same
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methodology, allowing for adequate comparisons between materials (Table 3). The surface areas follow
the expected relationship that smaller diameter corresponded to greater surface area on a mass-to-mass
basis. MW #1-3 had the greatest surface area. MW #4 was intermediate indicating a transition point in
physical dimensions. MW #5-7 and CNF #1 and 2 have the smallest surface area, almost an order of
magnitude less than MW #1-3.

2.3.1.8. Dustiness
Particle dustiness is a quantification of the tendency of a dry powder to aerosolize, an important
aspect for understanding the potential for human occupational exposure. Two independent measurements,
total and respirable dustiness, were simultaneously determined as previously described [20] and well
suited to characterizing these CNT/F materials. Total dustiness was the percent of the total dust (sample
using a closed face cassette) that can be aerosolized from the test sample, while the respirable fraction
(sampled with a cyclone) was the percent of the aerosolized dust that can penetrate to the deep airways,
or the alveolar region. Total dustiness may be approximated to the inhalable dustiness fraction, particularly
with these CNT/F materials [133] MW #1, #2, #5, and CNF #1 had total dustiness that ranged from 3-14
% and a respirable dustiness that ranged from 0.8-2.4 %. CNF #2 was not measured but was expected to
be very close to the values of CNF #1 and MW #5 published previously [20]. The total dustiness of MW
#3, #4, #6, and #7 ranged from 0.2-0.5 %, approximately an order of magnitude less that the other
materials. The respirable dustiness ranged from 0.08-0.20 %. The results indicate greater dustiness for
some CNT/F compared to others but not a consistent pattern with relationship to physical dimensions or
surface area.
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2.3.1.9. Density
As CNT/F mostly occur as agglomerates, the aerodynamic behavior is determined by the effective
density of the agglomerates [15]. Most CNT/F exposures are performed on a mass basis and the NIOSH
REL is based on mass concentration of elemental carbon. Given that density is directly proportional to
mass, theoretically, the lower the effective density, the more CNT/F particle would be needed for
equivalent dosing by mass. Recent computational modeling of engineered nanomaterials included density
in the analyses [80, 134, 135] with some indication it was a primary driver of toxicity [134]. Measurements
of bulk and tapped skeletal density were performed for all CNT/F (Table 3). MW #1, #3, and #4 were
comparatively denser than MW #2 and MW #5 by an order of magnitude. The remaining materials, MW
#6, MW #7, CNF #1, and CNF #2 were intermediate from the above-mentioned materials. As concluded
with dustiness, there was no apparent consistent pattern that linked skeletal density to other physical
dimensions, surface area, or dustiness.

2.3.1.10. Chemical and metal impurities
Chemical and metal impurities from the catalysts and production process were usually present at
some level in CNT/F end products. Some common metal impurities found in the CNT/F include iron,
nickel, chromium, cobalt, copper, zinc, molybdenum, and aluminum. Some of these metals such as iron
[26], nickel [136], molybdenum [137], chromium and cobalt [101] were found to influence the
toxicological profile of CNT. Thirty-one metals and chemical impurities were screened using inductively
coupled plasma atomic emission spectroscopy (ICP-AES). Most of the thirty-one metals evaluated were
below their respective analytical limits of detection (LODs). The metals that were present in one or more
CNT/F include iron (0.27-6.2%) and aluminum (0-2.2%) (Table 3). Trace amounts of cobalt,
molybdenum, zinc, nickel, manganese, lead and cadmium were in range of (0-0.17%), (0-0.05%), (00.1%), (0-0.004%), (0-0.006%), (0-0.002%) and (0-0.0005%) respectively. Most of the CNT/F currently
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used in U.S. facilities had minimum trace amounts of metal residues. Iron was a consistent catalyst ranging
from 0.27 % to 6.17 % (Table 3). MW #6 and #7 had the highest levels of residual iron catalyst. Another
metal of note was aluminum which was present in MW #3 at 2.1 % with residual amounts of 0.31 % or
less in other CNT/F (Table 3). All other metals were at levels of 0.17 % or less.

2.3.1.11. Thermal stability, degradation, and purity
Thermal stability, degradation, and purity of CNT/F was assessed using thermogravimetric
analysis (TGA). This technique analyzes change in the weight of a specimen in relation to increasing
temperature. The oxidation onset temperature, the temperature at which the oxidation of CNT/F starts, is
considered a measure of thermal stability and degradation varied across the CNT/F. The onset temperature
for the CNT/F ranged from 550-735 ºC (Table 3). The residual ash, or the content left after complete
oxidation, was evaluated to determine the purity of the CNT/F. The percentage of residual ash for MW
#1-7 and CNF 1-2 was 1.74±0.01% (means ± SD), 3.98±0.26%, 8.21±0.26%, 4.75±0.07%, 1.11±0.28%,
7.88±0.15%, 8.95±0.29%, 1.79±0.12%, and 2.21±0.16% respectively (Table 3). These values are
primarily indicative of metal content and were generally consistent with relative levels of residual metal
catalysts determined using ICP-AES. MW #3, #6, and #7 had the greatest residual ash and results are
consistent with the higher amount of metal catalyst measured.

2.3.1.12. Polycyclic Aromatic Hydrocarbons and Endotoxin
Airborne background contaminants and byproducts like polycyclic aromatic hydrocarbons (PAHs)
and endotoxin, a component of the bacterial cell wall, can be a major influence on the toxicity profile of
various engineered nanomaterial and environmental particulates [138-140]. Previous exposure and
emission monitoring at a CNF production facilities indicated the presence of PAHs with an average
concentration up to 336 μg/m3 [141]. To rule out the influence of PAHs and endotoxin, gas
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chromatography–mass spectrometry with selected ion monitoring (GC–MS SIM) and limulus amebocyte
lysate assay were performed, respectively. The levels of PAHs and endotoxin in the CNT/F were below
their LODs. The lack of endotoxin was supported by no significant induction of tumor necrosis factor-α
production (described below) from epithelial cells at the highest CNT/F dose tested.

2.3.1.13. Acellular Reactivity
Multiple physicochemical characteristics of the CNT/F including residual metal catalysts, surface
defects, functionalization, and redox active organic matter, such as quinones, will alter the reactivity of
the nanomaterial in biological matrices. This can lead to an imbalance in redox homeostasis that can
trigger oxidative stress and toxicity. The ferric reducing ability of serum (FRAS) assay was used as an
acellular screen to determine the antioxidant capacity, or the ability of CNT/F to react in biological
matrices and deplete antioxidants. This assay serves as a screen for oxidative stress and potential toxicity
[142]. Compared to untreated serum, reaction with CNT/F reduced the antioxidative capacity of serum by
65-100 % (Table 3). CNF #1 and 2 had 100 % remaining antioxidative capacity, indicating that these
materials were the lowest in their ability to independently react and induce oxidative stress. MW #1 and
MW #7, two very distinct CNT materials in terms of physical dimensions, consumed the most serum
antioxidants as indicated by the lowest remaining % antioxidative capacity. The remaining CNT ranged
from 75-91 %.

2.3.1.14. Grouping CNT/F by Principal Component Analysis of Physicochemical Characteristics
As a first step, feature selection using the Boruta algorithm was performed on three sets of
physicochemical property data for the nine different CNT/F materials: 1) detailed characterization of
length (L), diameter/width (labeled as W for figure clarity for easier distinction from L), and aspect ratio
(AR) from the binned data from Figures 3-5 (Figure 6B; L-W-AR binning); 2) standard physicochemical
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data using means only from Tables 1-3 (Figure 6C; Means only); and 3) the combination of L-W-AR and
means only data (Figure 6A; All characterization). Figure 6 displays the principal components analysis
(PCA) results for different CNT/F samples with confirmed variables of importance from the three separate
analyses (Supplemental Figure S1 A-C). It should be noted that the PCA plots did not change without
feature selection (Supplemental Figure S2). The first three principal components describe ~ 71 %, 68 %
and 82 % of the total variability among materials for the ‘all characterization’, ‘L-W-AR binning’, and
‘means only’ parameters, respectively. Most importantly, the PCA analysis of L-W-AR and all
characterization variables suggested a segregation of MW #1-4 materials from MW #5-7 and CNF #1-2
(Figure 6A-B). Overall, a combination of larger lengths and widths separated one group of materials (MW
#5-7, CNF #1-2) from the second group of materials (MW #1-4) (Figure 6A-B; Supplemental Figure S1
A-C). The categorization of MW #5-7 and CNF #1-2 together in the same group indicates common
physicochemical characteristics of these materials. However, this was not the case with PCA using
traditional variable data which were based on mean values only (Figure 6C). Often, the literature reports
only mean values without including the detailed size distributions for physical dimensions. Previous
studies proposed that providing distributions of dimensional characteristics would better segregate
different CNT/F for grouping and toxicity [101]. The difference in the material segregation between means
only compared to L-W-AR binning and all characterization suggests that varying the input parameters
will influence conclusions drawn in terms of which physicochemical characteristics may drive specific
toxicity outcomes. The variance in the PCA plots provided two initial suggestions: 1) binning of the
physical dimensions may be critical for accurate representation of the materials and potential toxicity and
2) binning of the physical dimensions without significant additional physicochemical characterization may
alone be enough to group CNT/F. The latter point agrees with the lack of a consistent pattern when
comparing surface area, density, residual metal catalyst, dustiness, etc. for the various CNT/F.
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Another important finding was that the use of L-W-AR binning alone parameters further separated
CNF #1 from CNF #2 and grouped CNF #1 together with MW #5-7 (Figure 6B). Furthermore, a closeclustering of CNF #1 with MW #6 and their overall grouping with MW #5 and #7 along with correlated
L-W-AR binning variables in the PC1 dimension, supports the notion that a greater range of sizes can be
found in CNF #1 compared to CNF #2. The PC1 dimension correlates MW #6 and CNF #1 materials with
L15, L10, Lmore, W0.1, W0.2 and W0.3 variables. Similarly, a correlation of MW #5 and MW #7 with
the variables L6, L8, L10, L25, L30, W0.15 and Wmore was also observed. Overall, these results suggest
that larger lengths and diameters separate MW #5-7 and CNF #1 from the rest of the materials investigated.
Importantly, the separation does not indicate a large fraction of the CNT/F sample has those larger
dimensions (Figure 3-4) but rather the sample contains some proportion of tubes with those specific
nominal physical dimensions.

2.3.2. In vitro Toxicity Assessment
2.3.2.1. Cell Viability
Human bronchiolar epithelial cells (BEAS-2B; selection detailed in Methods) were challenged
with the nine CNT/F at 0.024, 0.24, 2.4, and 24 µg/ml for 24 h and cell viability was assessed by measuring
the reduction of cell proliferation reagent WST-1 (Figure 7A). Dose selection and relevance is detailed in
the Methods. The lowest two doses (0.024 and 0.24 µg/ml) caused no significant change in cell viability.
The highest dose (24 µg/ml) significantly reduced viability with all the materials tested except with MW
#2. CNF #2 induced ~45% reduction in cell viability. The 2.4 µg/ml dose induced a small but significant
reduction in cell viability for MW #1-3 and CNF #1. These toxicity results are consistent with previous
results [46, 47, 143]. The IC80 for MW #1-7 and CNF #1-2 ranged from 11-43 µg/ml. Subsequent studies
of genotoxicity were done at 0.024 and 2.4 µg/ml in accordance with OECD TG487 [144] and ICH S2(R1)
[145] guidance for 80 % or greater cell viability.
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2.3.2.2. Oxidative stress
Reactive oxygen species (ROS) consisting of hydrogen peroxide, singlet oxygen, superoxide
anion, hydroxyl radical, and hypochlorous acid are constantly regulated by the cells, which is essential to
maintain homeostasis. Epidemiology studies of workers exposed to CNT/F during their manufacturing or
use in downstream applications found alterations in oxidative stress markers and antioxidant enzymes [70,
71, 78, 137]. Animal and in vitro studies using various cell types, including epithelial cells, confirmed
induction of oxidative stress with various CNT/F exposures. The response was amplified by metal
impurities and was found to be dependent on the physicochemical characteristics that influence the
reactivity, cellular internalization, and biopersistence [116, 146, 147]. In order to assess the oxidative
stress potential of the nine CNT/F, BEAS-2B cells were exposed for 24 h at concentrations of 0-24 µg/ml
and then labeled with CellROX, a non-fluorescent cell-permeant dye that fluoresces upon oxidation by
ROS. Fluorescence per cell was evaluated by flow cytometry. Only the highest dose (24 µg/ml) induced
a significant oxidative stress response for MW #4-7, and CNF #1-2 (Figure 7B). There was a trend for an
effect in MW #6-7 and CNF #1-2 at 2.4 µg/ml. The CNT/F with smaller physical dimensions (MW #1-3)
did not induce ROS even at the highest concentration tested.

2.3.2.3. Cytokines, chemokines, and growth factors
A selection of 27 cytokines, chemokines, and growth factors were assessed from cell supernatant
following exposure to 2.4 and 24 µg/ml of each of the nine CNT/F for 24 h (Figure 7C). Many of the
measured proteins were altered for most of the CNT/F tested. MW #2 exposure altered the least number
of proteins. The reduced response was likely due to the large bundled aggregate fraction (Table 2) not
having the same cellular effect as the other CNT/F. MW #6 and #7 caused the most significant changes,
especially at the lower dose evaluated, indicating these materials may be more adept at altering cellular
signaling than other materials in this study. All materials except MW #2 induced a significant increase in
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primary modulators of innate inflammation, IL-6, IL-8, IL-1β, etc., at the high dose and several at the low
dose (e.g., MW #6-7). Some molecules assessed, including IL-10, an anti-inflammatory cytokine, were
significantly reduced. FGF was increased while other growth factors measured, VEGF and PDGF-ββ,
were generally decreased. At the higher dose, suppression of certain cytokines was more evident with
MW #5-7 and CNF #1-2.

2.3.2.4. Genotoxicity
The potential for CNT/F to cause carcinogenicity is an area of active research [148, 149]. In vivo
and significant in vitro evidence suggested adverse health consequences following inhalation to CNT/F.
One material, MWCNT-7/Mistui-7, has been shown to be a complete carcinogen in rodent models, which
led IARC to designate this material as possibly carcinogenic to humans (Group 2B) [44]. All other
materials were considered as Group 3 as there was insufficient evidence to classify otherwise [115]. The
2020-2024 Report of the Advisory Group to Recommended Priorities for the IARC Monographs indicates
MWCNT as a high priority and ready for evaluation within five years [37]. While human health effects
studies have begun globally, the latency for carcinogenicity has not been reached [70-73, 77-79, 89, 90].
To date, most studies concerning the potential carcinogenicity of CNT/F have used in vitro
approaches to evaluate genotoxicity. The approach allows for a rapid screening after which detailed
mechanistic and in vivo studies can be conducted to expand initial evidence of genotoxicity. The
micronucleus assay was used to determine if CNT/F treatment results in disruption of the mitotic spindle
or chromosome breakage. This approach also allows for the simultaneous evaluation of a large group of
materials. Parallel cultures of human epithelial BEAS-2B cells were exposed to 0.024 and 2.4 µg/ml of
the 9 CNT/F, with MW#5 (Mitsui-7/MWCNT-7) serving as a documented positive control, for 24 h and
the number of cells with micronuclei were quantified (Figure 8A-B). The screening approach, including
cell type and exposure concentration, has been used previously by our group [42, 47, 143]. Viability in
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the high dose was ≥ 80%, and the low dose had ≥ 97% viability. In DM-exposed cells, few micronuclei
were detected, and background incidence was similar to previous studies [42, 47]. All CNT/F materials at
both the low and high dose induced significant increases in micronuclei number except for the low dose
of MW #2 (Figure 8B). The treatments were not significantly different from one another.
In complement, the phosphorylation of H2AX, a cellular response to repair double-strand DNA
breaks, was evaluated. Flow cytometry was used to quantify phosphorylated H2AX, or γ-H2AX. All high
dose-treated cells induced γ-H2AX except for MW #2 (Figure 8C). Increased levels of γ-H2AX were also
measured for MW #7, CNF #1 and CNF #2 for the low dose treatment. For CNF, the low and high doses
had similar effects. While measurements of γ-H2AX was considered a low priority indicator of
genotoxicity as it does not directly indicate irreversible mutations [149], the response was similar to the
micronuclei outcome.

2.3.2.5. Hierarchical clustering and PCA of the cellular outcomes
A hierarchical clustering analysis (HCA) was performed to distinguish or discriminate the BEAS2B cellular outcomes induced by CNT/F materials with varying physicochemical characteristics. HCA,
unlike model-dependent analyses such as supervised machine learning methods, is a model-free statistical
approach that makes no a priori assumptions about the class identification of data. The resulting
dendrogram from the HCA analysis of physicochemical properties of ‘all characteristics’ combined with
outcomes of the four primary in vitro assays, cell viability, cellular oxidative stress, micronuclei
formation, and γ-H2AX, is depicted in Figure 9A. Overall, the dendrogram initially divided CNT/F
exposure responses into two clusters or groups, one predominantly containing MW #1-4 together with the
control group, and the other containing MW #5-7 and CNF #1-2 (Figure 9A). HCA was also done for
outcomes in comparison to the ‘L-W-AR binning’ and ‘means only’ characterization profiles. The L-WAR binning profile produced the same two clusters (Figure 9B) as developed using all characterization
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parameters (Figure 9A). The means only HCA shifted MW #4 into the cluster with MW #5-7 and CNF
#1-2, suggesting similarities resembling more MW #6-7 than MW #1-3 (Figure 9C), indicating the input
selection of characteristics can vary the grouping in relation to toxicity outcomes. PCA results from ‘all
characterization’ combined with the four primary in vitro assay outcomes (Supplemental Figure 3A)
grouped similarly to ‘L-W-AR binning’ (Supplemental Figure 3B), producing a separation between the
two clusters. The ‘means only’ with in vitro outcomes (Supplemental Figure 3C), like the HCA
dendrogram (Figure 9C), was less clear in distinguishing groups of CNT/F.
HCA analysis was done for ‘all characteristics’ and the four primary in vitro outcomes along with
inflammatory protein production (Supplemental Figure 4). The grouping was unaltered compared to
Figure 9A except for a clearer separation in the two sub-clusters. This was evident as MW #6-7 had a
significant grouping of induced inflammatory proteins compared to MW #5 and CNF #1-2. What became
evident from Figure 9A-B and Supplemental Figure 4 was that binning of the aspect ratio data did not
segregate to any particular outcome and may be unnecessary for the HCA. To illustrate, Supplemental
Figure 5, HCA without aspect ratio binning, created the same two clusters of MW #1-4 and MW #5-7 /
CNF #1-2 for ‘all characterization’ (Supplemental Figure 5A) and ‘L-W-AR binning’ (Supplemental
Figure 5B) when considering the four primary in vitro epithelial toxicity outcomes. Within each subcluster, co-clustering between materials was also evident as all variations in HCA pulled out the two CNF
from the CNT and MW #6 and #7 clustered together even without secreted protein changes as in
Supplemental Figure 4. There were a few subtle differences in pairings between MW #1-4 and control for
the L-W-AR binning HCA compared to all characterization. As an additional step, HCA analysis was
done, without aspect ratio, to include the altered protein changes with the four primary toxicity outcomes
and the three variations in characterization parameters. Interestingly, all three scenarios (Supplemental
Figure 6A-C) now had the same two clusters, meaning the ‘means only’ HCA placed MW #4 with MW
#1-3 instead of MW #5-7 and CNF #1-2. Previously for ‘mean only’ HCA (Figure 9C), MW #4 was
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combined with MW #6-7. It was clear from Supplemental Figure 6C that the large group of induced
inflammatory proteins for MW #6-7, not seen with MW #4, altered the clustering. This series of analyses
suggests that when using ‘means only’ for physicochemical characterization, additional toxicity data may
be necessary to accurately categorize all materials in terms of epithelial cell toxicity. It also indicated that
altered inflammatory protein concentrations, at least the panel used in this study, were not necessary to
group CNT/F in terms of epithelial toxicity if binning of physical dimensions was available.
We next considered just the four primary outcomes of in vitro toxicity and protein production with
no physicochemical characteristics. The HCA analysis also grouped MW #1-4 separately from MW #5-7
and CNF #1-2 (Supplemental Figure 7). The toxicity only grouping consistently matched HCA analyses
using ‘all characterization’ or more simply the ‘L-W-AR binning’ as compared to the ‘means only’
characterization from Figure 9. The separation of oxidative stress, micronuclei formation, and γ-H2AX
from protein production when considering outcomes only (Supplemental Figure 7) further supports the
consistency of grouping when physical dimension binning was determined and analyzed without
inflammatory protein production (Supplemental Figure 4 and 6). The separation also suggests that
epithelial cell viability and inflammatory cytokine production, as assessed by the panel used, were not
primary drivers of genotoxicity.
The various analyses allowed for interpretation of which physicochemical properties drive which
epithelial cell toxicity outcomes. Three of the four in vitro outcomes evaluated, oxidative stress,
micronuclei formation, and γ-H2AX, grouped with certain physicochemical properties that were identified
in Figure 9 and Supplemental Figures 4-6 as distinguishing between the two CNT/F clusters. Bins of larger
lengths and diameters (W), including L15, L20, L25, L30, W0.1, W0.2, and Wmore, clustered with the
outcomes. Also clustering with the toxicity outcomes were bundled agglomerate singlet percentage,
length, and diameter from the two-dimensional sizing (Table 2). Inherently, that would be expected as the
increasing physical dimensions of length and diameter transition the CNT/F from a spherical agglomerate
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(e.g., MW #1 and #3) to a more elongated bundled agglomerate. Depending on the parameters for HCA,
the fourth primary outcome, cell viability, sometimes grouped with the other three toxicity variables of
importance (Figure 9B; Supplemental Figure 4), but other times did not (Figure 9A; Supplemental Figure
5 and 7), suggesting that cell viability may not always be a useful assay for determining differential
toxicity among materials. Overall, MW #1-4 materials clustered separately from MW #5-7 / CNF #1-2.
While all materials induced significant micronuclei formation (Figure 8B), when combined with γ-H2AX
(Figure 8C) and cellular oxidative stress (Figure 7B), there was a propensity for greater severity in the
cluster of materials that contained a greater proportion of tubes/fibers with larger physical dimensions,
MW #5-7 / CNF #1-2 (Figure 9). This was further supported by the fact that control samples always
clustered with MW #1-4.
Of note was the close clustering of cellular oxidative stress with γ-H2AX levels and micronuclei
formulation. This was especially evident with physicochemical variables of larger lengths and widths and
bundled agglomerate characteristics. The finding was consistent of genotoxicity through indirect oxidative
stress–related mechanisms upon exposure to high aspect ratio nanomaterials [150, 151]. Increased
oxidative stress, as a result of lysosomal damage by inefficient phagocytosis of high aspect ratio
nanomaterials, can cause double-stranded DNA damage and chromosomal aberrations leading to
micronuclei formation. γ-H2AX, an early indicator of DNA-double strand breakage and a process that
precedes the formation of micronuclei, segregated mostly with larger nominal tube/fiber diameter and
length of CNT/F. Oxidative stress responses clustered together with bundled agglomerate length support
the notion that oxidative stress due to inefficient cellular handling of aggregated particles and/or lysosomal
damage by particles of larger dimensions could be a contributing mechanism of genotoxicity, especially
for MW #5-7 and CNF #1-2.
Caution should be taken not to overstate the associations of the larger CNT/F as SWCNT have been
shown to be potent inducers of chromosomal damage [42, 45, 149]. Also, MW #1 and #3 in this study
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induced significant effects complementing a recent pulmonary exposure study of a MWCNT 7.5 nm in
diameter induced cancer [152]. Kuempel et al. concluded in a review of CNT genotoxicity studies that
there was not a straightforward relationship between length and genotoxicity, although most of the
evaluated studies had CNT length of only a few microns or less [148]. Jackson et al. (2015) and Poulsen
et al. (2016) described increased diameter as a physicochemical characteristic linking genotoxicity for the
15 and 10 MWCNT tested in those respective studies [12, 94]. Those studies represented materials similar
to MW # 1-5. The greater range of CNT/F physical dimensions in this study provided a clearer separation
of materials. Overall, all materials, from MW #1 to CNF #2, had the potential to induce in vitro
genotoxicity. When combining cellular oxidative stress and γ-H2AX with micronuclei formation and a
broad sampling of the class of CNT/F there was a general shift for greater length and diameter materials
to cluster together with some increased severity.
Many of the other physicochemical characteristics did not associate with epithelial cell toxicity
outcomes. This does not indicate a lack of importance but more the scope of the endpoints considered.
Subsequent studies will evaluate the association of the various physicochemical characteristics with
macrophage activation, fibrosis development, and translocation. It was noted that while cellular oxidative
stress consistently clustered with micronuclei formation and γ-H2AX, there was no clustering with
acellular reactivity measured by FRAS or residual metal catalyst. This indicates the residual metal catalyst
levels ranging from 0.3-6% were not the primary drivers of cellular oxidative stress compared with larger
physical dimensions. The clustering was confirmed by residual metal catalyst grouping with residual ash
measured by TGA as expected (Figure 9; Supplemental Figure 4). In conjunction with anti-oxidative
capacity (acellular oxidative stress), aspect ratio, hydrodynamic diameter, and the smaller length bins (L2
and L4) were unable to segregate materials and clustered away from all toxicity outcomes. Additionally,
density, specific surface area, zeta potential, the smaller width bins, and spherical agglomerate
measurements were also not predictive. Dustiness, while a critical factor for worker exposure assessment,
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was not predictive of epithelial cell toxicity. Cluster analysis of all the induced cytokines together with
physicochemical characteristics and toxicity outcomes measured (Supplemental Figure 4) placed the
proteins into four groups, two of which were exclusive for proteins. Most proteins did not cluster with the
physicochemical characteristics and none with the four primary biological outcomes. While significant
changes in inflammatory drivers, growth factors, and cell survival and proliferation signaling molecules
occur following CNT/F treatment in the epithelial cells, the change in these proteins did not correlate to
biological outcomes like oxidative stress and genotoxicity.

2.3.2.6. Summary
Advances in computational analysis are being applied to the almost two decades of engineered
nanomaterial research for grouping and understanding the physicochemical drivers of toxicity [80, 134,
135, 153, 154], including studies of carbon nanotubes [12, 101, 121, 155, 156]. The analyses of the data
from this study illustrate that detailed physical dimension characteristics provide a more consistent
grouping of CNT/F as compared to using only data means. In fact, analysis of binning of nominal tube
physical dimensions alone produced a similar grouping as to all characterization parameters.
Theoretically, working backwards, a predictive algorithm could be generated that allows classification of
CNT/F into distinct toxicity groups based on 200 paired length and diameter measurements. While all
materials induced micronuclei formation in human bronchial epithelial cells, when combined with
additional parameters associated with genotoxicity, there was an increase in the severity if the sample
contained some proportion of materials with larger diameters and longer nominal lengths. The population
of nominal tubes with longer length and larger diameters within a sample was not always the majority
(e.g., MW #7), meaning a significant percentage of the tubes with those characteristics was not needed for
increased severity of toxicity. The analyses indicate that a more detailed physicochemical characterization
of physical dimensions provides better understanding of the differential toxicity within a class of materials,
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implying that evaluating particle characteristic means alone may not be sufficient to accurately segregate
CNT/F for certain aspects of toxicity. Subsequent studies analyzing outcomes of inflammation,
histopathology, and translocation following CNT/F exposure will further develop clustering by
physicochemical characteristics and specific endpoint toxicity. In this study evaluating epithelial cell
toxicity, all materials induced some level of genotoxicity. However, of the CNT/F evaluated, materials
that contained a proportion of tubes with greater lengths and diameters were associated with increased
severity.

2.4. Conclusions
•

Binning of physical dimensions (length and diameter/width) offered greater resolution in terms
of grouping CNT/F based on physicochemical characteristics compared to using means only.
This was further evident when analyzing the physicochemical characteristics and epithelial cell
toxicity outcomes.

•

Binning of physical dimensions alone offered the same resolution for grouping CNT/F as using
all physicochemical characteristics suggesting the potential of reduced characterization needed
for grouping CNT/F fibers.

•

All CNT/F, with the lone exception of the highly aggregated low dose of MW #2, induced
genotoxicity. There was no difference between materials for micronuclei formation.

•

When micronuclei formation was combined with cellular oxidative stress and γ-H2AX levels,
CNT/F with increasing length and diameter grouped with slightly more toxicity.

•

Computational analysis illustrated that increasing length and diameter contribute to greater
epithelial cell toxicity. Binning of physical dimensions alone was sufficient to group CNT/F
in terms of epithelial cell toxicity. The nature of the bundled agglomerate formation, a
reflection of the physical dimensions, also grouped with toxicity outcomes.
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•

The increasing length and diameter CNT/F do not need to be the majority constituent of the
produced material. A small percentage of nominal tubes/fibers with increased length and
diameter was sufficient to alter the toxicity profile.

•

There was no consistent pattern of density, specific surface area, dustiness, residual metal
catalyst, and surface charge associating with physical dimensions or genotoxicity outcomes.

2.5. Materials and Methods
2.5.1. Materials
All CNT/F used in this study, with the exception of MW #5 (MWCNT-7/Mitsui-7/), were asproduced materials obtained from six different U. S. primary or secondary manufacturing facilities.
Occupational exposure assessments of these facilities were completed to provide insight into human
exposure risks and offer direct insight into the vast array of materials utilized [68]. MW #5 (MWCNT7/Mitsui-7/) was included in this study as a benchmark material as its toxicity profile is well-studied and
characterized (Figure 1).

2.5.2. Characterization
Length and Diameter: Tube and fiber length and diameter were measured using high resolution scanning
transmission electron microscopy as previously described [19]. Briefly, samples of CNT/F were sonicated
in isopropanol for 5 minutes. A STEM grid was dipped into the dispersed suspension and used for imaging
and analysis. Measuring tools included in the electron microscope’s software were used to determine
paired length and diameter. Length was determined by connected points at the two extremes without
following the curvature of the nanotube or nanofiber. High resolution images were collected with a Hitachi
HD-2300 STEM.
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Two-Dimensional Agglomerate Sizing: Samples of CNT/F were prepared in physiologic dispersion
medium and the dispersed samples were prepared for field emission scanning electron microscopy (FESEM; Hitachi S-4800, Tokyo, Japan). Measurements were collected using measuring tools of the
microscope’s provided software (FE-PC SEM Ver. 2.8, Hitachi High Technologies America). The largest
crosswise diameter of 75 agglomerates were measured for each material. Materials were subsequently
categorized into distinct groups of agglomeration defined as either spherical agglomerates or bundles of
fibers with one dimension greater than three times the other dimension, referred to as bundled
agglomerates. Bundled agglomerates had both a diameter and length measurement.
Aspect Ratio: Aspect ratio was calculated as the ratio of CNT/F length to diameter.
Hydrodynamic Diameter: The hydrodynamic agglomerated size of the various CNT/F dispersed in DM
was evaluated using DLS. DLS was performed on a Malvern Zetasizer Nano ZS90 (Worcestershire, UK)
equipped with a 633 nm laser at a 90o scattering angle. The DLS measurements were performed by
dispersing the CNT/F material in dispersion media. After two minutes of equilibration inside the
equipment, five measurements, each consisting of at least five runs were recorded.
Surface Area: Using Brunauer Emmet Teller (BET) methodology, the surface area of each CNT/F was
measured as described previously [22]. Briefly, samples were degassed in ultrahigh purity (UHP) nitrogen
for 30 minutes at 90 °C, and then for 90 minutes at 200 °C. The surface areas were determined by a 5point BET measurement with UHP nitrogen as the adsorbate and liquid nitrogen as the cryogen.
Zeta Potential: Zeta potentials were measured using a Nano ZS90 instrument (Malvern Instruments, UK).
Viscosity of the control medium was previously determined at room temperature using a VS-10
viscometer (Malvern Instruments) and used as the value for calculation of zeta potential. The pH of all
samples was measured using a calibrated electrode.
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Dustiness: Dustiness is a unitless measurement (mass/mass) measured using the Venturi dustiness device
as was previously described [20]. This measurement represents a percentage of total (~inhalable) and
respirable airborne mass normalized to the quantity of test powder prior to dispersion.
Density: Skeletal density of each CNT/F was determined based on ISO 23145. For tapped density, a 10
ml graduated cylinder was tared on a calibrated analytical balance and the material was added. To measure
tapped density, the container was gently tapped, and the level of the powder was recorded to the nearest
0.1 ml. The cylinder with powder was reweighed. Density was calculated as the mass of powder divided
by volume. The measurement was replicated three times for each sample and the results are expressed as
means ± standard deviation.
Metal Analysis: ICP-AES was used to measure metal content. Digestion was completed using a
microwave digestion system (MARS, CEM). Five mg of each sample and 10 ml of concentrated nitric
acid were added to the digestion vessel and were subsequently digested using the following program:
maximum power 400, 100% power, ramp 20 °C/min, 600 psi, temperature 230 °C, hold time 60 min.
Samples were then heated on a hot block to reduce the volume to 1 ml. The samples were then brought to
a volume of 10 ml using deionized water. Sample digests were analyzed according to NMAM 7300. Metal
analysis included aluminum, antimony, arsenic, barium, beryllium, cadmium, calcium, chromium, cobalt,
copper, iron, lanthanum, lead, lithium, magnesium, manganese, molybdenum, nickel, phosphorus,
potassium, selenium, silver, strontium, tellurium, thallium, tin, titanium, vanadium, yttrium, zinc, and
zirconium.
Endotoxin: Endotoxin contamination was measured using the Limulus amebocyte lysate test according to
the manufacturer’s protocol. The limit of detection was 0.1 EU/ml.
PAH: PAH levels were quantified by gas chromatography–mass spectrometry with selected ion
monitoring (GC–MS SIM) using method previously described [141]. Briefly, dry samples of CNT/F were
extracted in 10 ml methylene chloride with shaking for two minutes. The samples were extracted three
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times and the extracts were combined. The Limit of Quantification (LOQ) and Limit of Detection (LOD)
and other details were provided previously [141].
TGA: Thermogravimetric analysis (TGA) was performed to determine the residual ash contents and
thermal stability of the materials. Samples were analyzed as previously described using a Q50000IR TGA
(TA Instruments Inc., New Castle, DE) [22].
Acellular Oxidative Potential: The acellular oxidative potential of CNT/F was determined using ferric
reducing ability of serum (FRAS). Serum is a complex mixture consisting of various forms of antioxidants
that can quench chemically distinct oxidants. The oxidative potential of the CNT/F was determined by
reacting human blood serum (HBS; Sigma-Aldrich, St. Louis, MO; Cat # P2918) with CNT/F and
evaluating the decrease in antioxidants in HBS. The reduction in antioxidant capacity of the serum was
quantified by ferric to ferrous ion reduction and formation of a colored ferrous-tripyridyltriazine complex.
The decrease in antioxidative capacity in HBS was compared with Trolox, a vitamin E analog. This
modified total antioxidant capacity approach has been used to evaluate the oxidative potential of various
engineered nanomaterials [157-159].
Human blood serum was rapidly thawed and exposed to CNT/F at a concentration of 5 mg/ml in
low protein retention tubes. To properly disperse the nanomaterials, the samples were sonicated for 5
minutes. The dispersed samples were then incubated in the dark at 37 °C for three hours on an orbital
shaker set at 450 RPM. The CNT/F were removed from serum by centrifuging the mixture at 14,000 g for
three hours. 50 µl of the serum supernatant was reacted with 1 ml of the FRAS solution to quantify the
level of antioxidant depletion. The FRAS solution is a volume mixture of 10:1:1 consisting of 0.2021 g of
sodium acetic trihydrate and 1.060 ml of glacial acetic acid (Alfa Aesar, Haverhill, MA; Cat # 36289) in
100 ml of deionized water, 0.0946 g of TPTZ (2,4,6-tri(2-pyridyl)-s-triazine)(Sigma-Aldrich, Cat #
T1253) and 1.2 ml of 1M HCl in 30 ml of deionized water and 0.1635 g of FeCl3·6H2O (Sigma-Aldrich,
Cat # 44944) in 30 ml of deionized water respectively. For quantitative comparison of the level of
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antioxidant depletion, Trolox (Sigma-Aldrich, Cat # 238813) standards were prepared at concentrations
of 25-800 µM and reacted with the FRAS solution. The change in color was quantified by reading the
absorption at 586 nm.

2.5.3. In vitro Study Design and Methods
The goal of this study was to investigate the toxic effects of CNT/F on pulmonary epithelial cells.
Immortalized human bronchial epithelial cells (BEAS-2B), cells were exposed to several concentrations
of each of the nine materials. Changes in cell viability, oxidative stress, and protein production were
determined. Additionally, the genotoxicity of these materials was assessed using γH2AX detection and
micronuclei formation. The BEAS-2B cell line was selected as a non-tumorigenic cell line originally
derived from human bronchial epithelial cells immortalized by viral transfection[160]. Since their original
description, monocultures of these cells have been widely used and accepted by researchers to study
genotoxicity and potential lung carcinogenesis of test agents. The BEAS-2B cells have several advantages
that have made them suitable cell population for genotoxicity analysis. The cells have a stable karyotype
and a low background frequency of micronuclei at early passage[161-163] [45] [19] [46, 47]. These
cellular characteristics of the BEAS-2B are in accordance with the OECD guidelines as follows: “Because
the background frequency of micronuclei will influence the sensitivity of the assay, it is recommended
that cell types with a stable and defined background frequency of micronucleus formation and a stable
karyotype be used.” Previous investigations have demonstrated that the BEAS-2B cells double every 18
to 20 hours when seeded at 70% density[46, 47] [45] [162].
Correspondence to Human exposure: The experiments were performed on µg/ml basis. As the surface
area and volume required changes with the cell culture consumable used for the assays, in order to be open
and enable future comparative and meta-analysis of the data generated, we have reported the
concentrations in µg/cm2 basis alongside the µg/ml. Cellular toxicity and oxidative stress were performed
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at a range of approximately 0-15 µg/cm2 (0-24 µg/ml). Micronuclei formation and γ-H2AX were
evaluated at 0.009 and 0.9 µg/cm2, very much at the lower end of the toxicity range.
Based on Erdely et.al 2013[164], an inhalable elemental carbon mass concentration arithmetic mean of
10.6 µg/m3 (geometric mean 4.21 µg/m3) was found among workers exposed to MWCNT. The
concentration equates to a deposited dose of approximately 4.07 µg /d in a human. The in vitro exposure
of 0.009 µg/cm2, based on an human alveolar surface area of 102 m2 (1.02 x 106 cm2) [165] corresponds
to 9180 µg deposited in the human. With estimated 4.07 ug/d deposited, this would be equivalent to
exposure of approximately 2250 days. Assuming 5 days/week of work the 2250 days corresponds to ~ 9
years of exposure. The in vitro exposure of 0.9 µg/cm2 corresponds to 918,000 µg deposited in the human.
With estimated 4.07 ug/d deposited, this would be equivalent to exposure of 225000 days. Assuming 5
days/week of work the 225000 days corresponds to ~ 900 years of exposure.
CNT/F Dispersion in Cell Culture Media: Aqueous stock suspensions of CNT/F were generated by
weighing the dry powder and suspending in well-characterized dispersion medium [DM; 0.6 mg/ml mouse
serum albumin + 0.01 mg/ml 1,2-dipalmitoyl-sn-glycero-3-phosphotidyl (DPPC) in phosphate-buffered
saline (PBS) without calcium and magnesium] [166] at 2 mg/ml concentration. The stock suspension was
sonicated for 5 minutes at 70% amplitude using a cup horn sonicator (Sonics VibraCell VCX-750 with
Cup-type Sonicator; Newton, CT) immersed in continuous flowing cold water. The samples were vortexed
intermittently after every minute for 10 seconds. The stock solution at 2 mg/ml was dispersed in cell
culture media by diluting to highest test concentration i.e. 24 µg/ml. The CNT/F containing cell culture
media was then subjected to probe tip sonication (Branson Sonifer 450, continuous output) for a total of
2 minutes, with 10 second vertexing after every 30 seconds. CNT/F containing cell culture media at 0.024,
0.24 or 2.4 µg/ml were obtained by serial dilution.
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2.5.3.1. Cell culture and cytotoxicity
Human bronchial epithelial cells (BEAS-2B) were obtained from American type culture collection
(ATCC, Manassas, VA) and cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with
10 % heat inactivated fetal bovine serum (R&D Systems Inc, Minneapolis, MN) and 1% penicillin
Streptomycin (Invitrogen, Carlsbad, CA). Cells were cultured to 70% confluency in an incubator
maintained at 37 oC and 5% CO2. Trypsin-EDTA (0.25%) was used to detach the cells from the culture
flasks for sub-culturing. The cells between passage 4-10 were used and these cells had a doubling time of
18-20 hours. For evaluating the cytotoxicity, parallel cultures of cells were seeded at 46,900 cells/cm2
overnight in a 96-well plate and dosed at a concentration of 0.024, .24 or 2.4 or 24 µg/ml to the CNT/F
with MW #5 (Mitsui-7/MWCNT-7) serving as a positive control. In terms of surface area this corresponds
to 0.015, 0.15, 1.5 and 15 µg/cm2. Parallel cells cultures were exposed to CNT/F for 24 h and challenged
with fresh media containing 10 % volume/volume WST-1 cell proliferation reagent (Sigma-Aldrich, Cat
#5015944001). After 2 h of incubation the WST-1 consumption was recorded by measuring the
absorbance at 450 nm subtracted with absorbance at 660 nm to account for turbidity/background.
Cytotoxicity was evaluated by repeating the experiment on three separate days with each dose tested in
quadruplicates each day.

2.5.3.2. Oxidative stress
Intracellular ROS formation after 24 h post exposure of the CNT/F was assessed using CellROX®
Green (Invitrogen). Cells were seeded at 46,900 cells/cm2 overnight in a 24-well plate and dosed at a
concentration of 0.024, 0.24, 2.4, or 24 µg/ml of one of the nine materials tested. In terms of surface area
this corresponds to 0.012, 0.12, 1.2 and 12 µg/cm2. After 24 h of exposure to CNT/F, cells were detached
using Trypsin-EDTA, and washed and incubated with 50 µM CellROX for 20 minutes. Cells were washed
and fixed by incubating them with 10% formaldehyde in PBS. The change in CellROX fluorescence was
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captured using a BD LSR II flow cytometer (BD Biosciences, San Diego, CA). The cells were strained
through a Flowmi™ Cell Strainer (Bel-Art Products, Inc. Wayne, NJ) to achieve uniform single cell
suspensions and remove any aggregates. The mean fluorescence was determined using FlowJo (FlowJo
LLC, Ashland, OR). The experiment was performed on four separate days with each dose tested in
triplicates each day. At least 10,000 cells were analyzed per sample in each group

2.5.3.3. Protein quantification
Alteration in the proteins released due to CNT/F exposure was quantified by measuring twentyseven proteins in the supernatants after 24 h exposure to 0, 2.4 and 24 µg/ml of the CNT/F. In terms of
surface area, this corresponds to 0, 0.75 and 7.48 µg/cm2. The proteins were measured using a BIO-RAD
Bio plex Pro Human Cytokine Grp 1 Panel 27 plex (Bio-Rad Laboratories Inc, CA, Cat #
M500KCAFOY). The 27 proteins measured include cytokine FGF basic, eotaxin, G-CSF, GM-CSF, IFNγ, IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IP-10,
MCP-1 (MCAF), MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α and VEGF. These proteins are key
cytokines, chemokines and growth factors that play an important role in inflammation. The assay
sensitivities for these markers ranged from 0.1 to 33.3 pg/ml.

2.5.3.4. Double stranded DNA break
Phosphorylation of H2A histone family member X (H2AX) occurs during repair of DNA breakage
and is considered a sensitive marker for double stranded DNA breakage. Flow cytometric evaluation of
H2AX phosphorylation was performed as described earlier [167]. Cells were plated on a 12-well plate
overnight and challenged with 1.5 ml of CNT/F dispersed in cell culture medium for 24 h. The cells were
dosed with 0, 0.024 and 2.4 µg/ml of CNT/F. In terms of surface area, this corresponds to 0, 0.009 and
0.9 µg/cm2. After 24 h post exposure to CNT/F, the cells were lifted by trypsinization and fixed using
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10% formaldehyde in PBS. Cells were permeabilized with 0.2 % (v/v) Triton X-100 (Sigma-Aldrich) in
PBS for 30 minutes followed by blocking of nonspecific binding by incubating them with 1 % (w/v) of
bovine serum albumin (Sigma-Aldrich) for 1 hr. The cells were then incubated overnight with 1:50
dilution of Phospho-Histone H2A.X (Ser139) Rabbit mAb (Alexa fluor 488 conjugated) (Cell Signaling,
Beverly, MA). The cells were strained through a Flowmi™ Cell Strainer (Bel-Art Products, Inc. Wayne,
NJ) to achieve uniform single cell suspensions and remove any aggregates. Fluorescence from single cell
suspensions was captured using a BD LSR II flow cytometer (BD Biosciences, San Diego, CA). The mean
fluorescence was determined using FlowJo (FlowJo LLC, Ashland, OR). The experiment was performed
in triplicates and at least 10,000 cells were analyzed per sample in each group.

2.5.3.5. Micronucleus assay
BEAS-2B cells (>97% viability by trypan blue) were plated at 70% confluency on a two-well glass
chamber slides (Thermo Scientific Nunc Lab-Tek, Waltham, MA; Cat# 154461) overnight and challenged
with 1.5 ml of the 9 CNT/F dispersed in cell culture medium for 24 h. As outlined in previous
investigations, fresh media was added with the test agent to the cultured cells to stimulate cell proliferation.
The cells were monitored for cell rounding for 24 h following the addition of media to assure that mitosis
had occurred. Cell rounding is an accepted measure of cell proliferation because most attached cells in
culture round up when the cells enter mitosis [168]. The cells were harvested for analysis 24 h after the
addition of fresh media and test agent to avoid growing the cells to confluence. The potency of the test
CNT/F was compared to MW #5 (Mistui-7/MWCNT-7).
Parallel cell cultures were treated with 0, 0.024 and 2.4 µg/ml of the CNT/F, which included MW
#5 (Mistui-7/MWCNT-7) as a reference material known to be genotoxic. In terms of surface area, this
corresponds to 0, 0.009 and 0.9 µg/cm2. After 24 h post exposure to CNT/F, the slides were washed with
PBS and fixed with an ice-cold mixture of 3:1 methanol and acetic acid for 30 min and then stained with
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DAPI (Vector, Burlingame, CA) for nuclear content. The cells were imaged using a laser scanning
confocal microscope (LSM 780, CZ Microscopy, Thornwood, NY) using a 60x objective. The complete
depth of the cell was captured by taking Z-Sections and the 3D images were converted to 2D using
maximum intensity projection. Photographs of a minimum of 100 cells per slide were taken and the
number of micronuclei present was recorded, and the experiment was repeated in triplicate for a minimum
of 300 cells per treatment group. Two independent observers that were blinded to the treatment groups
recorded the number of micronuclei.

2.5.4. Statistical analysis
In vitro assays of cytotoxicity and oxidative stress were analyzed using one-way (particle type)
and two-way (particle type by dose) analyses of variance. Post hoc comparisons were evaluated with
Fishers LSD test. Some variables were transformed using the natural log prior to analysis to meet the
model assumptions of homogeneous variance. Significance was achieved at a p<0.05. All analyses were
carried out using SAS/STAT version 9.4 for Windows, and JMP statistical software version 12 (SAS,
Cary NC).

2.5.5. Feature selection and principal component analysis
To permit selection of the minimal number of features among all characterization and L-W-AR properties
that could potentially discriminate between each material investigated, feature selection was performed
with a random forest-based approach [169] using the “Boruta” algorithm [170] in the R statistical
environment [171]. The Boruta algorithm adds randomness to the variables in the dataset by creating
shuffled copies of all variables (“shadow features”). “Boruta” iteratively assesses if each variable has a
higher Z-score than the maximum Z-score of its shadow features. At each iteration, variables with Zscores lower than shadow features are deemed unimportant and removed subsequently by the algorithm
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to capture all the important, interesting features one might have in the dataset with respect to a dependent
variable, in this case each material itself. Then, using traditional, L-W-AR, and combined variables
retained after applying the “Boruta” algorithm, principal component analysis (PCA) was performed to
identify significant patterns that explained the majority of the variations in the physicochemical properties
among the different CNT/F materials investigated. PCA was performed using the prcomp command of
the R statistical software (R Core Team, 2016)

71

CHAPTER 2 TABLES

Table 2.1. Physical dimensions of CNT/F dispersed in isopropanol.
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Table 2.2. Hydrodynamic diameter, zeta potential, and two-dimensional sizing of CNT/F agglomerates
dispersed in physiologic dosing media.
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Table 2.3. Results of additional particle characterization of CNT/F.
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CHAPTER 2 FIGURES

Figure 2.1: Schematic of material diameter and TEM images of CNT/F. Materials selection was based
upon company reported diameter ranging from 6-150 nm in diameter to ensure a full range of materials
were included in this study and the material arrangement is depicted in the upper left corner. These
materials were identified as MW #1-7 and CNF #1-2. A well-studied benchmark material, MWCNT7/Mitsui-7, was included in this study as MW #5. Materials were dispersed in isopropanol and placed onto
a TEM grid to measure physical dimensions. Representative images of each material were selected with
scale bars representing 1 µm, 300 nm, and 50 nm from left to right.
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Figure 2.2: Representative scanning electron microscopy images of CNT/F in DM to measure twodimensional agglomerate sizes. LA = large agglomerates and SA = small agglomerates.
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Figure 2.3. Distributions of CNT/F diameter. Particles were binned according to size along the lower xaxis with frequency on the left y-axis. Additionally, percentage of accumulation is graphed on the right yaxis with the absolute diameter along the upper x-axis. The overlay line was 3 parameter sigmoidal curve
of best fit with the point of 50% accumulation indicated with dotted lines. Sizes are for particles in
isopropanol suspension.
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Figure 2.4. Distributions of CNT/F length. Particles were binned according to size along the lower x-axis
with frequency on the left y-axis. Additionally, percentage of accumulation is graphed on the right y-axis
with absolute length along the upper x-axis. The overlay line is 3 parameter sigmoidal curve of best fit
with the point of 50% accumulation indicated with dotted lines. Sizing was for particles in isopropanol
suspension.
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Figure 2.5. Distributions of CNT/F aspect ratio. Particles were binned according to size along the lower
x-axis with frequency on the left y-axis. Additionally, percentage of accumulation is graphed on the right
y-axis with absolute aspect ratio along the upper x-axis. The overlay line is 3 parameter sigmoidal curve
of best fit with the point of 50% accumulation indicated with dotted lines. Sizing was for particles in
isopropanol suspension.
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Figure 2.6. Principal component analysis (PCA) of different CNT/F materials comparing ‘all
characterization’ parameters (A), length – diameter – aspect ratio physical dimension (B; L-W-AR
binning) and means only (C) physicochemical characteristics. The first two principal components (PC),
PC1 and PC2, define the x- and y-axes of the scatter plots, respectively. The distance between two
materials reflects the proximity in physicochemical properties between them. PC1, PC2 and PC3 together
accounted for ~71%, 68% and 82% of the contribution to the variance in the case of all characterization,
L-W-AR binning and means only, respectively. The scatter plot of the PCA along with vectors depicting
the loadings of variables is shown.
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Figure 2.7. Toxicity assessment of BEAS-2B cells exposed to CNT/F. (A) WST-1 cell proliferation assay
was used to assess the viability of BEAS-2B cells following exposure to increasing concentrations (0.02424 µg/ml) of CNT/F. The dose at which the particle significantly reduced cell viability is indicated with
an asterisk (p<0.05). (B) Oxidative stress was measured using the CellROX assay. * p<0.05 fold change
vs. control cells represented as a reference line. (C) Protein secretions from cells exposed to 2.4 or 24
µg/ml of various CNT/F for 24 h represented as heat maps of fold change from controls with no exposure.
Significant changes from control cells were indicated with an asterisk (* p<0.05). Log fold change was
represented by color with green indicating a decrease in protein concentration and red indicating an
increase on a scale of -0.2 to 1. (*p<0.05).
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Figure 2.8. Genotoxicity assessments. (A) Cells with micronuclei were quantified and presented as
percentage of total cells at treatments of 0.024 and 2.4 µg/ml. (B) Inference into double stranded DNA
breaks were quantified via detection of γH2AX. Percentage change from DM is presented on the y-axis.
*p<0.05 represents significant change from control.
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Figure 2.9. Clustering of physicochemical characteristics with the epithelial cell toxicity outcomes of cell
viability, cellular oxidative stress, γH2AX and micronuclei formation. Toxicity outcomes compared to
(A) all characteristics, (B) L-W-AR binning, and (C) means only were presented.
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CHAPTER 2 SUPPLEMENTARY TABLES AND FIGURES
Supplementary Table 2.1 Supernatant protein concentrations following CNT/F exposure in BEAS-2B
cells
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Supplementary Table 2.1 Continued
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Supplementary Figure 2.1 Variable importance plots for all characterization (A), L-W-AR binning (B),
and means only (C)
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Supplementary Figure 2.2 Principle component analysis plots without feature selection plots for all
characterization (A), L-W-AR binning (B), and means only (C)
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Supplementary Figure 2.3 Principle component analysis results from all characterization (A), L-W-AR
binning (B), and means only (C) combined with the four primary in vitro outcomes
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Supplementary Figure 2.4 Hierarchical cluster analysis for all characterization and the four primary in
vitro outcomes along with inflammatory protein production
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Supplementary Figure 2.5 Hierarchical cluster analysis without aspect ratio inning for all
characterization (A) and L-W-AR binning (B) when considering the four primary in vitro epithelial
toxicity outcomes
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Supplementary Figure 2.6 Hierarchical cluster analysis without aspect ratio inning for all
characterization (A), L-W-AR binning (B), and means only (C) when considering the four primary in vitro
epithelial toxicity outcomes and protein changes
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Supplementary Figure 2.7 Hierarchical cluster analysis (A) and principle component analysis (B)
without aspect ratio binning for the four primary in vitro epithelial toxicity and protein production only
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3.1. Abstract
Background: Pulmonary exposure to carbon nanotubes or nanofibers (CNT/F), known to induce
inflammation, toxicity, or tumorigenesis, is a concern during production and dry powder handling. CNT/F
represent a large class of materials and it is unclear if all confer similar toxicity. Our aim was to
simultaneously assess pulmonary inflammation induced by CNT/F with variable physicochemical
properties obtained from U.S. facilities. Cytotoxicity and inflammation were assessed in mice 1, 7, 28,
and 84 d following oropharyngeal aspiration to 4 or 40 µg of one of nine CNT/F (MW #1–7 and CNF #1–
2). In complement, inflammasome activation and mechanisms of inflammation were assess in vitro in
human THP-1 macrophages, and computational modeling was used to investigate the relationships
between physicochemical characteristics and toxicity outcomes.
Results: Lactate dehydrogenase (LDH) activity, a marker of cytotoxicity, was dose-dependently increased
in bronchoalveolar lavage fluid (BALF) resolving toward baseline by 84 d in all groups. In materials with
a diameter greater than or equal to 50 nm, LDH was persistently increased. Polymorphonuclear cell
infiltration (%PMN), a marker of inflammation, was increased in all materials at 1 d post-exposure to 40
μg (<50 nm: 31.1%, ≥50 nm: 37.1%). With exposure to materials less than 50 nm, PMN influx mostly
resolved by 7 d while materials greater than or equal to 50 nm induced persistent inflammation (7 d: <50
nm: 10.5%, ≥50 nm: 48.9%). For complement, inflammatory gene expression in lung tissue (e.g., Il-1b,
Il-6, Ccl22, Cxcl2) and protein levels in BALF (e.g. Il-1b, Il-6, Il-5, Ccl22, Cxcl1), were elevated to a
greater extent in materials with a nominal tube diameter greater than or equal to 50 nm These findings
correlate with in vivo findings.
Conclusion: All CNT/F induced pulmonary inflammation, though more severe and more persistent
inflammation was associated with materials containing subpopulations of tubes with greater nominal tube
diameters and lengths.
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3.2. Introduction
Over a decade of research has been competed investigating the potential adverse health effects
following respiratory exposure to carbon nanotubes and carbon nanofibers (CNT/F). These studies have
consistently demonstrated that CNT/F could induce pulmonary inflammation, fibrosis, and more recently
genotoxicity and cancer [9, 11, 49, 51, 162, 172, 173]. Adverse systemic effects of the immune, nervous,
and cardiovascular systems following a pulmonary have been reported[63, 85, 87, 88, 121]. Additionally,
CNT/F can exit the lung either as small bundles or singlets and deposit in systemic organs [60, 64]. While
a multitude of outcomes have been investigated, minimal correlations between physicochemical
characteristics and toxicity outcomes have been elucidated while simultaneously evaluating a broad
spectrum of CNT/F. Even fewer studies connect human occupational exposure with laboratory-based
experimental approaches. Human exposure-informed design of in vivo and in vitro experimental
approaches allows for better extrapolation of potential human health concerns.
Knowledge of human health outcomes of CNT/F exposure are currently limited as the latency for
adverse chronic outcomes has not been reached due to the relatively young field of CNT/F large-scale
manufacturing. In fact, biomarkers of exposure and effect, especially for inflammation, were minimal and
inconsistent [73, 76-79]. More sensitive measures have been necessary to evaluate human exposure [89].
For this reason, studies using in vivo and in vitro modeling systems have become necessary to understand
and predict exposure risks. Historically, many of these studies have frequently investigated a single
material. The exposure science of CNT/F suggested varying physicochemical characteristics of the broad
class of CNT/F [68, 69, 133].
The International Agency for Research on Cancer (IARC) has only classified Mitsui-7/MWCNT7 as possibly carcinogenic to humans (Group 2B) while also classifying all other CNT/F as having
insufficient evidence of carcinogenicity (Group 3) [115]. This lack of evidence regarding the
carcinogenicity of CNT/F has sparked the need for more in-depth studies as well as study designs that
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include a sampling of materials with a broader representation of physicochemical characteristics.
Furthermore, IARC has issued their 2020-2024 Report of the Advisory Group to Recommend Priorities
for the IARC Monographs which suggests that MWCNT are a high priority and should be ready for
evaluation within five years [37].
In 2000, and again revisited in 2011, Hanahan and Weinberg established their theory of the
hallmarks of cancer, which are the biological processes that are altered during tumor formation [60, 174,
175]. One these hallmarks, inflammation, has been investigated for its role in carcinogenesis. Mitsui-7 is
known to induce chronic inflammation, though it is unclear if all CNT/F induce the same inflammatory
mechanisms or are equally persistent and potent inflammatory drivers.
Inflammation alone is not the only hallmark of carcinogenicity, and cancer is not the only toxicity
outcomes of CNT/F of concern. Understanding the four key toxicity outcomes including genotoxicity,
inflammation, histopathology, and extra-pulmonary translocation, and their relationships with one
another, is necessary to fully realize the risks associated with respiratory exposure to CNT/F.
The aim of this study was to generate and accurate and effective safety profile of numerous CNT/F
of varying physicochemical characteristics in conditions that best represent occupational exposure. Using
an extensive in vivo toxicity assessment of nine different materials, seven MWCNTs and two CNF, we
investigated the inflammation and cytotoxicity induced by these materials at both acute and sub-chronic
post-exposure time points as well as two doses, 4 and 40 µg. Furthermore, in vitro assessments were
completed to further investigate the mechanisms by which these materials induce inflammation and
cellular injury. Computational modeling was also incorporated to fully assess the relationships between
particle physicochemical characteristics and in vitro and in vivo toxicity assessments.
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3.3. Results and Discussion
The nine materials used in this study were selected to represent a broad spectrum of
physicochemical characteristics. Seven MWCNT and two CNF (CNT/F), which included the benchmark
material, Mitsui-7/MWCNT-7 (MW #5), were arranged according to their diameter as reported by the
production facility and are referred to as MW #1–7 and CNF #1-2. The details of this characterization was
previously published and can be found in the supplementary data (Supplementary Tables 1-3,
Supplementary Figures 1-2) [176]. In the previous study in this series, principle component analysis and
hierarchical clustering were used to determine the key role of particle size dimensions as a means of
grouping [176]. It was determined that the means of length, diameter, and aspect ratio alone were
insufficient for grouping CNT/F, and a fuller, more detailed understanding of the sub-populations of
particle dimensions was necessary. Furthermore, this study investigated the link between these
physicochemical characteristics and genotoxicity and found that CNT/F with notable sub-populations of
greater nominal tube diameter and length induced more severe genotoxicity than materials with more
homogenous populations of smaller diameters and lengths. For the current study, in vivo assessments were
evaluated to compare differences in lung injury, lung inflammation, and translocation and which
physicochemical characteristics contributed to those outcomes. Further, complementary assessments in
vitro addressed comparability to the in vivo setting with the potential elucidation of mechanisms driving
those toxicities.
In vivo dosing in the current study has been optimized to correlate to human workplace exposures
previously assessed [68, 69, 92]. Previously we have documented the importance of integrated exposure
and toxicity assessments for representative laboratory-based toxicity study design [19]. The ability to
accurately represent material characteristics from a worker exposure aids in providing the proper context
to address potential human health effects. As previously demonstrated for different CNT materials
dispersion methods were designed to replicate the agglomeration size and particle dispersion that is
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commonly observed in the personal breathing zone samples taken from facility workers [19].
Supplemental Figure 3 illustrates representative images of personal breathing zone samples paired with
images of the same material dispersed in physiologic dosing media used for toxicity evaluations.
Additionally, the doses in the current study were selected to represent human exposures. The lower dose
was selected due to its correlation to human occupational exposure. This 4 µg dose correlates to the
cumulative deposited dose of approximately 7.6 years spent working in in a facility at average workplace
exposures [164]. The 7.6 years also represents a good approximation of the current state of the workforces
in terms of average years working in a CNT/F facility. Previous studies have shown that a higher dose of
40 µg was necessary to induce pathological changes, significant pulmonary injury and inflammation, and
systemic effects for the reference material, MW #5/MWCNT-7/Mitsui-7.

3.3.1 In vivo toxicity assessments
For evaluation of toxicities in vivo, male C57BL/6J mice were exposed to 4 or 40 µg of CNT/F or
DM via oropharyngeal aspiration. Mice were euthanized at one of four time points: 1, 7, 28, and 84 days
post-exposure. These exposures were completed in a block design with a total of 12 sets of mice divided
into two groups. A schematic demonstrating the dosing timeline can be found in Supplemental Figure 4.
Bronchoalveolar lavage was performed on the first group of mice to quantify inflammation using markers
such as polymorphonuclear (PMN) cell infiltration, lactate dehydrogenase release, and changes in
inflammatory protein levels. In the second group of mice, tissue from the right lung was collected and
frozen to evaluate changes in inflammatory gene expression. The entirety of dosing and tissue collection
occurred within a 12-month window. Consistency of dosing and data collection across this expansive time
window was achieved as later demonstrated within the statistical analysis.
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3.3.2. Macrophage handling of CNT/F
At 7 d post-exposure, macrophages collected from bronchoalveolar lavage fluid (BALF) were
isolated and imaged using scanning electron microscopy (SEM). Representative images are shown in
Figure 1. Depending on particle size and agglomeration, macrophage uptake was variable. Macrophages
from mice exposed to materials of smaller physical size and agglomerates, such as MW #1 and #3, were
imaged as intact cells that are presumed to be able to easily engulf smaller particles and agglomerates
(Figure 1A, C). While not visible in SEM images, light microscopy images of macrophages from BALF
were seen to contain black agglomerates of particle (Supplementary Figure 5). MW #2 was most
commonly present in large agglomerates that are too large for phagocytosis (Supplemental Table 2; Figure
1B). Macrophages can be found adhering to the large agglomerates demonstrating some cellular
interactions. MW #4 is a transition material that has some agglomerates small enough to be phagocytosed,
as seen encapsulated in a presumably dying cell as well as in light microscopy images (Figure 1D,
Supplementary Figure 5D). Beginning with MW #5, CNT/F have length populations that becomes
difficult for macrophages to phagocytose, as seen in MW #5 (Figure 1E-I). Some materials have
subpopulations that are impossible to phagocytose resulting in the potential for diminished clearance,
persistent cellular injury, and increased inflammatory activation. This encumbered particle uptake is
further supported by images of BALF macrophages taken using standard light microscopy
(Supplementary Figure 5E-I).
Mercer et al. in 2011 commented on the macrophage uptake of MWCNTs compared to singlewalled carbon nanotubes (SWCNTs) [9]. As SWCNTs only have one wall, these tubes are drastically
smaller in diameter compared to many MWCNTs. The findings in the 2011 study suggest that there is a
lower limit regarding macrophage uptake. It can be hypothesized that SWCNTs are too small to engage
macrophage recognition and response in comparison to MWCNTS resulting in only 10% macrophage
uptake of SWCNTs, vastly reduced compared to 70% of MWCNT uptake. Of further note, in 2013 Mercer
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et al. also commented that MWCNTs dosed via bolus aspiration compared to inhalation had greater
macrophage uptake [10]. As bolus dosing results in more heavily agglomerated particles, these findings
suggest that agglomerate size will also influence macrophage response. Our findings support that
macrophage uptake occurs when particles are large enough to engage macrophage recognition but are not
too large that uptake cannot occur due to the size constraints of the cell.

3.3.2. Pulmonary Response
3.3.2.1. One day post-exposure
Lactate dehydrogenase (LDH) is a cytosolic enzyme that can be measured in BALF to quantify
cytotoxicity. CNT/F were suspected to induce cytotoxicity at this time point by piercing and damaging
cell membranes. At 1 d post exposure, LDH was increased dose dependently (Supplementary Figure 6A).
This was expected following bolus dose administration. MW #5-7 and CNF #1-2 low dose exposures also
induced a significant increase in LDH suggesting more cytotoxicity at lower deposited doses as the
physical dimensions increase in size.
As an additional measurement of inflammation, inflammatory cell infiltration was quantified.
Inhalation of CNF/F can result in injury to the epithelium and inflammasome activation of responding
alveolar macrophages, leading to cytokine and chemokine production and the subsequent infiltration of
inflammatory cells (Supplementary Figure 6B; Supplemental Table 4). Polymorphonuclear cells (PMN),
specifically neutrophils, were increased in all treatment groups at 1 d post-exposure. Eosinophils, another
type of PMN, were significantly increased in all groups except low doses of MW #1-3.
The relative fold change of mRNA expression for several genes were measured and represented
as a heat map compared to DM (Supplementary Figure 7; Supplementary Table 5). The specific panel of
genes measured included: Il-1b, Il-6, Ccl2, Ccl22, Cxcl2, Spp1, Mt1, Mt2, and Hmox1. Il-6 and Il-1b are
acute inflammatory markers, with Il-1b associated with activation of the inflammasome. Activation of
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these genes at early time points indicate cellular injury and increased inflammation acutely post-exposure.
Ccl2 is a monocyte chemoattractant to signal for the infiltration of inflammatory cells to the site of injury.
Ccl22 is a macrophage derived pro-inflammatory cytokine implicated in the promotion of persistent
inflammation and a biomarker linking inflammation and pathology of CNT/F exposure [155, 156]. Cxcl2
is a potent neutrophil chemoattractant. Increases in these genes indicate that pulmonary inflammation was
persistent through later time points. Spp1, or osteopontin, is a macrophage chemoattractant that is
implicated in histopathological changes specifically granuloma formation. Mt1, Mt2, and Hmox1 are stress
response genes that increase in response to many things including metal exposure, such as CNT/F
catalysts, and oxidative stress.
At 1 d post exposure to high doses of CNT/F, all treatment groups had significantly increased Il-6
and Ccl2 expression following high dose exposure. This was expected given the bolus exposure. Il-1β was
significantly increased following exposure to high doses of MW #4-7 and CNF #1. Ccl22 was significantly
increased following high dose exposure to all materials except MW #2. Cxcl2 was increased following
exposure to MW #4, #5, and #7 as well as CNF #1 and #2. At 1 d post-exposure to low doses of CNT/F,
Il-6, Ccl2, and Cxcl2 were significantly increased in all groups. Mt1 was increased with exposure to MW
#5 and 7, and Mt2 was increased with exposure to all but MW #1, 3, and CNF #2. Hmox1 had was
significantly increased following exposure to CNF #1.

3.3.2.2. Seven days post-exposure
At 7 d post exposure, a significant increase in LDH was seen in all materials following high dose
exposure with greater severity in MW #5-7, and CNF #1 (Figure 2A). MW #5-7 and CNF #1-2 also
induced a significant increase in LDH in the low dose. Inflammatory cell infiltration was significantly
increased as seen in Figure 2B. Macrophages were not significantly increased, although neutrophils were
increased in all exposures and doses. Interestingly, eosinophils also were significantly increased in all
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CNT/F except MW #2 high dose exposures and low dose exposures of MWCNT #5-7, and CNF #1-2.
Eosinophils made up over 30% of BALF harvested cells following MW #5 high dose exposure, and over
53% of MW #6 high dose exposure. This response is also often a greater response than seen at 1 d postexposure, particularly induced by particles of larger length and diameter. For Mitsui-7 (MW #5) similar
patterns of inflammation have been previously reported [51]. Previous studies have also linked MWCNT
exposure to an increase in eosinophil infiltration which may be linked to IgE mediated airway allergy
responses [56, 83, 177].
Changes in proteins that regulate inflammation were assessed. Rodent MAP 4.0 analysis
(Ampersand Biosciences, Saranac Lake NY) of 42 proteins was completed from BALF. At 7 d postexposure, several proteins associated with inflammation, wound response, and remodeling of the
extracellular matrix were elevated including (Figure 2C). This elevation was seen in almost all high dose
treatment groups, but the greatest increase was seen in materials of greater nominal tube diameter and
length, primarily MW #5-7, and CNF #1. These materials also induced significant increases in proteins
following low dose exposures (Figure 2C). MW #2 induced fewer changes in protein concentrations than
other materials as a general trend, this may specifically due to the highly entangled nature of the material
contributing to reduced alveolar deposition than other CNT/F [19]. Of special note, increases in eotaxin
verifies the increase in eosinophil infiltration observed in cell counts and differentials.
At 7 d post-exposure, gene expression was measured following exposure to high doses of
MWCNT/CNF (Supplementary Figure 6). Il-6 was significantly increased after exposure to all materials
except MW #4. Il-1b expression was significantly increased following exposure to MW # 2, 5-7, and CNF
#1 and 2. These results further support BALF protein quantifications. Additionally, Ccl2, Spp1, and Cxcl2
were increased in all groups, while Ccl22 was increased after exposure to MW #3-7, and CNF #1-2. These
findings further support the previously quantified increase in neutrophil infiltration. Furthermore, Mt1 was
increased following exposure to MW #4-7, CNF #1 and 2. Mt2 was increased in MW #5, 7, and CNF #1103

2, while Hmox1 was increased in MW #5, 7, and CNF #1 and 2 exposure indicating some oxidative stress
may be occurring following exposure to materials of greater diameter.

3.3.2.3. Twenty-eight days post-exposure
Persistent inflammation was observed at 28 d post-exposure to several materials. MW #5-7 and
CNF #1-2 had increased LDH following high dose exposures (Figure 3A). Total cell counts were not
significantly increased, though inflammatory cell infiltration of specific cell types remained elevated in
some treatment groups (Figure 3B). Macrophage infiltration was significantly increased in MW #1 and
#7 high dose exposed mice. Neutrophil infiltration was increased following exposure to all materials at
both doses. Eosinophil infiltration resolved in most groups except high dose exposure to MW #5-7 and
CNF #1-2. At 28 d post-exposure, several inflammatory proteins were still increased in groups exposed
to high doses of particles with minimal changes in proteins following exposure to MW #2 and #4 (Figure
3C). MDC, TNFα, Il-12-p40, and CCl6 were also increased following low dose exposure to MW #7, and
MIP-1γ was increased following low dose exposure to MW #5-7.
Gene expression was also assessed following high dose exposures at 28 d post-exposure
(Supplementary Figure 6). Il-6, Ccl22, and Cxcl2 expression was persistently increased in all groups
except MW #2. Spp1was increased in all groups. Ccl2 was increased following exposure to all except MW
#2 and 5, and Il-1β had fully resolved to baseline for all except MW #1 and 6. Mt1 was persistently
increased in materials of larger diameter (MW #4,-7, CNF #1-2), while Mt2 was still increased in MW #5
and 6. Hmox1 was also increased in all except M#1, 3, and 4.

3.3.2.4. Eighty-four days post-exposure
By 84 d post-exposure, LDH in all low dose exposures and several high dose exposures had
resolved. However, high doses of MW #5-7, and CNF #1 still had increased LDH (Figure 4A). While total
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cell counts and macrophage counts were not significantly increased, high doses of MW #1, 5-7, and CNF
#1-2 still had increased neutrophil infiltration (Figure 4B). All other treatment groups had completely
resolved inflammatory cell infiltration. Proteins from BALF were also assessed at 84 d post-exposure, and
some significant changes from DM persisted through later time points. IL-6, MMP-9, MDC, MIP-1β,
MIP-1γ, TNFα, KC/GRO, Il-12-p40, CCl6, IP-10, MCP-1, IL-28, VCAM1, Eotaxin, GM-CSF, IL-17a,
and CRP remained elevated, particularly in exposures to MW #1, 5-7, and CNF #1 (Figure 4C).
Most gene expression changes had resolved with a few exceptions of persistent activation
(Supplementary Figure 6). In high dose exposures, Il-6 and Ccl2, despite being markers of acute
inflammation, were still increased following MW#1, 3, and 5 exposures. Il-1b was resolved in all groups.
Ccl22 was still increased in most groups except MW #2-4, and Cxcl2 was increased in most groups
excluding MW # 2 and 4. The persistent activation of these markers support the continued infiltration of
inflammatory cells from BALF assessments. Spp1 was increased in most groups except MW # 2-3.
Markers of oxidative stress including Mt1, Mt2, and Hmox1 had resolved to baseline by 84 d post-exposure
except for Mt2 following CNF #2 exposure which had a significant increase in expression.
In low dose exposures, Il-6, and Il-1b had returned to baseline in all groups. MW #6 still induced
a significant increase in Spp1, while all except CNF #2 induced significant increases in Cxcl2, Ccl2 and
Ccl22 was still significantly increased CNF #1 and MW #7, respectively.

3.3.2.5. Inflammation summary
The general inflammatory response pattern was not unexpected due to findings previously
published regarding CNT/F inflammation. The toxicity outcomes having representation in all CNT/F at 1
d post exposure was expected following a bolus administration. What was noted in this study was the
persistence and increased magnitude of lung injury and inflammation for materials with larger physical
dimensions at 7 d post-exposure. The results were consistent with Porter et al. in 2010, which evaluated
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MW #5, in that 7 d post-exposure resulted in greater lung injury and inflammation compared to day 1 for
a 40 µg dose. Resolution of inflammation at 28 d and 84 d post-exposure measured in this study was
consistent with previous evaluation of various CNT [51, 82, 124].
As a general trend, materials of greater nominal tube diameter had more severe and more persistent
cytotoxicity and inflammatory cell infiltration than materials of smaller diameter, though almost all
materials induced cellular injury that persisted through 28 d post-exposure. These larger materials also
were more likely to induce the infiltration of eosinophils in addition to neutrophils and macrophages.
Changes in inflammation regulating proteins from BALF and their corresponding changes in relative
mRNA expression also follows a similar correlation to nominal tube diameter.
While particle size is frequently noted to be related to the observed inflammatory response, other
studies have noted the potential role of other physicochemical characteristics as drivers of toxicity
outcomes. In addition to noting the role of particle dimensions, a series of studies from the National
Research Centre for the Working Environment (Denmark) noted that BET surface area as well as diameter
and length significantly correlated with inflammatory cell infiltration as well as genotoxicity
measurements. Additionally, particle agglomeration and rigidity has also been considered as an influential
factor for CNT toxicity. Previous studies comparing the toxicity of CNT of various rigidity and
agglomeration patterns [56]. This study found that rigid MWCNT were more inflammatory and cytotoxic
than less rigid materials. These findings correlate with the conclusions of this study in which materials
with more classic fiber characteristics were more toxic than smaller agglomerated materials.

3.3.2.6. HCA – PCA for inflammation
To understand the relationship and grouping of CNT/F by inflammation the outcomes of
cytotoxicity and cellular inflammation at all days and time points were evaluated (Supplemental Figure
8). Clearly the most significant responders were MW #6, #7, and CNF #1 at 7 d post-exposure with an
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exposure to 40 µg. Interestingly, the same materials were evident with only 4 µg exposure. Given the
more realistic nature of the 4 µg deposited dose in terms of human relevance, that exposure was utilized
for modeling. Given the clear evidence of persistent inflammation at 7d that time point was chosen as a
representative discriminator to distinguish effects of the various CNT/F. Avoidance of a non-specific
bolus response to a deposited dose 1 d post-exposure and determining lung injury and inflammation
prior to resolution also made 7 d post-exposure the desired time point.
When modeling lung injury and cellular influx alone, MW #6, #7, and CNF #1 were clearly the
materials generating the greatest toxicity at relevant exposure levels (Figure 5). The other materials were
not without effect (Figure 2), but not as marked in the response at 7 d post-exposure following a 4 µg
deposited dose. Previously, when analyzing physicochemical characteristics alone and in conjunction
with genotoxicity, it was observed that binning of physical dimensions, either alone or in addition to
traditional characteristics means, provided greater resolution for grouping materials and determining
which characteristic predicted an outcome (Fraser 2020). An additional measure of two-dimensional
sizing, an exposure assessment driven additional characterization (Dahm 2018, Fraser 2020) was a good
predictor of toxicity outcomes but not typically included as part of general characterization. When
including all characterization parameters, mean, physical dimension binning, and two-dimensional
sizing, MW #6, MW #7, and CNF #1 were in the greater toxicity group along with MW #5 and CNF #2
(Figure 6). The physicochemical characteristics driving the greater severity in lung injury and cell influx
were greater physical diameters and length along with the lengths of bundled agglomerates. Analysis by
binned physical dimensions alone highlighted MW #7 and CNF #1 as particularly driving an adverse
response with greater length and width parameters associated with toxicity outcomes (Supplemental
Figure 9A). Using means only for physicochemical characteristics did not group any of the traditional
measures with outcomes (Supplemental Figure 9B). The only close grouped characteristic was bundled
agglomerate mean length, part of our added two-dimensional sizing.
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Proteins were evaluated separately given the large number analyzed. Analysis of protein changes
alone also had MW #6, MW #7, and CNF #1 as generally more toxic as would be predicted by the other
injury and inflammation markers (Supplemental Figure 10A). MW #5 was also included in the group
exhibiting an increased toxicity response. Similar separations were made when adding the
physicochemical characteristics, especially when binning of physical dimensions were considered
(Supplemental Figure 10B).

3.3.3. In vitro screening
The last two decades of research into CNT/F toxicity reveled mechanisms and signaling pathways
modulated by CNT/F exposure. Some of the key events modulated in macrophages include cell viability,
membrane damage, nuclear factor-κB (NF-κB)-based inflammation, NLRP3-based inflammasome
activation, pyroptosis, and alteration in innate immune function. Using differentiated THP-1 macrophages,
a traditional cell type used to mimic pulmonary macrophage function, parallel in vitro assessments were
performed to screen the nine CNT/F for their potency with respect to various biomarkers and endpoints
and explore mechanisms of inflammatory modulation.

3.3.3.1 Cell viability and membrane damage
Change in cell viability due to exposure of the nine CNT/F was assessed by challenging the
differentiated THP-1 macrophages with the nine CNT/F for 24 h at 0, 1.87 µg/ml, 3.75 µg/ml, 7.5 µg/ml,
15 µg/ml, 30 µg/ml, 60 µg/ml, and 120 µg/ml (Figure 8A). These concentrations in terms of surface area
corresponds to 0, 0.58 µg/cm2, 1.17 µg/cm2, 2.34 µg/cm2, 4.68 µg/cm2, 9.37 µg/cm2, 18.75 µg/cm2, and
37.5 µg/cm2 respectively. Change in cell viability due to CNT/F exposure was evaluated by measuring
bioreduction of tetrazolium salt WST-1 by CNT/F exposed cells and comparing it with healthy control
cells with no exposure. MW #6 and MW #7 were the most potent among the screened CNT/F. Compared
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to control cells a concentration of 3.75 µg/ml of either of these CNT/F was sufficient to significantly
reduce the viability of the cells. MW #1, #2, and #4 exposure caused decrease in viability at only the
highest dose tested of 120 µg/ml. CNF #1-2 and MW #3 caused decrease in viability from a concentration
of 30 µg/ml. MW #5 started effecting the viability after 15 µg/ml. With exception to MW #3, the general
trend showed that CNT/F with increasing physical dimensions caused increased toxicity.
Membrane damage was assessed by exposing cells to the nine CNT/F at the eight concentrations
between 0-120 µg/ml (0-37.5 µg/cm2) for 24 h and measuring the released lactate dehydrogenase (LDH)
from cells with a damaged membrane (Figure 8B). For most CNT/F a dose-dependent increase in
membrane damage was measured. Similar to cell viability, CNT/F with larger physical dimensions caused
increased membrane damage. MW #5 was the most potent CNT/F in the screened group and caused a
significant increase in toxicity at the lowest test concentration of 1.87 µg/ml (0.58 µg/cm2). Compared to
the WST-1 consumption assay, membrane damage was much more sensitive in resolving CNT/F induced
toxicity. The lowest concentrations at which the nine CNT/F caused membrane damage ranged from 1.87
- 30 µg/ml (0.58 - 9.37 µg/cm2). MW #2 did not cause any membrane damage even at the highest
concentration tested.

3.3.3.2. Nuclear factor-κB (NFκB) activation
NFκB activation after exposure to the nine CNT/F was monitored by using NFκB secreted
embryonic alkaline phosphatase (SEAP) Reporter THP-1 cells. Cells were exposed to the CNT/F at the 8
concentrations between 0-120 µg/ml (0-37.5 µg/cm2) for 12 h and the SEAP was quantified to determine
NFκB activation (Figure 8C). Within the dose tested, exposure to all the nine CNT/F caused a dosedependent increase in activation of NFκB signal transduction pathway. The lowest concentration at which
there was a significant change in NFκB activation ranged between 3.75 – 60 µg/ml (1.17 - 18.75 µg/cm2)
for the nine CNT/F. At the highest dose evaluated there was ~ 5-fold change in NFκB activation by MW
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#4 and #6. Among the screened CNT/F, MW #4 and CNF #1 were the most potent and caused significant
change at 3.75 µg/ml (1.17 µg/cm2) while MW#5 was the least potent and caused significant change at 60
µg/ml (18.75 µg/cm2).

3.3.3.3. NLRP3 inflammasome activation and pyroptosis
Previous structure activity relationship studies showed that high aspect ratio materials like asbestos
and CNT induced NLRP3 inflammasome activation and pyroptosis. We measured IL-1β (Figure 9A) and
IL-18 (Figure 9B) released by differentiated and primed THP-1 cells as a proxy biomarker measure for
NLRP3 inflammasome activation. Using an activity-based probe for caspase-1, we screened for active
caspase-1 as a marker for pyroptosis (Figure 9C). Compared to control cells, exposure to the nine CNT/F
caused ~1-3-fold change in IL-1β release and ~2-fold change in IL-18 release. MW#5-7 and CNF #1
caused significant increase in both IL-1β and IL-18 secretion and MW #2, 3, 4 and CNF#2 significantly
altered IL1β production but not IL-18. Active caspase-1 released due to NLRP3 inflammasome activation
is known to cleave the inactive cytoplasmic precursor pro-IL1β and pro-IL18 converting it into a bioactive
and mature IL-1β and IL-18. Caspase 1 is a cysteine-rich protease that is known to cleave key cellular
substrates leading to pyroptosis or programed cell death. Caspase 1 was measured as an additional marker
for NLRP3 inflammasome activation and as a marker for pyroptosis. Active Caspase-1 induced due to
CNT/F exposure was assessed by flow cytometry using the fluorescent inhibitor probe FAM-YVADFMK. All the nine CNT/F screened caused induction of active caspase-1 and compared to control cells
with MW #5-7 being potent inducers.

3.3.3.4. Alteration in phagocytic capacity
Immune dysfunction due to particle exposure has been hypothesized as a probable cause for
increase in respiratory infections after particulate exposure [178]. NLRP3 inflammasome activation
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orchestrates multiple innate and adaptive immune responses in infection and auto-inflammatory disorders.
To screen if CNT/F have a potential to alter innate immune function, THP-1 cells were exposed to 15
µg/ml (4.68 µg/cm2) of various CNT/F for 24 h. Change in phagocytic capacity due to CNT/F exposure
was quantified by challenging the exposed cells to green fluorescent protein Escherichia coli (GFP E.coli)
for 2 h at a multiplicity of infection (MOI) of 25. Exposure to all the CNT/F test subjects except MW #2
and #3 reduced the phagocytic capacity of the macrophages. The rank order in potency of the CNT/F for
reducing macrophage phagocytic capacity was greater for MW #5-7 and CNF #1-2 compared to MW #14. Within the CNT/F test group, the reduction in phagocytic capacity ranged between no change to 64%
of the normal phagocytic capacity.

3.3.3.5. HCA – PCA for in vitro
Computational modeling of all in vitro outcomes grouped CNT/F into two main groups, MW #14 and MW #5-7 with CNF #1-2 (Figure 10A). Control cells grouped with MW #1-4 indicating
attenuated toxicity in comparison to other CNT/F. The grouping remained the same no matter the
approach of analyzing with physicochemical characteristics although the binning of physical dimensions
offered greater resolution in terms defining effect. The evaluation using all characteristics indicated
consistency of inflammasome induction as IL-1β, IL-18, and caspase-1 all grouped together (Figure
10B). Cellular cytotoxicity, measured by LDH release, also grouped with inflammasome indicators.
Larger lengths and diameters, along with agglomerate characteristics induced greater inflammasome
induction and cellular cytotoxicity. Cell viability, NFκB, and phagocytic capacity grouped with smaller
widths, specific surface area, and material density. The cellular responses of THP-1 cells (Figure 10B)
grouped CNT/F the same as the in vivo responses of inflammation (Figure 6). These results infer the
submerged cell culture using THP-1 cells were sufficient to group CNT/F in terms of inflammation and
injury.
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3.3.4. Summary
It is quite clear there is a broad variance within the class of CNT/F and within a given sample.
Materials that were by majority small in length and diameter induced the least amount of inflammation
and were quicker to resolve over time. Materials that were larger in diameter and length, even if only a
small proportion of nominal tubes fit that criteria, induced greater and more sustained lung injury and
inflammatory response. This is likely a direct reflection on the innate immune response handling of
materials as the smaller materials were within the dimensions for routine macrophage accumulation.
More inflammatory CNT/F were often larger than resident alveolar macrophages and quite commonly
seen protruding cellular membranes.
Submerged monocultures of THP-1 cells are routinely used for in vitro particle toxicity studies
and accurately reflected in vivo outcomes of CNT/F inflammation and injury. These results, obtained
from a simultaneous evaluation of the broad class of CNT/F both in vivo and in vitro, will allow for a
rapid predictive outcome of inflammation for CNT/F.

3.5. Conclusions
•

All CNT/F have the potential to induce inflammation. Resolution of inflammation occurred with
all CNT/F. Materials with populations of CNT/F having larger physical diameters and lengths,
contributing to variances in how the materials agglomerate, comparatively had a more persistent
and greater magnitude of inflammation.

•

The population of larger diameter and length materials only needed to be a small proportion of
the CNT/F material to induced greater toxicity.

•

Differentiated submerged cultures of THP-1 cells equally grouped CNT/F as in vivo studies in
terms of inflammation parameters assessed.
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•

Computational modeling using the binned physical dimensions and two-dimensional sizing
offered far superior resolution for grouping and determining which physicochemical
characteristics were factors for greater inflammation.

3.6. Materials and Methods
3.6.1. Materials
Multi-walled carbon nanotubes and nanofibers used in this study were as-produced materials
provided by six different U. S. facilities. These materials correspond to human exposure assessments
previously reported [69, 92]. One material, MW #5 is used as reference material in this study as it has
been extensively characterized and its toxic effects are well understood.

3.6.2. In vivo study design
For the in vivo portion of the study, male C57BL/6J mice ages eight to ten weeks were exposed by
oropharyngeal aspiration to either vehicle (physiologic dosing medium; DM), one of seven multi-walled
carbon nanotubes (MW #1, MW #2, MW #3, MW #4, MW #5, MW #6, or MW #7), or one of two carbon
nanofibers (CNF #1 or CNF #2). Two doses were employed: Low (4 µg) or High (40 µg). The low dose
was selected to best represent current relevant human exposure levels, while the high dose was selected
as to induce histopathological changes as previous studies have reported [9, 164]. Mice were euthanized
at 1, 7, 28, and 84 d post-exposure to assess pulmonary inflammation and cytotoxicity.

3.6.3. Animals
Male C57BL/6J pathogen-free mice weighing 20-25g were obtained from Jackson Laboratories
(Bar Harbor, ME). All mice were housed in the Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC)-accredited NIOSH animal facility and afforded food and tap water
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ad libitum in ventilated cages on autoclaved hardwood chip bedding and an environment of controlled
humidity, temperature, and 12:12 light/dark cycles. Animals were allowed to acclimate for at least seven
days prior to use in any experiments. Animal care and use procedures were conducted in accordance with
the “PHS Policy on Humane Care and Use of Laboratory Animals” and the “Guide for the Care and Use
of Laboratory Animals” (2011). The procedures utilized in this study were approved by the National
Institute for Occupational Safety and Health Institutional Animal Care and Use Committee.

3.6.4. Facility representative material preparation and in vivo dosing
Personal Breathing Zone (PBZ): Images from personal breathing zone samples were generously
provided by Mathew Dahm for the comparison of in vivo dosing to relevant human occupational
exposures. PBZ samples were collected as previously reported [69, 92]. These samples were collected
from employees working in primary CNT/F manufacturing facilities and were imaged using
transmission electron microscopy also as previously reported. PBZ images demonstrate particle
appearance, agglomeration, and morphology in human occupation exposures. Images from PBZs taken
during particle production are paired with respective in vivo dosing images as available.
Material Preparation: For in vivo exposure, dosing media was prepared fresh prior to dosing and
contained mouse serum albumin (0.6 mg/ml) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC;
0.01 mg/ml) prepared in United States Pharmacopeia (USP) grade-phosphate buffered saline (PBS)
without calcium and magnesium. Samples were sonicated for 5 min at the highest setting using an external
sonicator (Hielscher Ultrasound Technology) and then for 5 min using a Branson Sonifier 450 probe
sonicator set to the lowest setting (10% duty cycle; output control of 1). These settings and times were
determined to best replicate collected PBZ samples as a representation of human exposures.
Oropharyngeal Aspiration: Mice were dosed according to the well-established protocols previously
described [179]. In brief, mice were anesthetized using isoflurane. Mice were suspended by their upper
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incisors against a board and the tongue held to prevent swallowing. Either dosing media or particle
dispersed in dosing media was pipetted into the throat and aspirated. Particle in dosing media was prepared
that each 4 or 40 µg dose equaled 50 µl of suspension.

3.6.5. Bronchoalveolar lavage and tissue collection
Mice (n= 6-9 per group, dose, and time point) were humanely sacrificed at 1, 7, 28, and 84 d postexposure. Mice received an intraperitoneal injection of >100 mg of sodium pentobarbital (Fatal-Plus
Solution, Vortech Pharmaceutical, Inc., Dearborn, MI, USA) per kg of body weight, and were
subsequently exsanguinated. The first set of mice was used to collect Bronchoalveolar lavage fluid
(BALF) as previously described [87]. In brief, following exsanguination, the trachea was exposed and
cannulated. USP-grade PBS was flushed into the lungs then recovered and divided into cellular and
acellular using centrifugation. The cellular fraction was used to determine the total cell count using a
hemocytometer in addition to cell differentials. The acellular fraction was used for cytotoxicity
measurements and protein analysis. The second set of mice (n=4-6 per group, dose, and time point) was
used for tissue collection to determine gene expression changes. Following an intraperitoneal injection of
sodium pentobarbital, the left lung lobe was removed and frozen at -80 °C for gene expression analysis as
previously described [164].

3.6.6. BALF macrophages and imaging
The cellular fraction collected from BALF was collected and imaged using electron microscopy
using methods previously described [180]. In brief, the cellular fraction from BALF was collected and
stored in Karnovsky’s fixative solution (2% paraformaldehyde/2.5% glutaraldehyde in sodium cacodylate
buffer) and agarose. Cells were postfixed using 1% Osmium tetroxide and stained with 1% Tannic acid
and 0.5% uranyl acetate followed by dehydration in 100% ethanol and lastly infiltrated with propylene
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oxide and LX-112 epon. Sections were cut and embedded on copped grids for imaging with JEOL JEM
1400 transmission electron microscope (JEOL USA) with an AMT XR-81 M-B digital camera.

3.6.7. In vivo toxicity assessments
Cytotoxicity: Lactate dehydrogenase (LDH) is a cytosolic enzyme that can be measured as an indicator of
cellular damage. LDH activity in the acellular fluid was quantified using a Cobas Mira chemistry analyzer
(Roche Diagnostic Systems; Montclair, IN). This quantification is obtained through the detection of the
oxidation of lactate coupled to the reduction of nicotinamide adenine dinucleotide at a spectrophotometric
setting of 340 nm.
Cell Counts and Differentials: Total cell counts in BALF were quantified using a hemocytometer. Cells
from BALF were mounted on slides using a Cytospin 4 (Thermo Fischer) and were fixed and stained
using a Hema 3 kit (Fisher Scientific; Kalamazoo, MI) to differentiate cell types. 300 cells were counted,
and the percentage of macrophages, neutrophils, and eosinophils was determined. The percentage was
then multiplied by the total number of cells to quantify the total number of each cell type. Cells were also
imaged using standard light microscopy at 40x magnification.
Protein Analysis: Rodent MAP 4.0 Mouse Sample Testing from Ampersand Biosciences (Saranac Lake,
NY) was used to quantify 42 proteins present in BALF at 7, 28, and 84 d post exposure. The data is
presented in a heat map representing the fold change from control (DM).
Gene Expression: mRNA was isolated from the left lung and converted to cDNA using previously
described methods [164]. To assess inflammation, changes in relative fold change for six genes were
calculated using the 2–∆∆Ct method. The six genes measured include Il-1b, Il-6, Ccl2, Ccl22, Cxcl2, and
Spp1.
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3.6.8. In vitro toxicity study design and toxicity assessments
Submerged cultures of differentiated macrophage from human peripheral blood monocyte cell line
(THP-1) were used to screen the nine CNT/Fs for their toxicity potential In vitro. A mechanism-based
screening approach was used, and the nine CNT/Fs were screened for toxicity (LDH, WST-1), Nuclear
factor-κB (NF-κB) activation (inflammation), Inflammasome activation (IL-1β and IL-18) and Pyroptosis
(Caspase-1). Finally, functional innate immune changes due to exposure of the nine CNT/Fs was evaluated
by challenging the CNT/F exposed cells with green fluorescent protein Escherichia coli (GFP E. coli) and
quantifying the relative uptake by flow cytometer.

3.6.9. Macrophage culture, differentiation and priming
Human peripheral blood monocyte cell line, THP-1 cells, were cultured, differentiated, and primed
using procedures described previously [180, 181]. The human monocyte cells (THP-1) were obtained
from the American Type Culture Collection (ATCC # TIB 202) and were cultured in HEPES buffered
RPMI-1640 media supplemented with 10% fetal bovine serum (FBS), 100 µg/mL penicillin–
streptomycin, and 50 µM of β mercaptoethanol. The THP-1 monocytes were differentiated to
macrophages by treating the cells with fresh culture media supplemented with 150 nM 1α, 25-DihydroxyVitamin D3 (Vit D3; MilliporeSigma, MA; # 679101) for 48 h. Cells were subsequently treated for 12 h
with media supplemented with 10 nM Phorbol, 12-myristate, 13-acetate (PMA, MilliporeSigma, MA; #
P8139). For the inflammasome activation, the differentiated THP-1 cells were primed by co-exposing
particulate matter with 10 ng/ml Lipopolysaccharide (LPS; MilliporeSigma, MA; # L-4516) to induce the
transcription of pro-IL-1β. Cells were cultured in a humidified incubator maintained at 370 C and 5 %
CO2.
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3.6.10. CNT/F Aqueous Stock Preparation and Dispersion in Cell Culture Media
CNT/F aqueous stock was prepared by dispersing the CNT/F dry powder at 2 mg/ml concentration
in dispersion medium [DM; 0.6 mg/ml mouse serum albumin + 0.01 mg/ml 1,2-dipalmitoyl-sn-glycero-3phosphotidyl (DPPC) in phosphate-buffered saline (PBS) without calcium and magnesium] [166]. CNT/F
dispersion in the aqueous stock was achieved by sonicating for 5 min at 70% amplitude using a cup horn
sonicator (Sonics VibraCell with Cup-type Sonicator; Newton, CT) immersed in continuous flowing cold
water. The samples were vortexed intermittently after every minute for 10 s. The aqueous stock was
dispersed in cell culture media by diluting to highest test concentration and performing probe tip
sonication (Branson Sonifer 450, continuous output) for a total of 2 min, with 10 s vertexing after every
30 s. Other test concentrations were obtained by serial dilution.

3.6.11. Cell viability and membrane damage
Cell viability with CNT/F exposure was determined using WST-1 cell proliferation reagent
(MilliporeSigma, MA; #5015944001). Membrane integrity of the cells after CNT/F exposure was assessed
using CytoTox-One homogenous membrane integrity assay (Promega, WI; # G7892). Cells were plated
on a 96 well plate at 60,000 cells per cm2 (19,200 cells per well; 1.92 x105 cells per ml) in 100 µl of cell
culture media. The differentiated cells were challenged for 24 h with fresh media containing the nine
CNT/F’s at eight serial doses of 0, 1.87 µg/ml, 3.75 µg/ml, 7.5 µg/ml, 15 µg/ml, 30 µg/ml, 60 µg/ml, and
120 µg/ml. These concentrations in terms of surface area corresponds to 0, 0.58 µg/cm2, 1.17 µg/cm2,
2.34 µg/cm2, 4.68 µg/cm2, 9.37 µg/cm2, 18.75 µg/cm2, and 37.5 µg/cm2 respectively. At 22 h post
exposure, half of the wells for each dose tested (4 of 8 wells) were lysed with 1% Triton X-100
(MilliporeSigma, MA; #T8787). At 24 h, 70µl of the supernatant was transferred to a 96 well plate and
spun on a centrifuge at 1000 RPM for 5 minutes to settle the particulate/debris. 50 µl of debris free
supernatant was transferred to a fresh plate with equal amount of CytoTox-One reagent and the
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fluorescence was read at 560 nm excitation / 590 nm emission after 30 minutes. For determining the
cellular viability, cells were challenged with fresh media containing 10% volume/volume WST-1 cell
proliferation reagent. After 2 h of incubation, the WST-1 consumption was recorded by measuring the
absorbance at 450 nm subtracted with absorbance at 660 nm to account for turbidity/background.
Experiments were performed three times with each dose tested in quadruplicates each turn (n = 3 x 4 for
each dose).

3.6.12. NFκB activation
NFκB activation after CNT/F exposure was monitored by using NF-kB SEAP Reporter THP-1
cells (THP1-Blue™ NF-κB Cells; Invivogen, CA). NF-κB cells are derived from human THP1 monocytes
by stable transfection of an NF-κB-inducible SEAP reporter (secreted embryonic alkaline phosphatase).
These cells allow monitoring of NF-kB activation by measuring SEAP expression. To maintain selection
pressure, THP-1 growth media was treated with 10 µg/ml blasticidin (Invivogen, CA; # ant-bl) every other
passage. Cells were plated on a 96 well plate at 60,000 cells per cm2 (19,200 cells per well; 1.92 x105
cells per ml) in 100 µl of cell culture media. After differentiation, cells were challenged with fresh media
for 12 hours containing the nine CNT/F’s at eight serial doses of 0, 1.87 µg/ml, 3.75 µg/ml, 7.5 µg/ml, 15
µg/ml, 30 µg/ml, 60 µg/ml, and 120 µg/ml. These concentrations in terms of surface area corresponds to
0, 0.58 µg/cm2, 1.17 µg/cm2, 2.34 µg/cm2, 4.68 µg/cm2, 9.37 µg/cm2, 18.75 µg/cm2, and 37.5 µg/cm2
respectively. After 12 h of exposure the supernatant was extracted and centrifuged at 1000 RPM for 5
minutes. 20 µl of the debris free cell supernatant was transferred to a 96 well plate containing 180 µl of
warm QUANTI-Blue™ solution (Invivogen, CA #rep-qbs). The plate was incubated at 37 °C for 3 h and
the change in color intensity to purple/blue due to secreted embryonic alkaline phosphatase (SEAP) was
quantified by measuring absorbance at 635 nm.
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3.6.13. Caspase-1, IL-1β and IL-18
Active caspase-1 was quantified using a fluorochrome inhibitor of caspase-1 (FAM-YVAD-FMK)
(Immunochemistry Technologies, MN; Catalog #98). The differentiated THP-1 cells were challenged
with 30 µg/ml (9.37 µg/cm2) of the nine CNT/F for 12 h. The cells were washed with PBS and extracted
using Accutase (Thermofisher, CA; #4555-56). The detached cells were collected on ice and then
centrifuged at 300 g for 5 min. FAM-YVAD-FMK enters the cells freely and covalently binds to activated
caspase-1. The FLICA reagent was diluted as per manufacturers recommendation and incubated with cells
on ice for 15 min and washed with PBS. The FLICA labeled cells were fixed using the fixative provided
by the manufacturer and the fluorescence was determined using a BD LSR II flow cytometer (BD
Biosciences, CA). All experiments were performed using triplicate samples and at least 10,000 cells were
acquired per treatment. The mean fluorescence was determined using FlowJo (FlowJo LLC, Oregon).
IL-1β and IL-18 production in differentiated and primed THP-1 culture supernatants exposed to
18.75 µg/cm2 (60 µg/ml ) of the nine CNT/Fs for 24 h was determined using Human IL-1 beta/IL-1F2
Quantikine ELISA (Cat#DLB50, R&D Systems, Minneapolis, MN) and Human IL-18 ELISA (Cat#7620,
MBL International Corporation, Woburn, MA) following the manufacturers recommendation.

3.6.14. Phagocytosis functional assay
Alteration in phagocytic capacity of macrophages exposed to the nine CNT/F was evaluated by
challenging the CNT/F exposed macrophages with Escherichia coli GFP (ATCC # 25922GFP). The
differentiated macrophages were exposed to the nine CNT/F at 4.68 µg/cm2 (15 µg/ml) for 24 h. At 24 h,
the cells were washed and challenged with fresh media containing E. coli GFP at multiplicity of infection
(MOI) of 1:25. In order for the bacteria to reach the cells at the bottom of the well, the plate containing
the cells and bacteria was centrifuged at 1000 RPM for 10 min before placing them in an incubator at
37°C. After 2 h of challenge, the cells were washed with PBS, harvested by trypsinization, and scraping,
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centrifuged at 1000 RPM for 5 min, and re-suspended in PBS. The cell-associated bacteria were quantified
using a BD LSR II flow cytometer (BD Biosciences, CA). All experiments were performed using triplicate
samples and at least 10,000 cells were acquired per treatment. The mean fluorescence was determined
using FlowJo (FlowJo LLC, Oregon).

3.6.15. Feature selection and principal component analysis
To permit selection of the minimal number of features among all characterization and L-W
properties that could be used to segregate each material investigated, feature selection was performed with
a random forest-based approach [169] using the “Boruta” algorithm [170] in the R statistical environment
[171]. The Boruta algorithm adds randomness to the variables in the dataset by creating shuffled copies
of all variables (“shadow features”). “Boruta” iteratively assesses if each variable has a higher Z-score
than the maximum Z-score of its shadow features. At each iteration, variables with Z-scores lower than
shadow features are deemed unimportant and removed subsequently by the algorithm to capture all the
important, interesting features one might have in the dataset with respect to a dependent variable, in this
case each material itself. Then, using traditional, L-W, and combined variables retained after applying the
“Boruta” algorithm, principal component analysis (PCA) was performed to identify significant patterns
that explained the majority of the variations in the physicochemical properties among the different CNT/F
materials investigated. PCA was performed using the prcomp command of the R statistical software (R
Core Team, 2016).

3.6.16. Statistics
Data are presented as mean with standard error or standard deviation as indicated in the figure
legends. Figures were prepared using SigmaPlot software (Systat Software, INC). Statistical analysis was
performed using SAS/STAT software, Version 9.4 of the SAS system for Windows (SAS Institute, Cary,
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NC). Analysis used include one-way analysis of variance. Differences were considered significant at p <
0.05. Post hoc comparisons were evaluated with Fishers LSD test. Some variables were transformed using
the natural log prior to analysis to meet the model assumptions of homogeneous variance.
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CHATER 3 FIGURES

Figure 3.1. Representative electron microscopy images of macrophages isolated from bronchoalveolar
lavage fluid at 7 days post-exposure. Smaller, spherically agglomerated particles are not highly visible
due to their complete phagocytosis (MW #1 and 3). Particles of large, bundled agglomerate size and
singlets of larger nominal tube lengths and diameters are less readily phagocytosed due to the limitations
of macrophage size and phagocytic capacity. These particles (MW #2, 4-7, and CNF #1-2) may induce
frustrated phagocytosis and diminished lung clearance.
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Figure 3.2. Inflammation outcomes at 7 days post exposure including lactate dehydrogenase (A),
inflammatory cell infiltration (B), and bronchoalveolar lavage fluid proteins (C). While all materials
induced significant inflammation in the high dose, and occasionally in the low dose, materials of larger
nominal tube size (MW #5-7, CNF #1-2) were generally more likely to induce more severe or greater
inflammatory responses compared to materials of smaller nominal tube size (MW #1-4) (*p>0.05).
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Figure 3.3. Inflammation outcomes at 28 days post exposure including lactate dehydrogenase (A),
inflammatory cell infiltration (B), and bronchoalveolar lavage fluid proteins (C). Materials of larger
nominal tube size (MW #5-7, CNF #1-2) generally induced significant inflammatory responses compared
to materials of smaller nominal tube size (MW #1-4) that were sustained through 28 days post-exposure
(*p>0.05).
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Figure 3.4. Inflammation outcomes at 84 days post exposure including lactate dehydrogenase (A),
inflammatory cell infiltration (B), and bronchoalveolar lavage fluid proteins (C). While inflammation was
trending toward resolution to baseline, MW #5-7 and CN #1 induced significant, persistent inflammation
at this chronic time point. All other Materials achieved resolution (*p>0.05).
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Figure 3.5. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) grouping of
inflammation outcomes alone including lactate dehydrogenase and inflammatory cell infiltration for the 4
µg dose at 7 days post-exposure.
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Figure 3.6. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) grouping of
inflammation outcomes for the 4 µg dose at 7 days post-exposure and physicochemical characterization
using ‘all characterization’ parameters
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Figure 3.7. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) grouping of
inflammation outcomes for the 4 µg dose at 7 days post-exposure and physicochemical characterization
using length-width (L-W) parameters.
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Figure 3.8. Toxicity assessment of inflammation in THP-1 macrophage cells exposed to CNT/F. (A)
WST-1 cell proliferation assay was used to assess the viability of THP-1 cells following exposure to
increasing concentrations (01.875-120 µg/ml) of CNT/F. The dose at which the particle significantly
reduced cell viability is indicated with an asterisk (p<0.05). (B) Lactate dehydrogenase is indicative of
membrane damage and was quantified in the cell supernatant following 24 hours of particle exposure.
*p<0.05 fold change vs. control cells represented as a reference line. (C) Changes in phagocytic capacity
of macrophages was assessed following 24 h treatment. Significant changes from control cells were
indicated with an asterisk (* p<0.05).
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Figure 3.9. Inflammasome activation and toxicity assessment of THP-1 macrophage cells exposed to
CNT/F. Caspase 1 activity (A), Il-1β (B), NFκB (C), and IL-18 (D) were quantified and presented as fold
change from control. Significant changes from control cells were indicated with an asterisk (* p<0.05).
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Figure 3.10. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) grouping THP1 inflammation outcomes alone (A) and THP-1 inflammation outcomes with length- width (L-W)
physicochemical characteristics (B). Similar groupings as in the in vivo findings were generated.
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CHAPTER 3 SUPPLEMENTARY TABLES AND FIGURES
Supplementary Table 3.1. Physical dimensions of CNT/F dispersed in isopropanol.
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Supplementary Table 3.2. Hydrodynamic diameter, zeta potential, and two-dimensional sizing of
CNT/F agglomerates dispersed in physiologic dosing media.
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Supplementary Table 3.3. Results of additional particle characterization of CNT/F.
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Supplemental Table 3.4. Inflammatory cell counts of total cells and cell differentials listed as
means and standard errors of raw values
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Supplemental Table 3.5. Changes in mRNA expression of inflammatory cytokines and
chemoattractants listed as means and standard errors

Interleukin 6
Il-6
Interleukin 1 beta
Il-1B
C-C motif chemokine ligand 2
Ccl2
C-C motif chemokine ligand 22
Ccl22
Chemokine (C-X-C motif) ligand 2 Cxcl2
Secreted Phosophoprotein 1
Spp1
Metallothionein 1
Mt1
Metallothionein 2
Mt2
Heme oxygenase 1
Hmox1

1 Day High Dose
DM
MW #1
1.00±0.24 3.57±0.91
1.00±0.23 1.20±0.14
1.00±0.30 4.02±0.48
1.00±0.08 1.75±0.12
1.00±0.55 1.12±0.21
1.00±0.22 1.13±0.13
1.00±0.22 0.90±0.08
1.00±0.43 1.31±0.18
1.00±0.14 1.11±0.05

MW #2
6.32±1.24
1.27±0.26
1.78±0.29
1.04±0.03
1.84±1.06
1.50±0.12
0.99±0.06
1.68±0.20
1.07±0.07

MW #3
3.79±0.85
1.15±0.18
2.35±0.51
1.32±0.11
1.23±0.50
1.25±0.06
0.82±0.11
1.15±0.29
1.06±0.13

MW #4
10.53±2.40
1.96±0.45
7.48±2.25
1.78±0.23
2.37±0.76
2.17±0.37
1.40±0.13
3.57±0.61
1.08±0.06

MW #5
9.33±1.38
1.72±0.16
6.74±1.36
1.86±0.20
1.97±0.39
4.34±0.68
1.96±0.40
5.13±1.20
0.99±0.05

MW #6
9.52±2.34
1.75±0.48
4.73±1.16
1.61±0.17
1.49±0.63
2.55±0.57
1.80±0.63
4.28±1.88
1.05±0.02

MW #7
13.13±1.04
1.71±0.13
7.96±1.04
1.87±0.13
1.93±0.19
5.67±0.52
2.31±0.26
6.99±0.90
1.04±0.03

CNF #1
7.87±1.81
1.97±0.29
6.63±1.21
1.85±0.17
2.71±0.69
2.66±0.47
1.22±0.18
2.96±0.55
1.13±0.06

CNF #2
3.85±0.63
1.70±0.56
3.87±0.91
1.61±0.19
1.64±0.47
1.36±0.25
0.96±0.25
1.63±0.55
1.15±0.12

Interleukin 6
Il-6
Interleukin 1 beta
Il-1B
C-C motif chemokine ligand 2
Ccl2
C-C motif chemokine ligand 22
Ccl22
Chemokine (C-X-C motif) ligand 2 Cxcl2
Secreted Phosophoprotein 1
Spp1

1 Day Low Dose
DM
MW #1
1.00±0.10 2.09±0.29
1.00±0.25 1.15±0.25
1.00±0.09 2.42±0.45
1.00±0.12 1.68±0.21
1.00±0.20 2.27±0.36
1.00±0.12 0.96±0.20

MW #2
3.43±0.19
0.93±0.07
2.48±0.27
1.07±0.24
1.89±0.27
0.85±0.07

MW #3
1.97±0.25
0.71±0.09
1.91±0.11
1.17±0.10
1.92±0.19
0.85±0.09

MW #4
3.47±0.93
1.09±0.11
3.84±0.89
1.10±0.22
2.71±0.38
0.80±0.19

MW #5
2.44±0.24
1.17±0.18
3.89±0.49
1.73±0.13
3.15±0.35
0.86±0.08

MW #6
8.69±1.46
1.68±0.16
7.98±0.87
1.58±0.22
4.69±0.50
1.18±0.11

MW #7
5.99±0.73
1.28±0.18
6.85±1.20
2.02±0.17
3.92±0.37
0.97±0.12

CNF #1
2.67±0.37
1.53±0.38
3.43±0.32
1.67±0.33
2.03±0.26
0.92±0.09

CNF #2
1.97±0.15
0.81±0.12
2.34±0.28
0.90±0.23
1.79±0.24
0.99±0.15

Interleukin 6
Il-6
Interleukin 1 beta
Il-1B
C-C motif chemokine ligand 2
Ccl2
C-C motif chemokine ligand 22
Ccl22
Chemokine (C-X-C motif) ligand 2 Cxcl2
Secreted Phosophoprotein 1
Spp1
Metallothionein 1
Mt1
Metallothionein 2
Mt2
Heme oxygenase 1
Hmox1

7 Day High Dose
DM
MW #1
1.00±0.20 3.28±0.59
1.00±0.11 1.32±0.24
1.00±0.16 8.95±2.20
1.00±0.11 1.21±0.11
1.00±0.13 5.21±0.96
1.00±0.14 6.98±1.30
1.00±0.08 1.14±0.12
1.00±0.13 0.94±0.11
1.00±0.06 1.14±0.11

MW #2
2.17±0.70
1.66±0.30
2.21±0.38
1.14±0.13
3.50±0.55
2.55±0.31
1.35±0.11
1.24±0.12
0.93±0.04

MW #3
2.20±0.66
1.31±0.26
3.92±1.17
1.54±0.16
2.66±0.44
5.39±0.88
1.10±0.10
1.09±0.11
1.02±0.03

MW #4
2.62±0.65
1.71±0.16
7.64±2.82
1.97±0.26
3.31±0.78
7.00±3.28
1.41±0.13
1.74±0.26
1.15±0.07

MW #5
6.41±1.34
2.82±0.24
15.57±4.20
3.06±0.37
9.84±1.34
16.70±2.84
2.07±0.20
2.68±0.48
1.47±0.08

MW #6
3.73±0.79
3.14±0.75
4.35±1.04
2.69±0.33
8.66±2.13
3.38±0.99
1.96±0.20
2.73±0.52
1.21±0.07

MW #7
6.59±1.67
5.58±1.26
14.81±3.95
4.72±0.48
14.41±3.06
6.80±1.57
3.92±0.48
6.92±1.53
1.97±0.18

CNF #1
3.74±0.58
2.47±0.15
5.53±0.86
3.03±0.35
8.13±0.60
5.08±1.35
2.21±0.19
2.85±0.31
1.37±0.09

CNF #2
3.13±0.95
2.59±0.52
5.46±1.80
3.24±0.55
5.58±1.15
2.65±0.73
1.95±0.35
2.36±0.52
1.39±0.19

Interleukin 6
Il-6
Interleukin 1 beta
Il-1B
C-C motif chemokine ligand 2
Ccl2
C-C motif chemokine ligand 22
Ccl22
Chemokine (C-X-C motif) ligand 2 Cxcl2
Secreted Phosophoprotein 1
Spp1
Metallothionein 1
Mt1
Metallothionein 2
Mt2
Heme oxygenase 1
Hmox1

28 Day High Dose
DM
MW #1
1.00±0.17 4.89±1.36
1.00±0.08 1.76±0.23
1.00±0.12 6.72±2.17
1.00±0.05 1.88±0.26
1.00±0.16 7.92±2.51
1.00±0.14 4.36±0.97
1.00±0.08 1.17±0.21
1.00±0.19 3.29±1.94
1.00±0.07 1.31±0.13

MW #2
1.27±0.31
1.08±0.25
1.06±0.12
1.21±0.13
1.28±0.24
2.55±0.53
1.33±0.15
1.48±0.40
1.12±0.08

MW #3
3.61±0.87
1.03±0.04
3.08±0.86
1.56±0.24
3.14±0.84
8.34±4.80
1.37±0.19
1.65±0.45
1.28±0.17

MW #4
2.79±0.46
1.32±0.05
2.06±0.50
1.96±0.24
3.15±0.65
7.58±2.24
1.39±0.12
1.63±0.16
1.32±0.10

MW #5
3.61±1.31
1.45±0.27
2.10±0.75
1.85±0.32
3.83±0.73
14.22±6.10
1.75±0.08
2.65±0.41
1.62±0.13

MW #6
2.92±0.27
1.66±0.17
2.08±0.28
2.14±0.18
6.06±1.25
8.72±1.50
1.91±0.12
2.16±0.32
1.46±0.11

MW #7
3.24±0.39
1.38±0.10
2.18±0.12
2.09±0.19
4.56±0.58
12.942.59
1.88±0.15
2.18±0.23
1.80±0.16

CNF #1
2.74±0.31
1.33±0.18
2.30±0.20
2.26±0.17
4.34±0.17
9.81±1.48
1.46±0.16
1.59±0.35
1.44±0.09

CNF #2
2.85±0.32
1.38±0.37
1.84±0.22
2.15±0.14
4.31±0.41
9.60±1.25
1.85±0.18
2.27±0.35
1.60±0.15

Interleukin 6
Il-6
Interleukin 1 beta
Il-1B
C-C motif chemokine ligand 2
Ccl2
C-C motif chemokine ligand 22
Ccl22
Chemokine (C-X-C motif) ligand 2 Cxcl2
Secreted Phosophoprotein 1
Spp1
Metallothionein 1
Mt1
Metallothionein 2
Mt2
Heme oxygenase 1
Hmox1

84 Day High Dose
DM
MW #1
1.00±.21 4.94±2.93
1.00±0.20 1.30±0.47
1.00±0.21 9.03±5.43
1.00±0.15 1.77±0.18
1.00±0.21 3.14±0.76
1.00±0.11 3.56±.39
1.00±0.11 0.90±0.12
1.00±0.11 3.90±2.40
1.00±0.08 1.21±0.16

MW #2
1.11±0.12
0.61±0.07
1.05±0.14
1.35±0.17
1.22±0.12
1.77±0.20
1.03±0.10
1.25±1.07
0.76±0.08

MW #3
2.97±1.37
0.75±0.09
4.24±1.65
1.46±0.40
4.64±2.12
2.37±0.67
0.70±0.20
1.07±0.62
0.90±0.10

MW #4
1.29±0.18
0.62±0.07
1.22±0.12
1.61±0.30
1.83±0.22
2.34±0.42
1.12±0.07
3.42±2.26
0.88±0.04

MW #5
2.19±0.35
0.73±0.05
3.34±0.54
2.35±0.20
4.26±0.44
12.77±2.19
1.210.05
1.36±0.05
1.20±0.03

MW #6
1.71±0.07
0.58±0.07
1.98±0.34
1.96±0.12
4.31±0.70
5.86±1.35
1.42±0.21
1.94±0.37
1.17±0.08

MW #7
1.75±0.21
0.68±0.11
2.11±0.49
1.91±0.22
4.89±1.41
6.79±1.97
1.36±0.14
2.11±0.55
1.04±0.11

CNF #1
1.86±0.25
0.71±0.14
1.71±0.20
1.73±0.12
3.05±0.35
4.43±0.64
1.16±0.09
1.49±0.09
0.93±0.07

CNF #2
1.61±0.20
0.62±0.12
1.84±0.25
1.74±0.16
2.89±0.34
4.12±0.79
1.18±0.05
13.25±7.45
1.05±0.09

Interleukin 6
Il-6
Interleukin 1 beta
Il-1B
C-C motif chemokine ligand 2
Ccl2
C-C motif chemokine ligand 22
Ccl22
Chemokine (C-X-C motif) ligand 2 Cxcl2
Secreted Phosophoprotein 1
Spp1

84 Day Low Dose
DM
MW #1
1.00±0.141 1.17±0.14
1.00±0.12 0.79±0.06
1.00±0.10 0.96±0.10
1.00±0.17 0.94±0.14
1.00±0.31 2.73±0.51
1.00±0.07 0.95±0.16

MW #2
1.29±0.14
1.23±0.21
0.88±0.07
1.01±0.10
3.37±1.57
1.27±0.12

MW #3
1.11±0.10
1.16±0.28
0.95±0.17
0.93±0.16
2.08±0.18
0.98±0.09

MW #4
1.02±0.08
1.29±0.39
0.74±0.05
0.90±0.06
2.15±0.35
1.31±0.19

MW #5
1.12±0.27
1.15±0.16
0.87±0.09
1.16±0.13
2.01±0.37
1.16±0.15

MW #6
1.05±0.10
0.78±0.09
1.02±0.09
1.25±0.08
3.98±1.10
1.83±0.25

MW #7
1.37±0.25
0.86±0.21
1.03±0.04
1.37±0.07
5.84±1.24
1.54±0.15

CNF #1
0.96±0.06
0.82±0.12
0.72±0.05
0.91±0.05
3.52±0.40
0.82±0.15

CNF #2
0.80±0.11
0.67±0.06
0.76±0.07
0.93±0.08
1.99±0.66
1.24±0.10
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Supplementary Figure 3.1. Distributions of CNT/F diameter. Particles were binned according to size
along the lower x-axis with frequency on the left y-axis. Additionally, percentage of accumulation is
graphed on the right y-axis with the absolute diameter along the upper x-axis. The overlay line was 3
parameter sigmoidal curve of best fit with the point of 50% accumulation indicated with dotted lines. Sizes
are for particles in isopropanol suspension.
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Supplementary Figure 3.2. Distributions of CNT/F length. Particles were binned according to size along
the lower x-axis with frequency on the left y-axis. Additionally, percentage of accumulation is graphed
on the right y-axis with absolute length along the upper x-axis. The overlay line is 3 parameter sigmoidal
curve of best fit with the point of 50% accumulation indicated with dotted lines. Sizing was for particles
in isopropanol suspension.
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Supplementary Figure 3.3. Representative micrographs of CNT/F collected from personal breathing
zone samples (PBZ) compared to particle dispersion in dosing media (DM) used for in vivo and in vitro
dosing in the current study. Particle in DM retained similar profiles of particle size and agglomeration
compared to PBZs to ensure proper representation of human occupational exposures.
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Supplementary Figure 3.4. Schematic of the mouse dosing and euthanasia schedule illustrating the
timing of each rodent group across a year of time and distinguishing the bronchoalveolar lavage groups
from the histopathology and tissue collection groups.
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Supplementary Figure 3.5. Representative micrographs of BALF macrophages at 1 d post-exposure.
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Supplementary Figure 3.6. Lactate dehydrogenase and inflammatory cell infiltration at 1- day postexposure to CNT/F
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Supplementary Figure 3.7. Changes in mRNA expression of inflammatory cytokines and markers of
oxidative stress from lung tissue at all four time points expressed as a heat map

144

Supplementary Figure 3.8. Hierarchical clustering analysis comparing inflammatory outcomes from
bronchoalveolar lavage fluid at all four times points.
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Supplementary Figure 3.8. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) comparing inflammatory outcomes from bronchoalveolar lavage fluid with length-width L-W) and
‘means only’ of physicochemical characterization

146

Supplementary Figure 3.9. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) comparing proteins from bronchoalveolar lavage fluid alone and with length-width (L-W)
physicochemical characterization parameters.
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4.1 Abstract:
Background: Carbon nanotubes and nanofibers (CNT/F) have been previously investigated for their
potential toxicities, however comparative studies of the broad material class, especially those with a larger
diameter, are lacking. Additionally, computational modeling correlating physicochemical characteristics
and toxicity outcomes have been infrequently employed, and it is unclear if all CNT/F confer similar
toxicity, including histopathology changes, pulmonary fibrosis, and extra-pulmonary translocation. Male
C57BL/6 mice were exposed to 40 µg of one of nine CNT/F (MW #1-7 and CNF #1-2) commonly found
in exposure assessment studies of U.S. facilities with diameters ranging from 6-150 nm. Human fibroblasts
(0-20 µg/ml) were used to assess the predictive value of in vitro to in vivo modeling systems.
Results: All materials induced histopathology changes, though specific outcomes were variable in severity
and distribution. In general, MW #5-7 and CNF #1 induced greater histopathology changes compared to
MW #1and #3 while MW #4 and CNF #2 were intermediate in effect. Differences in individual alveolar
or bronchiolar outcomes and severity correlated to physicochemical characteristics of nominal tube
physical dimensions and how the materials agglomerated. Human fibroblast monocultures were found to
be insufficient to fully replicate in vivo fibrosis outcomes suggesting the need for more advanced cell
culture in vitro models. Transport of the CNT/F to the tracheobronchial lymph nodes was present for any
material with significant alveolar deposition. Singlet accumulation in the lung at day 1 provided predictive
power for liver accumulation 84 d post-exposure. Pleural penetrations were observed more consistently
in CNT/F with larger lengths and diameters.
Conclusion: Physicochemical characteristics, notably nominal tube dimension and agglomerate size, were
predictive of histopathology and were essential for grouping of materials. Particles of greater nominal tube
length were generally associated with increased severity of histopathology outcomes. Larger particle
lengths and agglomerates were associated with more severer bronchi-bronchiolar outcomes. Spherical
agglomerated particles of smaller nominal tube dimension were linked to granulomatous inflammation
while a mixture of smaller and larger dimensional CNT/F resulted in more severe alveolar injury. Extrapulmonary translocation was also associated with particle size, suggesting that particles of moderate
length and diameter with minimal agglomeration were more likely to translocate to the liver while particles
of all sizes were observed in the tracheobronchial lymph nodes. Notably, singlet lung burden at 1 d postexposure correlated with liver burden at 84 d post-exposure.
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4.2. Introduction:
Recommended exposure limits (REL) established by NIOSH take into consideration two key
factors when determining the quantitative risk: the severity and likelihood of adverse effects upon
exposure to a hazardous material during a 45 year working lifetime. For carbon nanotubes and
nanofibers, the REL has historically been established primarily upon the fibrogenic and inflammatory
capabilities of these materials and relied upon short term and subacute animal studies that investigated
pulmonary inflammation, granulomatous response, thickening of the alveolar septum, and extrapulmonary translocation [57]. From these studies, human exposure equivalents can be predicted, thus
allowing for the generation of the recommended exposure limit.
Due to lack of carcinogenicity studies and the difficulties in predicting long term effects from
acute inflammation studies, histopathological changes following CNT exposure have been critical to
establishing occupation exposure limits. These changes, such as fibrosis, are critical as they represent
fundamental and potentially irreversible changes in the lung [9, 10, 51, 56, 116]. However, to date, it is
in unclear if all CNT/F confer the same histopathology changes in the lung. Furthermore, systemic
effects and systemic translocation have been minimally investigated due to difficulties in monitoring
particle behavior and translocation post-exposure [59, 60, 66].
Due to the broad differences in physicochemical characteristics of CNT/F including
agglomeration, length, diameter, and respirability, extrapolations and predictive modeling have been
severely limited. This study aims to generate an accurate and effective safety profile for a series of
MWCNT/F of various physicochemical characteristics. Specifically, in this portion of the study, Part III,
an in-depth evaluation of histopathology and systemic translocation was completed to assess differences
in a particle’s ability to induce long term structural changes in the lung as well as the potential for
adverse systemic effects.
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4.3. Results and Discussion:
The nine materials used in this study were selected to represent the broad class of CNT/F. In brief,
seven MWCNT and two CNF were ordered according to their diameter as reported by the production
facility and are referred to as MW #1-7 and CNF #1-2 (Figure 1). MWCNT-7/Mitsui-7, labeled as MW
#5 in this study, was used as a benchmark material for comparison. Analyses and interpretation of detailed
physicochemical characteristics and genotoxicity [182] were presented separately. In this section of the
evaluation of CNT/F toxicities, in vivo assessments for pathological changes and translocation were
compared and correlated to physicochemical characteristics. Male C57BL/6J mice were exposed to 40 µg
of CNT/F or DM via oropharyngeal aspiration and euthanized at 1 and 84 d post-exposure. Historically,
a 40 µg dose of CNT/F was sufficient to induce pathological changes within an 84 d post-exposure time
point and necessary to induce significant alveolar fibrosis [9, 10, 19, 51]. Liver, tracheobronchial lymph
nodes, and right lungs were fixed with formalin with the lungs being gravity filled to preserve inflation to
evaluate particle distribution, alveolar fibrosis, and other histopathology changes.
Additional assessments in vitro were used for comparison and to further investigate the
mechanisms by which the pathological changes occurred. For comparison, human fibroblast cells were
cultured and exposed to 0-20 µg/ml of each of the nine CNT/F for 24 hours and subsequently assessed for
cell viability and proliferation as well as collagen-1, α-smooth muscle actin, and TGF-β production.

4.3.1. Particle characterization
The CNT/F used in this study were extensively characterized in a previous publication and can be
found in the supplementary data (Supplementary Tables 1-3, Supplementary Figures 1-2) [182].
Representative micrographs from transmission electron microscopy (TEM) images of each particle are
shown in Figure 1. It was quite evident that as CNT/F increase in nominal tube diameter and length, a
general decrease in bundled agglomeration was observed with a transition point around MW #4. MW #1
and #3 were predominately spherical agglomerates with a geometric mean under 1 µm (Supplemental
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Table 2). MW #2 was a unique high entangled MWCNT as previously described [19, 182] that forms two
separate populations of extensive ‘rivers’ of aggregates, and agglomerates of aggregates, in the micron
size range (Figure 1; Supplemental Table 2). MW #4-7 and CNF #1-2 were almost exclusively bundled
agglomerates exceeding a 3:1 aspect ratio (≥ 96 %) or as singlets.

4.3.2. Histopathology
For comparative potency between materials, 40 µg CNT/F is a known administered dose to induce
pathology including alveolar fibrosis. Previously we have indicated this dose to likely exceed a lifetime
exposure at average exposure levels in U.S. facilities [68, 164]. The goal of this study was less concerned
with deposited dose with relation to human equivalency as compared to relative potency. Combined with
the known fact that MW #5 (Mitsui-7/MWCNT-7) does not induce a significant alveolar fibrosis up to 20
µg, the dose of 40 µg was selected to be able to evaluate differences of effect between the nine CNT/F [9,
10]. A representative micrograph of healthy control tissue can be found in Figure 2A.
At 84 d post-exposure, CNT/F often caused granulomatous inflammation, defined as an organized
infiltrate of epithelioid macrophages which may form giant cells and are often admixed with lymphocytes,
plasma cells, and fibrosis. Diagnoses within this category included granulomatous bronchopneumonia,
but also included histiocytic bronchopneumonia, granulomatous bronchointerstitial pneumonia,
lymphogranulomatous interstitial pneumonia, and granulomatous alveolitis. An example image can be
found in Figure 2B. The distribution and severity of the granulomatous response was significant among
all treatment groups (Table 1).
Morphologic responses to CNT/F sometimes included proliferative changes within airways that
sometimes obstructed the lumen bronchioles and alveolar ducts. These were classified as proliferative
bronchiolitis obliterans (Figure 2C) when bronchioles were affected. If the alveolar ducts were involved,
these were classified as bronchiolitis obliterans-like lesions of the alveolar duct. These potentially
153

obstructive lesions often formed in association with granulomatous inflammation and projected into the
lumen of bronchioles and alveolar ducts. MW #1, 5 and CNF #2 did not induce proliferative bronchiolitis
obliterans or bronchiolitis obliterans-like morphologic alterations and the incidence was only 1/5 for MW
#3 (Table 1). MW #4 had incidence in half the analyzed lungs, but significance was not reached in terms
of severity and distribution. MW #2, 6, 7, and CNF #1 induced significant bronchiolitis obliterans-like
changes (Table 1). We have previously shown proliferative bronchiolitis obliterans lesions to occur
following MW #2 exposure consistent with the large aggregates [19].
In the alveolar region of the lungs, mice exposed to CNT/F often had accumulations of alveolar
macrophages, a finding also known as alveolar histiocytosis (Figure 2D). In some cases, alveoli with
alveolar macrophage accumulation also showed evidence of a tissue response (histiocytic alveolitis)
and/or neutrophils accompanied the macrophages (histiocytic and neutrophilic alveolitis). Because the
responses represented a spectrum of predominantly histiocytic responses, these diagnoses were grouped
together in the summary table. All CNT/F induced alveolar histiocytosis except for MW #2 (Table 1), the
CNT with larger aggregates and agglomerates that has less alveolar deposition compared to other CNT/F
[19].
Exposed mice also developed hypertrophy of the bronchiolar epithelium as well as alveolar
epithelial hypertrophy and hyperplasia (Table 1; Figure 2E-F). Particle deposition and persistence were
necessary for bronchiolar hypertrophy and alveolar hypertrophy and hyperplasia. MW #1 and #3 did not
induce bronchiolar epithelial hypertrophy while MW #2 did not induce alveolar epithelial hypertrophy
and hyperplasia. MW #4-7 and CNF #1-2 had significant effects for both.
Additional morphologic changes regarding lymphatics are of note. The lymphatics of the lung
control interstitial fluid balance, transport cells of the immune system, and participate in particle clearance
in the lung [183-185]. In this study, particle accumulation, particularly in materials of longer length, could
be found at the bronchoalveolar junction, the location of some of the smallest lymphatic vessels (Figure
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2G). This accumulation has the potential to obstruct lymphatic flow and may be a mechanism for
decreased clearance in fibrotic and inflamed airways. Similarly, needle-like particles can damage
macrophages attempting to reach the areas of smaller lymphatic flow surrounding the terminal bronchioles
resulting in further particle accumulation. Even when unobstructed by previous particle deposition,
clearance of long, somewhat rigid particles may be difficult in the narrow and curving lymphatic
pathways. Ectasia, or dilation, of lymphatic was observed as was also previously reported following
MWCNT exposure [51]. It remains to be determined whether pleural accumulation of CNT/F and the
airway fibrosis were attributable to altered lymphatic clearance, if airway fibrosis attributed to altered
particle clearance, or both. However, in some cases clusters of CNT/F could be seen extending from
dilated lymphatic through the airway wall to the surface of airways suggest lymphatic obstruction and
potential release of CNT/F back into airways (Figure 2G). Furthermore, lymphatics are not restricted to
the pulmonary lobule, but also present in interlobular septa and the pleura [185]. Macrophages containing
particles often traffic to the lymphatics to clear particles from the lung. Additionally, macrophagemediated transport of CNT/F to pleural lymphatics can potentially release CNT/F near the pleural lining
if the particles are cytotoxic. At least more than one incidence of pleural penetration or accumulation at
the pleural surface was seen following MW #5-6 and CNF #1-2 exposures, though more refined techniques
such as enhanced darkfield microscopy may be necessary to definitively conclude that some, but not all
particles were capable of pleural penetrations (Figure 2H). MW #5 has been previously reported to
penetrate the pleura, though it is unclear if all particles, particularly spherical agglomerates (e.g., MW #1
and #3) may penetrate the visceral pleura [51].

4.3.3. Histopathologic assessment of pulmonary fibrosis
Severity and distribution for two types of pulmonary fibrosis, bronchial / bronchiolar and alveolar,
was determined (Table 1, Figure 2I-J). Bronchial and bronchiolar fibrosis occurred frequently in
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conjunction with bronchiolitis obliterans and/or granulomatous inflammation. Incidence of 100% was
observed for MW #5-7 and CNF #1. MW #2 also had 100 % incidence given the nature of the highly
entangled particle that deposits significantly in the conducting airways [19]. MW #1, #3, and CNF #2,
although not without effect, had less severity and distribution. Histopathologic assessment of alveolar
interstitial fibrosis indicated greater severity and distribution with MW #4-7 and CNF #1 as compared to
other materials, especially MW #3 and CNF #2 (Table 1).

4.3.4. Morphometric analysis of pulmonary fibrosis
To further investigate pulmonary fibrosis, bronchiolar and alveolar fibrosis was quantitatively
evaluated by morphometry. To measure fibrosis in the terminal bronchioles, photomicrographs were taken
of trichrome-stained lung sections. Using ImageJ, the area of bronchiolar fibrosis, the total area of the
region, and the length of the basement membrane were measured. This enabled calculation of the area of
fibrosis per micron of basement membrane (Figure 3) and as percent area of fibrosis per area of the total
field of view (Supplemental Figure 3). Two distinct regions were systematically sampled in each lung
section: 1) areas of minimal to no severity, or least affected bronchioles, and 2) areas of most severe
fibrosis, or most affected bronchioles. In the least affected areas, no significant differences were seen from
control (Figure 3A). For the most affected regions, a significant increase in bronchiolar fibrosis was
measured in MW #2, 4-7 and CNF #1 exposed lung tissue, but not for MW #1, 3, or CNF #2 (Figure 3B).
Fibrosis was consistent with areas of prominent particle deposition, particularly areas with particle
agglomerates. Similar findings were reported by Duke et al. in 2018 in which they quantified the area to
perimeter ratio of airway fibrosis and found that “rod-like” MWCNT that are similar in morphology to
MW #5-7 and CNF #1-2 of the present study were more likely to induce greater airway fibrosis than
“tangled” MWCNT similar to MW # 1 and #3 in the present study [124]. These differences in airway
fibrosis were attributed to variability in clearance mechanisms and the translocation of “rod-like” particles
156

across the epithelium where pathways driving fibroblast activity can be initiated. Interestingly, CNF #2,
while having a diameter more like MW #5-7 and CNF #1, did not induce significant bronchiolar fibrosis
as measured by morphometry. This may be due to the smaller nominal tube lengths (Supplemental Table
1; Supplemental Figure 2). These findings support the conclusion that the physical presence of particle
deposition in airways, with physical dimensions of greater diameter and length, act as a potent driver of
airway fibrosis.
Alveolar fibrosis is a well-documented outcome following CNT exposure [9, 10, 51].
Morphometric point and intercept counting was used to measure the thickness of alveolar fibrillary
collagen at 84 d post-exposure. Fibrillary collagen was significantly increased in mice exposed to MW
#5-7 and CNF #1 (Figure 4A). Representative micrographs of vehicle exposed as well as MW # 3, 6, and
CNF #1 can be found in Figure 4B-E respectively. This fibrosis was also related to the presence of particle
in the interstitium. The increased alveolar fibrosis of MW #5 exposed lungs was consistent with previous
investigations [9, 10]. Increases were found for MW #1, MW #4, and CNF #2 but significance was not
achieved, suggesting a greater than 40 µg delivered dose would be necessary to induce significant alveolar
fibrosis. Mercer et al., compared single-walled (SW)CNT and MWCNT rodent lung exposures and
reported that macrophages were less likely to recognize and phagocytose SWCNT compared to MWCNT,
leading to greater interstitial accumulation and fibrosis [9]. As the size of MW #1 in the current study
approaches the size of SWCNT, it is suspected that the infrequent singlet or very small agglomerates may
escape macrophage recognition permitting translocation to the alveolar interstitium and induction of
interstitial fibrosis, therefore behaving in a similar fashion to SWCNT resulting in the mild but not
significant increase in interstitial fibrosis. There was no effect for MW #2 or #3. This was expected for
MW #2 given the sample is less likely to accumulate in the alveolar region [19]. Of note, several instances
were observed, particularly in MW #3 exposed lung tissue, where small agglomerates of particles were
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present in the interstitium, but fibrosis was not present, suggesting that particle singlets were more likely
to induce fibrosis than tangled agglomerated particles (Figure 4C).

4.3.5. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) of the
histopathology outcomes
HCA and PCA were performed to group CNT/F by adverse histopathology. Initially all outcomes
assessed were analyzed (Figure 5). Overall, severity of response was greater for MW #4-7 and CNF #1 as
compared to MW #1-3 and CNF #2 which grouped more closely with the sham group. These results were
intriguing as the lesser responding grouping included a large nominal diameter material in CNF #2 as well
as MW #2 which primarily has bronchiolar effects. To segregate regional effects, the alveolar and
bronchiolar responses were evaluated separately. The bronchiolar effects were like the overall response
except for MW #2 which corresponded in response more closely with MW #6 and #7 (Figure 6A). MW
#1, #3, and CNF #2 localized with the sham exposed mice indicating minimal to no bronchiolar effects.
The analysis to address specifically the alveolar outcomes indicated that MW#5, #7, and CNF #1 had
significant effects compared the remaining materials (Figure 6B). These three materials segregated out as
they induced marked responses in all five alveolar assessments (Figure 5, Table 1). The other materials
had variable significance in alveolar responses. MW #2 and #3 induced milder responses in general with
the exception of granulomatous inflammation and MW #4 and #6 had generally stronger effects than MW
#2 and #3 but less than MW #5, #7, and CNF #1 (Figure 6B, Table 1). In summary MW #5, #7 and CNF
#1 overall induced the strongest with effects in both the bronchiolar and alveolar regions hence their close
clustering in Figure 5. MW #4 and MW #6 were positive in effect for bronchiolar and alveolar effects but
generally milder compared to MW #5, #7 and CNF #1. MW #1-3 and CNF #2 generally induced milder
or specific regional effects as was the case with MW #2 in the bronchiolar region.
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4.3.6. HCA and PCA of the histopathology outcomes with physicochemical characteristics
The next step was to include the physicochemical characteristics to provide inference into specific
characteristics that contributes to developing pathology. The analysis was done in three ways: 1) detailed
characterization of binned length (L) and diameter/width (labeled as W for figure clarity for easier
distinction from L); 2) standard physicochemical data using means only from Supplemental Tables 1-3;
and 3) the combination of binned length and diameter/width and means only data. The data were generated
for all pathology outcomes as well as bronchiolar and alveolar separately. Previously we have shown that
the binned length and diameter provided the resolution to accurately group CNT/F in comparison to using
means only [182]. In fact, the grouping using binned length and diameter alone was comparable to
extensive characterization of all physicochemical parameters. For the histopathological outcomes in this
study, adding the physicochemical characteristics did not exactly group as outcomes alone. Variations of
MW #1-4 were typically in the lower responding group with remaining materials in the more toxicity
group (Figures 7-8; Supplemental Figures 4-9). The analysis of outcomes with physicochemical
characteristics indicate that MW #1 and #3 consistently are of lower toxicity compared to MW #5-7 and
CNF #1. MW #4 and CNF #2 represent a transition in toxicity from less to greater severity.
For alveolar pathology responses, in general all analyses highlighted associations with length, the
larger

length

bins,

and

the

agglomeration

state

(per_bundle_agglomerate_singlet,

bundle_agglomerate_mean_length, bundled_agglomerate_mean_diameter). These results indicate that
materials which contain nominal tubes with larger lengths, which were more prevalent for MW #5, #7,
and CNF #1 (Supplemental Figure 2) can induce more significant injury to the alveolar region. This was
consistent with the material grouping for alveolar effects alone (Figure 6B) and with physical dimension
binning (Figure 8B). The two-dimensional sizing was also a key factor in predicting alveolar pathology.
MW #1 and #3 clearly form more spherical agglomerates (Supplemental Table 2). MW #4 was the
transition point switching from majority spherical agglomerates to bundled/elongated agglomerates. The
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switch from spherical agglomerates to more elongated agglomerates and singlets is driven by increasing
physical size. Therefore, as increasing length corresponds more with general severity of alveolar
pathology, association with the transition away from spherical agglomerates (e.g., MW #1 and MW #3)
was consistent. The inclusion of binning of the physical dimensions was able to better separate
granulomatous inflammation from the rest of the alveolar-associated pathology with an association of the
L2, L4, and W0.05 bins (Figure 7 and 8B). As all materials induced granulomatous inflammation (Table
1), correspondence with the smaller length bins, something that was consistent for all samples
(Supplemental Figure 2), were the associated drivers. Using means only (Supplemental Figure 7 and 9),
the association of granulomatous inflammation and alveolar interstitial fibrosis did not provide
associations with any physical dimensions of length or width.
For bronchiolar pathology responses, the primary physicochemical characteristics driving the 4
measured outcomes were bundle_agglomerate_mean_length as well as longer lengths and wider diameters
(e.g., L25, L30, and W0.15). This indicates a combination of increasing length and width, with a larger
bundle_agglomerate_mean_length (e.g., MW #6 and #7) conferred greater bronchiolar toxicity. The
analysis of bronchiolar effects alone grouped MW #1, MW #3, and CNF #2 with the sham group suggested
a diminished response. This was intriguing given CNF #2 is a larger diameter material. Looking in more
detail at the physicochemical characteristics, CNF #2, while having an increased diameter, did not have
the corresponding increased length, especially in comparison to CNF #1 (Supplemental Figure 1 and 2;
Supplemental Table 1). This was further illustrated for the bundle_agglomerate_mean_length for CNF #2
that was closer to MW #1 than CNF #1 (Supplemental Table 2). Overall, increasing length and diameter,
corresponding to bundled agglomerate that are larger than a 3:1 ratio conferred greater bronchiolar toxicity
which can be stratified as MW #6 and MW #7 > MW #4, MW #5, and CNF #1 > MW #1, MW #3, and
CNF #2. We confirmed the conducting airway effects of MW #2 as the larger of the two subpopulations
of aggregates/agglomerates was too large to reach the alveolar space and had the largest
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bundle_agglomerate_mean_length. The L2, L4, and W0.05 bins did not correspond to any bronchiolar
effects (Figure 7 and 8A), which was consistent with those factors primarily driving alveolar
granulomatous inflammation.

4.3.7. In vitro fibrosis assessments
Human fibroblasts were used in this study to investigate the mechanisms driving fibrosis outcomes
observed in vivo and to explore the efficiency of this in vitro system to model in vivo observations. The
same nine CNT/F were used at concentrations of 0-20 µg/ml ranging from occupationally-relevant to
overtly high doses in order to observe the full range of potential effects. These concentrations correlate to
roughly 0-100 µg doses respectively in vivo for mice. Using a WST-1 assay, the percentage of cell viability
and proliferation was quantified (Figure 9A). Within this dose range, minimal changes in cell viability
were seen suggesting that doses up to 0.2 µg/ml did not induce cell death.
Fibroblasts are the key generators of collagen-1, the main collagen isoform comprising pulmonary
fibrosis. Western blot was used to quantify collagen-1 production following 0.06 µg/ml exposure.
Collagen-1 outputs were variable, though CNF #1 did induce a significant increase (Figure 9B).
Additionally, α-smooth muscle actin was not significantly increased following 0.06 µg/ml particle
exposure in any treatment group (Figure 9C). Previous studies have demonstrated the key role of TGF-β
as an upstream modulator of pulmonary fibrosis. TGF-β was also variable between particle exposures and
doses in a manner that did not always correlate to dose (Figure 9D). However, as a general trend, materials
MW #4-7 and CNF #1-2 induced greater TGF-β production.

4.3.8. Hierarchical clustering and PCA of the fibroblast outcomes with physicochemical characteristics
The initial analysis of the four fibroblast endpoints (Figure 10), cell viability with collagen, αSMA,
and TGFβ protein levels, did not correspond to in vivo for all histopathological outcomes (Figure 5) or
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separation of alveolar (Figure 6B) or bronchiolar outcomes (Figure 6A) especially with MW #7 closely
associated with MW #2, #3, and control cells. The additional of the physicochemical characteristics
(Supplemental Figure 10-11) with outcomes offered something closer to the in vivo outcomes in that MW
#7 and CNF #1 grouped as did MW #1 and control cells. While this was the case, collagen and TGFβ
production group separately. Collagen and SMA group with larger lengths and diameters while TGFβ
grouped with smaller length and diameters (Supplemental Figure 10 and 11B). Previous in vitro studies
have investigated the role of TGFβ in collagen production and found that SWCNT and MWCNT induced
TGFβ1 production and subsequent collagen-1 production through the SMAD signaling cascade [186].
Furthermore, TGFβ and SMA are associated with the epithelial-mesenchymal transition (EMT) of
pulmonary epithelial cells to a migratory cell phenotype associated with cancer and metastasis, and has
been found to drive similar EMT outcomes in other nanoparticle exposures including cerium oxide [187189].
While the in vitro data did not fully represent findings in vivo, we can conclude that fibroblast
monocultures alone may not accurately represent in vivo findings due to the complex interactions of
several cell types and the structure of the extracellular matrix. Alternative, more advanced methods such
as co-culture and air-liquid interface models may be more inclusive of the complexities absent in
monoculture and may be employed in future experiments. Had a smaller in vitro study been conducted,
such as MW #1 compared to MW#7 or CNF#1, the conclusion could have been made that larger physical
diameter and length materials cause a greater response when considering outcomes alone. When
examining a broader set of materials at one time, those conclusions were not as apparent.

4.3.9. CNT/F Singlets one day post-exposure
To assess the particle distribution at 1 d post-exposure, dark-field microscopy was employed to
visualize CNT/F present in the lung tissue. Dark field microscopy allows for the detection and imaging of
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singlets that are not typically visible using standard light microscopy. Representative images are shown
in Figure 11. Materials of smaller diameter that form spherical agglomerates are likely to be seen within
macrophages (Figure 11A, 11C). However, as the materials increase in diameter becoming less
agglomerated, singlets were more abundant (Figure 11D-I). Bundled agglomerates are still frequently seen
within macrophages, but some singlets can be seen within the alveolar interstitium. MW #2 due to its size
limited alveolar deposition was mostly found in the bronchioles and the terminal bronchioles (Figure 11B).
Singlet lung burden was quantitated and expressed as 100% of MW #5, the reference material evaluated
previously for translocation [64]. Materials of primarily small nominal tube diameter and length were less
likely to be present in singlets. However, with an increase in the number of tubes with larger diameter, the
number of singlets increased. MW #4 and 5 have the greatest number of singlets present in the lung, with
MW #6, #7, and CNF #1 having a significant number of singlets present, but less that MW #4 or #5 (Figure
12A). CNF #2 had a moderate burden of singlets, but less than MW #6, 7, and CNF #1. It was intriguing
that further increasing diameter (e.g., CNF #1 and #2) and length (e.g., MW #7) did not continue to
increase singlets within the lung with translocation to the liver suggesting a sweet spot in terms of physical
dimensions for MW #4 and MW #5.

4.3.10. Translocation
CNT/F mostly are biopersistent materials with minimal alveolar clearance, even up to one year
post-exposure [9]. However, while this clearance is minimal, particle is known to translocate from the
lung to other systemic tissues including kidney, liver, spleen, brain, and bone marrow [59, 60, 64, 66].
Understanding systemic translocation of CNT/F is important as the ability to induce systemic effects may
potentially occur as a direct result of CNT/F interaction on other tissues. Particle which reach the alveolar
space will often first be cleared in rodents to the tracheobronchial lymph nodes (TBLN) located in close
proximity to the lungs [60]. Green counterstain (Figure 12) was used to visualize black particle
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agglomerates, while dark-field microscopy (Figure 13) was used to assist in the visualization of singlets
within the TBLN at 84 d post-exposure. All materials were able to translocate to the TBLN to various
degrees of severity and were often contained within cells. MW #1 and #3 were present mostly as spherical
agglomerates similar to alveolar deposition at d 1 post-exposure (Figure 11, 13, and 14). However, MW
#4-7, and CNF #1-2 were found as both bundled agglomerates and singlets (Figure 13D-I; Figure 14D-I).
MW #2, given the large agglomerates/aggregates and greater deposition in the conducting airways, did
not translocate to the TBLN with the exception of rarely seen small agglomerates (Figure 13B; Figure
14B).
Of note, many of the singlets present in the TBLN were quite long in length, beyond the ability to
be engulfed by a single macrophage. These longer CNT/F may appear in the TBLN as bundles. It is
suspected that the particles may arrive as singlets, though their length results in particles being trapped at
areas of narrow lymphatic flow, resulting in a dam of particles being generated leading to impaired
clearance or potentially damaged lymphatics [64]. Alternatively, macrophages may play a role in particle
translocation to the TBLN. CNT/F that are smaller and more tightly agglomerated may be more effectively
phagocytosed by macrophages. Therefore, macrophage mediated transport to the TBLN may be greater
for materials of smaller agglomerate size (e.g., MW #1 and #3).
In conjunction with CNT/F exiting the lung and accumulating in the TBLN, translocation to the
liver at d 84 post-exposure was quantified (Figure 12B). This quantification was presented in comparison
to MW #5, the reference material. MW #1-#3 had minimal to no particle translocation to the liver.
However, MW #4 had translocation to the liver at a slightly greater level than MW #5. A representative
dark-field micrograph of MW #4 can be found in Figure 12C. Moderate translocation occurred for MW
#6, #7, and CNF #1 (~25-50% of MW #5) with some translocation for CNF #2 (~10% of MW #5). CNT/F
in the liver was only present as singlets.
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Due to the apparent trend between particle singlet burden at 24 hours post-exposure and extra
pulmonary translocation of particle to the liver at 84 d post-exposure, this correlation was assessed using
linear regression (Figure 9D). A clear trend can be seen in which particles can be binned into three distinct
groups. The first group containing MW #1-3 has no to minimal translocation to the liver and singlets in
the lung at 1 d post-exposure. The median group has a moderate amount of singlet lung burden with a
fractional percentage translocating to the liver. This group contains MW # 6-7, and CNF #1-2. The final
group contains MW #4-5. These two materials had the most singlet burden in the lung as well as the
highest percentage of liver translocation. Using this trend, it may become possible to predict extra
pulmonary translocation to the liver at later time points based solely on particle singlet lung burden at
acute time points.

4.3.11. Hierarchical clustering and PCA of the translocation outcomes
Clustering of lymph node accumulation, one d singlet lung burden, and 84 d accumulation in the
liver provided a similar segregation of materials as Figure 14D (Figure 15A). MW #4 and #5 were paired
and associations between MW #6, MW #7, CNF #1, and CNF #2 were also present. MW #2 was very
similar to the controls and MW #1 and #3 were mostly driven by lymph node accumulation. In the three
scenarios of physicochemical characteristics, all variables (Supplemental Figure 12), means only
(Supplemental Figure 13), and binned physical dimensions only (Figure 15B), the characteristics
illustrating the properties the CNT/F have in dispersion solution, spherical bundles (e.g., MW #1 and #3)
vs elongated bundled agglomerates (MW #4-#7, CNF #1-#2) offer a prediction of whether the potential
exists for singlets to be found within the lung with subsequent liver accumulation. What was not readily
apparent from our analyses was the physicochemical characteristic separating MW #4 and MW #5 from
the rest of the materials in terms of a greater propensity for liver accumulation. The upper range of length
and width dimensions were not a predictive determinant, especially when considering MW #4 (Figure
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15B). The binning of nominal tube physical dimensions (Figure 15B), as opposed to using means only
(Supplemental Figure 13), created a separation of lymph node accumulation from 1 d pulmonary singlets
and 84 d liver accumulation suggesting that lymph node accumulation alone was not a prerequisite for
liver accumulation. The binning also indicated that the smaller length and width parameters (e.g., L2, L4,
and W0.15), something that all materials exhibited to some extent, were predictive of lymph node
accumulation. These parameters would be consistent with alveolar macrophage uptake and transport to
the lymph nodes.
MW #4 and #5 accumulating more in the liver compared to other materials suggests multiple
contributing factors and/or physicochemical characteristics not determined in this study and may
correspond to the rate at which singlets in the lung develop. For example, Mercer et al. 2013 using the
same materials as MW #5 from this study, classified singlets, and groups of 2, 3, 4, or >5 CNT at 1, 14,
and 168 d post-exposure [10]. While MWCNT in agglomerates containing many fibers decreased at 168
d post-exposure, singlet burden did not significantly change. This was concluded to be due to clearance
of singlets from the lung, while particle bundles were disassociated into singlets at a rate that gave the
impression singlets were not cleared from the lung. While the rate of singlet burden and agglomerate
disassociation over time was not determined in this study, it likely would offer insight into the prevalence
of MW #4 and #5 to accumulate in the liver more readily. The liver accumulation could be the result of
cell mediated transport, cell independent transport, or perhaps a combination of both. Previous studies
have shown that CNT/F exposure disrupts lung epithelial barriers [190] as well as vascular integrity [88,
191]. This disruption in combination with the lipophilic nature of CNT/F may increase particle passage
through membranes and vascular walls resulting in particle entry into systemic blood flow. The
combination of the propensity to generate singlets in the lung, the potential for cell dependent and
independent transport, suggest a potential nonspecific particle accumulation in tissues such as the liver.
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Interestingly, using the binned approach of physical dimensions, TBLN accumulation was
separated from translocation to the liver suggesting a potential different or additional mechanism such as
cell mediated transport (Figure 15B). Given MW #1 and #3 accumulated in the TBLN like other CNT/F
but was rarely visualized in the liver, does not necessarily reject the notion of systemic accumulation in
other tissues. MW #1 and #3 were observed within cells in the TBLN. If those cells were to enter the
general circulation, perhaps immune filtering organs such as the spleen would preferentially have
accumulation. While the spleen was not examined for this study, our previous work examined MW #3 at
the same dose and 84 post-exposure time point [19]. The tissues from that study indicated significant
accumulation in the spleen as compared to the liver (Supplemental Figure 14). These results suggest
differential accumulation systemically depending on whether the material forms singlets in the lung or
remains in bundled agglomerates that macrophages can scavenge.

4.3.12. Summary
The overall goal of this study was to assess severity in pulmonary histopathology and
extrapulmonary particle translocation at a sub-chronic time point from CNT/F exposure of various
physicochemical characteristics. In depth histopathological analysis was completed to assess both the
severity of tissue changes and injury as well as the regional distribution of those changes. Furthermore,
translocation to the proximal lymph nodes and liver were assessed. The standard toxicological outputs
indicated obvious differences between materials that was put into perspective using computational
analyses.
Previously with a combination of genotoxic responses (Fraser et 2020), CNT/F with larger
physical dimensions, a combination of length and diameter, conferred greater toxicity. This was generally
the case for histopathology outcomes, especially MW #5-7 and CNF #1. Regional specificity was noted
for some as MW #2, a highly entangled material, only had bronchiolar effects while CNT #2 lacked
marked bronchiolar effects. The importance of combined length and width was the separation between
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CNT #2 and MW #5-7 and CNF #1, as CNT #2 had a reduced length and bundled agglomerate mean
length. MW #1 and #3, while not observed as singlets in the lung, were not without effect. Those materials,
primarily in the L2, L4, and W 0.05 bins exhibited granulomatous inflammation as the small spherical
bundles can easily deposit in the deep airways. The lack of larger physical diameter nominal tubes and
singlets in MW #1 and #3 was the likely reason for a lack of bronchiolar effects and significant alveolar
fibrosis.
Prior studies with MW #5 (Mitsui-7/MWCNT-7) indicated that singlet carbon nanotubes in the
lungs were the form responsible for transport and general accumulation in extrapulmonary organs. In the
present study, where a wide range of CNT/F species were examined, the one day singlet in the lung was
compared to the 84 day liver singlet burden to determine if that relationship between initial lung singlet
burden and extrapulmonary transport was present. We found the initial singlet lung burden to be quite
variable with very few if any singlets for MW #1-3. MW #4-7 and CNF #1-2 were able to form singlets.
Liver accumulation was most apparent for MW #4 and #5 followed by MW #6-7 and CNF #1.
Evaluating the general similarity in initial lung singlet and liver accumulation indicated the initial
dispersion in the lung was a relatively strong determinant for subsequent liver accumulation 84 days
later. The significance of those findings suggests the potential for predicting singlet translocation out of
the lung early and using computational modeling to group materials can predict which materials were
more likely to translocate from the lung.

4.4. Conclusions
•

The broad class of CNT/F resulted in variable pathology and severity of outcomes. The
smaller diameter and length materials, which was present in most all CNT/F, consistently
resulted in granulomatous inflammation and alveolar effects. The addition of populations
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of CNT/F with both and increased nominal tube diameter and length induced bronchiolar
pathology and increased the severity of alveolar pathology.
•

CNT/F containing nominal tubes of increased length and diameter caused ectasia of the
lymphatics. Accumulation at the bronchoalveolar junction may contribute to alveolar
fibrosis and pleural accumulation by obstructing clearance mechanisms.

•

Similar to our previous evaluations, binning of physical dimensions (length and
diameter/width) offered greater resolution in determination of specific physicochemical
characteristics contributing to various aspect of developing pathology [10]. The
combination of how the CNT/F agglomerate, or two-dimensional sizing, and binning of
nominal tube physical dimensions were the best segregators of predicting pathology.
Traditional characterization of means only did not offer great resolution for effect
determination.

•

In terms of toxicity outcome alone and our study design, fibroblasts did not group materials
as the in vivo evaluations. Perhaps a different approach than a single cell submerged
cultures would provide different outcomes.

•

The transition of materials from spherical (MW #1 and #3) to elongated bundled
agglomerates (MW #4-7, CNF #1-2) corresponded to visualization of singlets in the lung.

•

Lymph node accumulation was consistent for all CNT/F except for the highly entangled
MW #2. Conversely, liver accumulation was only singlets from MW #4-7 and CNF #1-2.
In complement, computational modeling using binning of physical dimensions separated
lymph node accumulation from day 1 lung singlets and day 84 liver accumulation. Despite
the detailed characterization, there was no clear explanation as to why there was a greater
propensity for MW #4 and #5 to translocate to the liver more proficiently than all other
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materials. Irrespective, day 1 singlets visualized in the lung was a good predictor for
accumulation in the liver 84 days later.
•

As previously indicated for genotoxicity outcomes, the increased length and diameter
CNT/F contributing to greater severity in pathological outcomes do not need to be the
major fraction of nominal tubes in the sample [10]. A small proportion of tubes with those
characteristics were sufficient to alter the severity of the toxicity profile.

4.5. Materials and Methods:
4.5.1. Materials
Nine materials were assessed in this study including seven multi-walled carbon nanotubes and two
carbon nanofibers and are the same materials used in this series of studies. These materials are produced
or used in U. S. facilities with the exception of MWCNT #5, the well-known MWCNT Mitsui-7 which
was used as a benchmark material in this study. These materials were extensively characterized as
previously reported.

4.5.2. In vivo study design
Male C57BL/6J mice ages eight to ten weeks were exposed by oropharyngeal aspiration to either
vehicle (physiologic dosing medium; DM), one of seven multi-walled carbon nanotubes (MW #1, MW
#2, MW #3, MW #4, MW #5, MW #6, or MW #7), or one of two carbon nanofibers (CNF #1 or CNF #2).
Only the high dose of 40µg was used in this study. Previous studies have shown that a 40 µg dose of the
benchmark material was necessary to induce pathological changes, making it necessary for this study.
Mice were euthanized at either 1 or 84 d post-exposure and tissue was collected to assess changes in
histopathology as well as systemic translocation.
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4.5.3. Animals
Male C57BL/6J pathogen-free mice weighing 20-25g were obtained from Jackson Laboratories
(Bar Harbor, ME) and were housed in the Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC)-accredited NIOSH animal facility. Mice were provided food and tap water ad
libitum in ventilated cages, on autoclaved hardwood chip bedding and an environment of controlled
humidity, temperature, and 12:12 light/dark cycles. Animals were allowed to acclimate for at least seven
d prior to use in any experiments. Animal care and use procedures were conducted in accordance with the
“PHS Policy on Humane Care and Use of Laboratory Animals” and the “Guide for the Care and Use of
Laboratory Animals” (2011) and the procedures utilized in this study were approved by the National
Institute for Occupational Safety and Health Institutional Animal Care and Use Committee.

4.5.4. Facility representative material preparation and in vivo dosing
Fresh dosing media (DM) was prepared prior to dosing. Dosing media contained mouse serum
albumin (0.6 mg/ml) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC; 0.01 mg/ml) prepared in
United States Pharmacopeia (USP) grade-phosphate buffered saline (PBS) without calcium and
magnesium. To disperse the particles in DM, samples were sonicated for 5 min at the highest setting using
an external sonicator (Hielscher Ultrasound Technology) and then for 5 min using a Branson Sonifier 450
probe sonicator set to the lowest setting (10% duty cycle; output control of 1). Mice were dosed by
oropharyngeal aspiration according to the well-established protocols previously described [179].

4.5.5. Tissue collection
Mice were sacrificed at either 1 or 84 d post-exposure. Following an intraperitoneal injection of
fatal plus, the abdomen was exposed, and mice were exsanguinated. The right lung was ligated and inflated
with 10 % buffered formalin by gravity fixation. The liver and tracheobronchial lymph node were also
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removed and formalin fixed. Fixed tissue was then embedded in paraffin wax, cut into 5 µm sections, and
mounted on slides for staining.

4.5.6. General Histopathology
H&E and trichrome stained tissue section were assessed by a board-certified veterinary
pathologist. At 84 d post-exposure to 40 µg CNT/F or vehicle (n=4-8 per group), The right lung was fixed
in 10% neutral-buffered formalin and then stained with either Masson’s trichrome stain or hematoxylin
and eosin (H&E). Two semi-quantitative scores were assigned for each morphologic alteration. The
severity score is the numerical equivalent of the following intensities of tissue morphologic change: 0=
none, 1= minimal, 2= mild, 3= moderate, 4= marked, and 5= severe. The second was a distribution score
to quantify the extent (amount) of the tissue involvement. The distribution scoring is as follows: 0= none,
1= focal, 2= locally extensive, 3= multifocal, 4= multifocal and coalescent, and 5= diffuse. These scores
were combined to generate a total score ranging from 0-10 with 10 a severe and diffuse injury. These
scores as well as incidences are listed in Table 2 and representative micrographs of the morphologic
alterations are found in Figure 2.
Lung tissue from 84 d post-exposure was sectioned and mounted on slides where it was stained
with either Masson’s Trichrome stain or hematoxylin and eosin (H&E). H&E-stained slides were
examined by a veterinary pathologist using bright field microscopy and polarizing light microscopy.
Changes in morphology as well as areas of tissue injury and inflammation were assessed and scored for
both severity (1 = minimal, 2 = mild, 3 = moderate, 4 = moderately severe, and 5 = severe) and distribution
(1=focal, 2= locally extensive, 3= multifocal, 4= multifocal and coalescent, 5= diffuse). These scores were
then added together to create a total score out of a possible 10, with 10 being the most severe and diffuse.
Photomicrographs were captured using an Olympus BX53 microscope equipped with a DP73 camera
(Olympus, Tokyo, Japan).
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4.5.7. Morphometry and alveolar fibrosis
Morphometric analysis was used to measure changes in alveolar fibrosis. Lung sections from 84 d
post-exposure were stained with picrosirius red to detect collagen fibers as previously described [10].
Briefly, 5 µm sections of lung were immersed in 0.1% Picrosirius solution for 1-2 hours and were rinsed
with 0.01 N HCL. Subsequent counterstaining with hematoxylin was completed followed by
coverslipping. Quantitative morphometric analysis was used to determine the volume density of alveolar
collagen and measure alveolar collagen thickness using basic point and intercept counting. Point and
intercept counts were made using an 11-line overlay graticule (12.5 mm square with 100 divisions), at
100x magnification, taken at eight locations equally spaced across each section. One section was used per
animal with a total of 4-7 animals per treatment group. (Weibel ER. Stereological Methods: Practical
Methods for Biological Morphometry. 1. New York, NY: Academic Press; 1980.)

4.5.8. Bronchiolar fibrosis
To assess the severity of bronchiolar fibrosis at 84 d post-exposure, images of the broncho-alveolar
duct in the most affected regions were taken using an Olympus BX63 microscope equipped with a DP73
camera and CellSens Dimension software (Olympus Corporation, Tokyo, Japan). For each animal lung
section, a total of six images were taken. Three images were taken of most affected junctions with minimal
severity of bronchiolar fibrosis. Additionally, three images were taken of most affected junctions
representing the most severe fibrosis. Only three images were taken of control animals. For each treatment,
one section per mouse was taken for a total of n=4-7 per treatment group. Bronchiolar fibrosis was
quantified using ImageJ (National Institutes of Health, Bethesda, MD) as previously described [192].
Briefly, using the color deconvolution pluggin, the image was separated into color channels, with green
representing areas of fibrosis. The areas of bronchiolar fibrosis were selected, and the area and percent
area was quantified. This percent area was then divided by the total area of the field of view to quantify
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the total percent area of fibrosis. Additionally, the area was then normalized to the length of the basement
membrane to express the fibrosis as a measurement of area per micron of basement membrane.

4.5.9. Lung and liver particle burden
The singlet lung burden and total liver particle burden was quantified using dark field microscopy
to visualize particle present in lung and liver tissue as previously described [10]. Morphometric point and
intercept counting was used as earlier described in the quantification of alveolar fibrosis, however only
lung singlets and all liver particles were counted and quantified. Particle in the liver was only present as
singlets.

4.5.10. Translocation
Tracheobronchial lymph nodes (TBLN) were sectioned and mounted onto plus slides as previously
described and were stained with green counterstain to visualize the presence of black particle.
Furthermore, additional sections of the lung, TBLN, and liver were mounted onto Schott slides. Using
CytoViva, (CytoViva; Auburn, AL) images of the lymph nodes were collected to visualize particle
deposition and extra-pulmonary accumulation in the liver and lymph nodes.

4.5.11. In vitro Study Design
Primary normal human lung fibroblasts were exposed to either DM or one of one of the nine
CNT/F at doses relevant to human occupational exposure to assess cytotoxicity and the potential
mechanisms by which histopathological changes may be occurring. Additionally, this study aims to find
correlations between in vivo and in vitro experimental findings to determine the degree to which in vitro
methods may predict in vivo toxicity.
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4.5.12. Cell culture
Primary normal human lung fibroblasts (NHLFs) were acquired from Lonza (Walkersville, MD) and
cultured at sub-confluent densities in fibroblast growth medium which contained FGM2 BulletKit growth
supplements (FGM2, Lonza) and 100 U/ml penicillin/streptomycin as previously described [193]. Briefly,
cells were passaged by washing with a HEPES-based buffer, suspension via 5% trypsin, and neutralization
using trypsin neutralization buffer (Lonza) following manufacturer’s procedures. Cells maintained in a 37
°C incubator in a humid, 5% CO2 atmosphere. 3rd to 7th passage NHLFs were used for all assays.

4.5.13. MWCNT preparation and dispersion
Dry MWCNT were weighed and placed into labeled, separate Eppendorf tubes. Dispersion medium (DM)
containing 0.6 mg/ml albumin and 10 µg/ml DPPC in sterile phosphate-buffered saline (PBS) was freshly
made for each assay. For each assay, DM was added to each dry MWCNT sample to achieve a 3 mg/ml
stock solution. Next, MWCNTs were sonicated for 5 minutes using an external sonicator (Hielscher
Ultrasound Technology) at 4 °C as an initial dispersion procedure. Then, each MWCNT was then hand
sonicated for 20 seconds using a microtip sonicator (Fisher Scientific) at 4 °C three separate times and
immediately serially diluted in FGM2 medium for cellular assays.

4.5.14. WST-1 assay
To screen MWCNT cytotoxicity and changes in cell metabolism, WST-1 assay was conducted as
previously described with modifications [194]. Briefly, NHLFs were passaged and seeded into tissue
culture-treated 96-well plates (Corning Inc., Corning, NY) at 5,000 cells per well overnight in 100 µl
volume. Cells were then exposed to seven dilutions of each MWCNT in fresh medium ranging 0.02 – 20
µg/cm2 in 200 µl volume along with unexposed cells and medium-only blanks for 24 hours. All treatment
groups were run in triplicate. 1 hour prior to the assay time point, 1% Triton-X solution was added to a
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subset of unexposed cells to serve as a 100% cytotoxicity control. Next, WST-1 reagent was added to each
well and the plate was allowed to incubate for 2 hours in the culture incubator following manufacturer’s
instructions (Roche LifeScience, Indianapolis, IN). Absorbance of metabolized WST-1 was read on a
SpectraMax 250 microplate spectrophotometer (Molecular Devices, Sunnyvale, CA) at 462 nm while 650
nm served as a background measure. Absorbance values were subtracted from mean blank values and
means calculated. Three independent assays were run. Since high MWCNT concentrations in the wells
increased baseline absorbance values, two separate assays with the same MWCNT dose scheme, but
without cells, served as particle controls and were used to correct absorbance values for all cellular assays.
Mean absorbance values were converted to percent viability.

4.5.15. Collagen I, α-SMA, and TGFβ expression
MWCNTs were screened for pro-fibrotic markers in exposed NHLFs as evidence for direct fibroblast
stimulation ability as previously described [186, 195]. Briefly, suspended NHLFs were seeded into tissue
culture-treated 6-well plates (Corning) at 3E5 cells per well overnight. NHLFs were then exposed to 0.02,
0.06, and 0.2 µg/cm2 in 2 ml volume for 48 hours, which match a 10 µg, 30 µg, and 100 µg dose per
mouse lung assuming 500 cm2 surface area [195]. Unexposed cells and 1 ng/ml human TGFβ served as
negative and positive controls. Since the design was spread across four plates, one well of unexposed cells
on each plate served as a plate control. Following exposure, digital phase contrast images of dispersed
MWCNTs on NHLFs were acquired at 10X and 20X using a Revolve microscope (ECHO, San Diego,
CA). Cell lysates were prepared for western blot analysis. Briefly, after plates were chilled on ice for 5
minutes, conditioned medium was collected into Eppendorf tubes, centrifuged at 1000 rpm for 5 minutes
to pellet cell debris, followed by the collection and storage of the supernatant at -80 °C for TGFβ assay.
Collected conditioned medium was assessed in technical triplicate for secreted total TGFβ concentrations
via DuoSet ELISA after latent TGFβ activation via acid incubation following manufacturer’s instructions
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(RandD Biosystems, Minneapolis, MN) as previously described[186]. Absorbance was measured at 450
nm on a 96-well microplate reader.
Next, exposed NHLFs were washed in cold PBS followed incubation in lysis buffer (Invitrogen,
Carlsbad, CA) containing 0.1 mM PMSF and complete protease inhibitor cocktail. Lysate samples were
scraped, collected into tubes, briefly homogenized using microtip sonication, and centrifuged at 12,500
rpms for 15 min at 4 °C. Collected supernatants were assayed for total protein using a BCA kit following
manufacturer instructions (Pierce, Rockford, IL). 30 µg protein samples were separated on 7% SDSPAGE gels followed by semi-dry transfer (Fisher Scientific, Hampton, NH) to nitrocellulose membranes.
Following blocking in 0.5% or 5% non-fat dry milk in TBS buffer with 1% Tween20 (TBS-T), membranes
were probed for rabbit Collagen I (Fitzgerald, Acton, MA), rabbit α-SMA (AbCam, Cambridge, MA), and
mouse monoclonal β-actin (Sigma Aldrich) using primary antibodies either using MiniBlot 2.0 system at
room temperature (Millipore, Burlington, MA) or overnight at 4 °C. After rinsing thrice with TBS-T,
membranes were incubated with either rabbit or mouse HRP-conjugated secondary antibodies (Santa Cruz
Biotechnology, Dallas, TX) for 1 hour at room temperature. Lastly, membranes were incubated with
SuperSignal chemiluminescent substrate (ThermoFisher Scientific, Waltham, MA) for 5 minutes and then
exposed to X-ray film. Films with bands were digitized and densitometry performed on ImageJ. Protein
expression was calculated as fold change compared to unexposed controls following correction using βactin expression for each sample. All experiments were performed three independent times.

4.5.16. Feature selection and principal component analysis
To permit selection of the minimal number of features among all characterization and L-W
properties that could potentially discriminate between each material investigated, feature selection was
performed with a random forest-based approach [169] using the “Boruta” algorithm [170] in the R
statistical environment [171]. The Boruta algorithm adds randomness to the variables in the dataset by
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creating shuffled copies of all variables (“shadow features”). “Boruta” iteratively assesses if each variable
has a higher Z-score than the maximum Z-score of its shadow features. At each iteration, variables with
Z-scores lower than shadow features are deemed unimportant and removed subsequently by the algorithm
to capture all the important, interesting features one might have in the dataset with respect to a dependent
variable, in this case each material itself. Then, using traditional, L-W-AR, and combined variables
retained after applying the “Boruta” algorithm, principal component analysis (PCA) was performed to
identify significant patterns that explained the majority of the variations in the physicochemical properties
among the different CNT/F materials investigated. PCA was performed using the prcomp command of
the R statistical software (R Core Team, 2016).

4.5.17. Statistics
Data are presented as mean with standard error or standard deviation as indicated in the figure
legends. Figures were prepared using SigmaPlot software (Systat Software, INC). Statistical analysis used
include one-way analysis of variance. Differences were considered significant at p < 0.05. This analysis
was performed using SAS/STAT software, Version 9.4 of the SAS system for Windows (SAS Institute,
Cary, NC).
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CHAPTER 4 TABLES
Table 1: Histopathology scores for distribution, severity, total score, and incidence at 84 days postexposure
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CHAPTER 4 FIGURES

Figure 4.1. Representative TEM images of particle dispersed in isopropanol. Scale bar represents 1 µm.
Images A-I are of MW #1, 2, 3, 4, 5, 6, 7, and CNF #1, and 2 respectively. These images serve to illustrate
differences in particle size and agglomeration patterns. Materials of small diameter and length (MW #1,
3) tend to be more heavily agglomerated in tangled spherical agglomerates. MW #2 is a unique material
that forms large and long rivers of agglomerates. As materials increase in diameter and length, the
agglomeration becomes looser and singlets are more common. Some materials including MW #6 and #7
have mixed populations of sizes with some small, moderate, and large diameter tubes present.
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Figure 4.2. Representative micrographs at 84 d post-exposure of pathologies typically seen following
MWCNT and CNF exposure. A) Representative trichrome stained image from the lung of a DM exposed
mouse demonstrates healthy tissue and airways. B) Granulomatous Bronchopneumonia is an
encapsulation of foreign material by inflammatory cells seen following exposure to all materials.
Representative image is of MW #7 exposed lung tissue stained with H&E. Particles are frequently visible
within these encapsulations. C) Bronchiolitis obliterans-like changes were seen following exposure to
MW #2, 6, 7, and CNF #1 in areas of high of particle deposition in the bronchioles. Representative image
is taken from MW #7 exposed lung section. D) Alveolar histiocytosis, hypertrophy, and hyperplasia is
identifiable by a lesion of inflammatory cell concentration in the peribronchiolar and alveolar regions and
as thickening of alveolar epithelium. This is common seen following exposure to most MWCNTs and
CNFs in this study except MW #2. Representative image is of MW #7 exposed lung following H&E
staining. E) Morphologic alterations in this section of mouse lung from a MW5-exposed mouse include
alveolar epithelial cell hypertrophy and hyperplasia, alveolar histiocytosis, and interstitial fibrosis. MW5
nanotubes are retained in this lung section, and because they block transmitted light, are demonstrable in
this section as dark fiber-like structures in alveolar macrophages and the fibrotic interstitium. F)
Bronchiolar epithelium hypertrophy is also commonly observed as a thickening of the epithelial layer of
the bronchioles. Representative image is of CNF #1 exposed lung. G) Disruption of lymphatic flow can
be seen following exposure to several materials including MW #7 as seen in the representative image.
Dark particles can be seen in a massive tangle forming an obstruction and subsequent back flow of the
lymphatics. H) Pleural penetrations were seen following exposure to MW #5, 6, and CNF #1 and 2 in at
least one occurrence. Representative image is a partially polarized image of H&E stained tissue from CNF
#1 exposed mouse tissue. I) Bronchiolar fibrosis and J) alveolar interstitial fibrosis is a thickening of
collagen deposition in the broncho-alveolar duct region and the alveolar interstitium respectively
Representative images are of MW #7 and MW #5 exposed lungs, respectively, with Masson’s trichrome
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stain. All materials induced this response with variable severity and distribution with correlation to the
region of particle deposition.
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Figure 4.3. Bronchiolar Fibrosis at 84 days post-exposure to 40 µg dose of MWCNT or CNF. The total
area of bronchial/bronchiolar fibrosis per mm of basement membrane was quantified in two regions, both
the least affected and most affected regions for comparison. While all treatment groups had normal,
unaffected bronchoalveolar duct regions, MW #2, 4-7, and CNF #1 had severely impacted
bronchi/bronchioles. (*p<0.05)
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Figure 4.4. Alveolar Fibrillary Collagen quantification. A) At 84 days post-exposure to the high dose of
MWCNTs or CNFs, the thickness of alveolar fibrillary collagen was measured using morphometric point
and intercept counting. Reference line is relative to DM. Statistically significant increases were seen
following exposure to MW #1, #4-7, and CNF #1-2. MW #2 deposition is limited to the conducting
airways due to particle agglomerate size. While MW #3 does reach the alveolar region, fibrosis is minimal
overall. Representative micrographs of picrosirius red stained tissue are as follows: B) DM, C) MW #3,
D) MW #6, and CNF #1. Particle is visibly present in the interstitial walls in D and E. (*p<0.05)
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Figure 4.5. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) of different
CNT/F materials comparing MWNCT/CNF and histopathology outcomes.
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Figure 4.6. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) of different
CNT/F materials and bronchi/bronchiolar histopathology outcomes (A) and alveolar histopathology
outcomes (B).
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Figure 4.7. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) of different
CNT/F materials comparing length – diameter physical dimension (L-W binning) combined with all
histopathology outcomes.
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Figure 4.8. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) of different
CNT/F materials comparing bronchial/bronchiolar histopathology outcomes (A) and alveolar pathology
outcomes (B).
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Figure 4.9. Human fibroblast in vitro cell viability (A), collagen-1 production (B), αsmooth muscle actin
production (C), and TGFβ secretion (D) following exposure to MWCNT/CNF at 0-20 µg/cm3 for 24
hours. Collagen-1 production was significantly increased following exposure to MW #7. No changes in
αsmooth muscle actin were seen, and variable changes in TGFβ secretion were noted with significance.
(*p<0.05)
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Figure 4.10. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) of
different CNT/F materials comparing in vitro fibroblast outcomes.
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Figure 4.11. Representative Dark Field Micrographs of lungs at 1 Day post-exposure to 40 µg MWCNT
or CNF. Images A-I are of MW #1, 2, 3, 4, 5, 6, 7, and CNF #1, and 2 respectively. MW #1 and 3
deposition is common in the alveolar region, typically as small spherical agglomerates. MW#2 deposition
is limited to conducting airways as large aggregates. MW #4-7 and CNF #1-2 are found as both bundled
agglomerates and singlets in the alveolar region. Scale bar is 5 µm.
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Figure 4.12. Lung singlet burden at 1 d post exposure predicts extra-pulmonary translocation at 84 d
post-exposure. A) Lung singlet burden was quantified at 1 d post exposure and is presented as a
percentage normalized to 100% MW #5. Reference bar indicates 100%. MW #1-3 were almost
exclusively present as agglomerated material with minimal to no singlet present. MW #4 had the
greatest lung singlet burden, followed by MW #5. MW #6, #7, and CNF #1 had notable singlet burden
with CNF #2 having a moderate singlet burden. B) Extra-pulmonary translocation to the liver was
quantified and is presented as percentage normalized to 100% MW #5. Reference bar indicates 100%.
MW #1-3 had none to little translocation to the liver at 84 d post-exposure. MW #4 had the greatest,
followed by MW #5. Some translocation of MW #6, #7, and CNF #1 was measured, with CNF #2 have
minimal but notable translocation. C) Representative dark field micrograph of MW #4 singlet present in
the liver at 84 d post-exposure. Scale bar is 10 µm. D) Relationship of lung singlet burden at 1 d postexposure to extra-pulmonary translocation at 84 d post exposure. Greater presence of singlets in the lung
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at 1 d post-exposure correlates strongly to greater extra-pulmonary translocation. MW #4 has the
greatest singlet lung burden and the greatest liver translocation followed by MW #5. Translocated
particles in the liver were only observed as singlets. Particles with minimal singlet burden had none to
minimal translocation with the moderate singlet burden materials having moderate translocation.
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Figure 4.13. Representative Micrographs of Tracheobronchial Lymph Nodes at 84 Days post-exposure
to 40 µg MWCNT or CNF. Images A-I are of MW #1, 2, 3, 4, 5, 6, 7, and CNF #1, and 2 respectively at
60x magnification. Green counterstain was used to visualize black particle presence in the tissue. MW #1
and MW #3 had the most prominent translocation, though all materials with the exception of MW #2 had
notable translocation.
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Figure 4.14. Representative Dark Field Micrographs of Tracheobronchial Lymph Nodes at 84 Days postexposure to 40 µg MWCNT or CNF. Images A-I are of MW #1, 2, 3, 4, 5, 6, 7, and CNF #1, and 2
respectively. Dark field microscopy was used to visualize both agglomerates and singlets present in the
tissue. The presence of singlets in MW #5-7, and CNF #1-2 can be more easily identified in addition to
the presence of agglomerated or accumulated particle. Scale bars represent 10 µm.
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Figure 4.15. Hierarchical clustering analysis (HCA) principal component analysis (PCA) of different
CNT/F materials comparing translocation outcomes alone (A), as well as length – diameter physical
dimension (B; L-W binning) with extra-pulmonary translocation outcomes.
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CHAPTER 4 SUPPLEMENTARY TABLES AND FIGURES
Supplementary Table 4.1. Physical dimensions of CNT/F dispersed in isopropanol.
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Supplementary Table 4.2. Hydrodynamic diameter, zeta potential, and two-dimensional sizing of
CNT/F agglomerates dispersed in physiologic dosing media.
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Supplementary Table 4.3. Results of additional particle characterization of CNT/F.
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Supplementary Figure 4.1. Distributions of CNT/F diameter.
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Supplementary Figure 4.2. Distributions of CNT/F length.
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Supplementary Figure 4.3. Bronchial/bronchiolar fibrosis as a percentage of the area of fibrosis over the
total area of the field of view for least affected and most affected bronchoalveolar junctions
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Supplementary Figure 4.4. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘All characterization’ and all histopathology outcomes
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Supplementary Figure 4.5. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘All characterization’ and all bronchi-bronchiolar outcomes
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Supplementary Figure 4.6. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘All characterization’ and alveolar outcomes
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Supplementary Figure 4.7. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘means only’ and all histopathology outcomes
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Supplementary Figure 4.8. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘means only’ and bronchi/bronchiolar outcomes
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Supplementary Figure 4.9. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘means only’ and alveolar outcomes
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Supplementary Figure 4.10. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘all characterization’ and in vitro fibroblast outcomes
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Supplementary Figure 4.11. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘means only’ and (A) length-diameter binning (B) with in vitro fibroblast outcomes
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Supplementary Figure 4.12. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘all characterization’ and extra-pulmonary translocation outcomes
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Supplementary Figure 4.13. Hierarchical clustering analysis (HCA) and principal component analysis
(PCA) of ‘means only’ and extra-pulmonary translocation outcomes
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Supplementary Figure 4.14. Previously published image of extra pulmonary translocation and particle
accumulation of MW #3 in the spleen
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CHAPTER 5:
General Discussion

216

5.1 General Discussion
The toxicities associated with pulmonary exposure to MWCNTs has been of concern for over a
decade driving the demand for the development of exposure modeling systems, expansive toxicity testing,
and translational research between in vivo, in vitro, and human studies. This study aimed to expand upon
previous toxicity assessments of MWCNT and CNFs by being broadly inclusive of a wide range of
particles. Four pillars of toxicity outcomes including genotoxicity, inflammation, histopathology, and
extrapulmonary translocation were investigated using a combination of in vivo and in vitro models. Lastly,
this study utilized a novel approach to modeling the relationships between these characteristics and
toxicity outcomes to identify key drivers.

5.2. Particles and Characterization
This study selected nine materials for comparison, including the well-studied Mitsiu-7 MWCNT
as a benchmark. Mitsui-7 is a rod-like MWCNT that can be dispersed moderately well while still retaining
minimal agglomeration. Averaging around 63 nm in diameter and 4 µm in length, this material generally
can be considered to fall in the center of the spectrum of MWCNT and CNF sizes. Four materials of
smaller company reported diameter, and four materials of greater company reported diameter were also
selected for comparison in this study. Few studies have attempted to compare this large of a group of
materials within the same study, and those that do often do not fully represent the full range of particle
sizes, thus inadequately addressing important questions. The current study aimed to include this full
spectrum of materials of various sizes, agglomeration states, and physicochemical characteristics.
However, one noted limitation in this study was the utilization of as-produced materials only, no coatings
or surface functionalization were included. While these characteristics are important to safety and are
reported to alter to toxicity outcomes, the current study did not include these factors. Other studies
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addressing these factors have been published, including Bishop et al. 2017, and may serve as an additional
resource for addressing these concerns [19].
The current study aimed to extensively characterize these materials to maximize the number of
variables that may have been considered for their potential influence on toxicity outcomes. One notable
advancement in this study compared to numerous previously published studies was the detailed reporting
of the distributions and range of particle sizes and histogram presentation. Many studies consider the
geometric or arithmetic mean sufficient as the sole reported value, but the conclusions of this study suggest
the need for a complete size assessment. While many of the quantified characteristics, such as the antioxidative capacity (FRAS), did not seem to be as potent of a driver as others, these findings are still
relevant to the overall conclusions for the future of particle safety-by-design and for future particle toxicity
assessments.

5.3. Translational Considerations
For the in vivo studies in this project, two key doses were utilized, 4 and 40µg per mouse. The
higher of these two doses was selected as previously published studies of the toxicities of MWCNTs have
demonstrated that 40 µg of MWCNT, particularly Mitsui-7 was necessary to induce significant and
notable histopathological changes in the mouse lung, including alveolar fibrosis and inflammation. Due
to the previously published implications of this dose in the determination of toxicity outcomes, this dose
was also included in the current study design for comparison to the findings of existing studies and to
determine the relevance of this dose as a benchmark across all CNT/Fs. While this is a notably higher
dose that may not translate efficiently for comparisons to human studies, this historically important dose
was necessary for use in this study.
Furthermore, a lesser dose of 4µg per mouse was used due to its relevance of dosimetry to human
outcomes. In exposure assessments completed to evaluate human exposures to MWCNT and CNFs in
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U.S. primary and secondary manufacturing facilities, it was reported that workers were exposed to an
inhalable elemental carbon mass concentration arithmetic mean of 10.6 µg/m3, or 4.07 µg/day [69, 164].
This dose is equal to 2 ng/day in a mouse of alveolar lung deposition from particle inhalation. Dosimetry
calculations would suggest that a 4µg bolus dose would be equal to approximately 7.4 years spent working
in a U.S. facility, which at the time of study development, was relevant to the current state and timeline
of the industry and was therefore important to include in this study design.
One key goal of the current study was to bridge the translational gap between human exposure
assessments and laboratory rodent studies. As the latency of adverse human health outcomes from
exposure to CNT/F has not been reached, dosimetry studies were designed to monitor human exposure.
These studies aim to identify biomarkers of exposure as well as early detection of adverse health outcomes
to prevent the onset of toxicity outcomes that may occur. Additionally, these studies assist in the
optimization of safety practices and the use of engineering controls and personal protective equipment to
ensure safe worker handling.
This study was completed with contributions of several collaborators who completed human
exposure assessments, epidemiological studies, and dosimetry assessments to ensure that the rodent model
system used in the current study were representative of human exposures. The materials used in this study,
with the exception of the reference material, Mitsui-7, were produced in U.S. facilities that were also
included in exposure assessments as well as investigations for potential human health effects [68, 69, 79,
92, 164]. As previously mentioned, the doses in this study were selected in consideration of human
exposures. Furthermore, the methodology of dispersion of the CNT/F in dispersion media were developed
to ensure that the sizes of particles as well as the agglomeration shapes and sizes were similar to those
particles observed during human studies. Several toxicity outcomes observed in the mouse model can be
also be directly compared to those quantified in human studies such as cytokines, chemokines, and other
markers of inflammation and toxicities.
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In vitro modeling systems were also incorporated into the current study in addition to in vivo
aspects and human health effects collaborations to challenge the potential of mono-cell culture models
and to begin to elucidate the potential mechanisms behind the observed toxicities in vivo. For genotoxicity,
inflammation, and histopathology, a relevant cell type was selected and underwent similar toxicity testing.
First, BEAS-2B cells are a human epithelial cell line commonly used in nanoparticle toxicity
testing, including genotoxicity assessments. In this study, in vitro testing of genotoxicity was the primary
model. In addition to standard testing of cell viability with dose, markers of oxidative stress, γH2AX, a
marker of double stranded DNA damage, and micronucleus formation, another marker of DNA damage
or disruption in cell replication, were assessed. While these assays are broad and cannot fully elucidate
the extent of the mechanisms of genotoxicity, alone, they serve as a valuable screening tool for generating
comparisons between particles to detect variability in their outcomes. This allows generalizations to be
made regarding whether all MWCNT/CNF are equally genotoxic or if some particles act through variable
mechanisms leading to genotoxicity outcomes.
Second, for the assessment of inflammation, THP-1 cells, human macrophage cells, were used as
a counterpart to the extensive in vivo assays. These cells are also a commonly used model in toxicity
assessments as they are relatively easy to culture, can be differentiated to various states of activation, and
are capable of phagocytosis. In addition to the dose-response cell viability assay, these cells were also
used to assess potential activation of the inflammasome, changes in proteins relevant to cell signaling,
cytokine and chemokine release, and tissue repair, as well as changes in phagocytic capacity to determine
the potential mechanisms and alterations in cell functions that can occur as a result of particle exposure.
These protein changes in particular were useful for direct comparisons between in vivo and in vitro
findings as well as an initial screening for changes in basic macrophage activity suggestive of downstream
effects of particle exposure.
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Human lung fibroblasts, CRL-1490s, were the third cell model used in this study. While monocell cultures alone cannot be used as a representation of complex multi-cell histopathology changes and
cannot be representative of extrapulmonary translocation, these cells were used to attempt to model
pulmonary fibrosis and explore potential mechanisms driving the fibrotic response. The in vivo findings
in this study revealed the complexities of fibrosis outcomes dependent upon physiological factors such as
airway size, region of deposition, and time, that unfortunately, resulted in limited usefulness of fibroblast
cultures alone. Two-dimensional monoculture cannot be accurately representative of the regional
bronchial or alveolar fibrosis quantified in the in vivo study. Advances in cell culture models such as airliquid interface, lung-on-a-chip, three-dimensional, or co-culture models may be more useful to this
application for future studies.
Overall, this study was designed to exemplify human exposures to CNT/F to bridge laboratory and
human research together to answer the yet unanswered questions in the field regarding human safety and
risk. By including the findings of human exposure assessments in the design of the current study, our
model was, to the best of our ability, able to accurately represent human occupational exposures via dose,
agglomeration shape and size, and particle dispersion with consideration to assessing endpoints that are
translational to human health outcomes.

5.4. Toxicity Outcomes and Study Findings
As one key goal of the current study was to identify the relationships between physicochemical
characteristics and toxicity outcomes, the first step was to ensure complete and proper characterization for
all nine materials. While information on particle sizes and surface chemistry are often reported by the
company of production, it is necessary to independently characterize these materials to verify these reports
and to expand upon characterization information not reported by manufacturers. In the current study the
full panel of characterization included in depth size characterization of length, width, and aspect ratio,
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providing both means and ranges, but a full histogram to identify critical subpopulations of sizes. The
agglomeration states of these particles were also defined and measured, and we reported the percentage
of tubes present as either spherical or bundled agglomerates and the sizes of those agglomerates.
Additionally, the dustiness, density, and anti-oxidative capacity were assessed, and the quantity of
potential contaminants including metal catalysts, PAHs, and endotoxin levels were quantified.
Following this characterization, principal component analysis was utilized to first determine if the
physicochemical characteristics alone could be used to group similar materials. This initial analysis
compared groupings that varied depending on which characteristic data was selected for input. Using the
means alone for length, width, and aspect ratio resulted in a different grouping than including bins of
particles sizes generated via histogram, which was also somewhat different from the groupings generated
when all characterization data was included. L-W-AR and All Characterization analysis grouped MW #14, MW #5-7, and CNF #1-2 together, while including size means alone produced less distinct groupings.
Of note, L-W-AR PCA analysis also grouped CNF #1 as closer to MW #5-7 while beginning to segregate
out CNF #2. This grouping would later come to relevance with the inclusion of toxicity outcomes in
additional analysis. Overall, this grouping was of interest for first determining the variability between the
materials used in this study and for laying the groundwork for elucidating which characteristics would
play a larger role in subsequent assessments.
Genotoxicity was the first toxicity outcome assessed in the current study. Cell viability, the
generation of reactive oxidative species, and the production of cytokines, chemokines, and growth factors
were first assessed followed by assessing double stranded DNA breaks and micronuclei formation. These
standard assessments provided a useful screening tool for detecting potential DNA damage, though the
use of an in vitro model does not provide an accurate assessment of the full carcinogenicity of these
materials. This study reported that a significant increase in ROS was found following exposure to high
doses of MW #5-7 and CNF #1-2, and numerous significant increases in proteins including IL-6, IL-8,
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IL-1β, and other markers of inflammation and cell injury were observed following exposure to both high
doses of most materials and low doses some materials. Furthermore, it was reported that all materials were
capable of inducing micronuclei formation, and all materials except MW #2 induced double stranded
DNA damage at the higher dose. These findings alone are significant as they indicate that all the materials
in the present study can induce genotoxicity regardless of physicochemical characteristics, though the
mechanisms and pathways driving this outcome may be variable.
Once completed, these toxicity outcomes were included in the modeling parameters. Hierarchical
clustering of the cellular outcomes was combined with the three physicochemical characteristics groups
previously modeled. When ‘all characteristics’ and ‘L-W-AR’ parameters were included, only two
clusters emerged, MW #1-4 were separated from the rest of the materials. When ‘means only’ were used,
then MW#4 was switched to the second group containing MW #5-7 and CNF #1-2. This is the first
suggestion that MW #4 may be a transitional material between these two groups displaying characteristics
and subsequent outcomes that can shift between these two groups, as seen when variable parameters were
included in the clustering.
Additionally, this modeling indicated that certain subpopulations of particle sizes, particularly
lengths between 15 and 30 µm are more distinguishing regarding toxicity outcomes. This is the first
notable size population to emerge in relation to toxicity outcomes. Overall, the initial modeling parameters
included in part one of the current study have shown that key data points that may not have been previously
investigated in regard to drivers of toxicity must be considered and that the average size of a whole
population may not be efficient for predicting toxicity outcomes, rather the presence of a particular sub
population of particles of a certain size, shape, or characteristic may be more pertinent.
Part two of this study addressed inflammation as a toxicity outcome. First, an in-depth in vivo
study investigated outcomes including LDH, inflammatory cell infiltration, and changes in proteins
including markers of inflammation, tissue repair, and growth factors at two key doses and four time points.
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Initial observations of these findings suggested that materials of larger diameter were more likely to induce
greater and more persistent inflammation. While all materials induced a bolus response and initial acute
inflammation, beginning at 7 days post-exposure, several trends began to emerge. Materials of larger
diameter and length were associated with more severe and more persistent inflammation. Computer
modeling of these outcomes indicated that following a similar trend, MW #1-4 could be organized into a
separate bin from MW #5-7, and CNF #1 with CNF #2 transitioning between the two bins.
In vitro outcomes for inflammation were assessed using human THP-1 macrophages. Almost all
materials induced functional changes in the phagocytic capacity of macrophages except for MW #3.
Additionally, all materials resulted in increased caspase-1 activity. All materials induced cell death,
significant increases in markers of inflammation and membrane damage, though the dose at which
significance was achieved was variable. Similar to in vivo outcomes, materials of larger nominal tube
diameter and length were more potently inflammatory than smaller, more agglomerated materials.
Modeling of these outcomes further identified and elucidated these relationships between
outcomes and physicochemical characteristics. Several bins of materials were segregated and when all
traditional variables as well as length and width bins were considered, the materials were divided into
groupings similarly identified with the consideration of genotoxicity outcomes.

MW #1-4 were

distinguished from MW #5-7 and CNF #1-2. This segregation was confirmation of the frequently
observed descriptive trends noting differences between materials and their severity and persistence of
inflammation.
The third toxicity outcomes assessed in this project was histopathology outcomes. This assessment
was to observe chronic changes in the morphology of the lung as well as additional markers of tissue
injury, inflammation, and other changes that may result or be suggestive of long-term functional changes.
The outcomes scored in this study include granulomatous inflammation, bronchiolitis obliterans-like
changes, alveolar histiocytosis, bronchiolar epithelial hypertrophy, alveolar hypertrophy and hyperplasia,
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and fibrosis, both bronchial and bronchiolar fibrosis. Additional morphometric assessments were made to
further quantify and delineate pulmonary fibrosis by region.
Like previously assessed outcomes, these histopathology outcomes were added to the modeling
system. When considering the physicochemical characteristics combined with the histopathology
outcomes based on their region of effect, the materials can be binned into unique groupings not previously
seen in this study, though when all outcomes are considered together, the same trends emerge
distinguishing MW #1-4 from MW #5-7 and CNF #1-2, though when considerations were given to region
of the lung affected (alveolar or bronchi/bronchiole) there may be some variations in binning.
In addition to these in vivo assessments, human fibroblast cells were employed in vitro assessments
to begin to elucidate mechanisms and pathways driving some of these in vivo outcomes. Findings from
using a monoculture to represent the entirety of pulmonary fibrosis was limited. As a monoculture is not
distinct to the regions of the lung and functionally cannot represent both alveolar and
bronchial/bronchiolar regions of the lung, more advanced methods are necessary for a fully representative
in vitro model. Incorporation of techniques and culture methods such as air-liquid interface or the “lungon-a-chip” may be necessary for future research.
Translocation was the fourth and final class of toxicity outcomes assessed. The current study was
focused on respiratory exposures and respiratory outcomes, though it is well established that particles
deposited in the lung may not stay within the lung. Either by diffusion or active transport via macrophages,
lymphatics, or systemic circulation, particles may eventually be deposited in other extrapulmonary tissues
including the lymph nodes, kidney, liver, spleen, and cardiovascular system. While previous studies of
this translocation often suggest limited or very minimal extrapulmonary translocation, clearance from the
lung remains a necessary question regarding respiratory toxicology. The current study investigated
translocation to the tracheobronchial lymph nodes (TBLN) and the liver. While almost all particles were
able to reach the TBLN, the mechanism of transport to the lymph nodes may vary depending on particle
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physicochemical characteristics. Furthermore, translocation to the liver initially suggested three groups of
particles, small particles with almost zero to minimal liver deposition, a second group of moderately sized
particles with the most liver deposition, and a third group of larger particles that had some, but not
extensive liver deposition. These outcomes were further investigated using the established modeling and
clustering.
Linear regression modeling suggests that singlet lung burden at one day post-exposure may be
useful for predicting liver extra-pulmonary transport at 84 days post-exposure. However, as translocation
to other tissues such as the spleen were not assessed, this predictive model for extrapulmonary
translocation to all other organ systems is limited. Modeling of translocation outcomes combined with
physicochemical characteristics categorized the materials into two bins, similar to the binning previously
made using other toxicity outcomes which does not fully match the binning trends made with translocation
outcomes alone. This may be due to the computer model placing greater value in the physicochemical
characteristics as a means to segregate materials, and prioritizing these differences over the contributions
of the translocation outcomes to the overall model

5.5. Relationships Between Toxicity Outcomes
The four key toxicity outcomes investigated in this study are not stand-alone considerations. Each
of these outcomes are interwoven with one another and influence the severity and progression of adverse
health effects (Figure 1). One example is the relationship between inflammation and carcinogenicity.
Several biological processes have been identified as being hallmarks of cancer including more recently,
inflammation [174, 175]. Weinberg and Hanahan published an update in 2011 suggesting the role of
chronic inflammation as a driver of genotoxicity and cancer [174]. In the current study, several materials,
including materials of larger nominal tube dimension were capable of inducing sustained and persistent
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inflammation at 84 days post exposure. This chronic inflammation may therefore be a contributor to the
carcinogenicity of MWCNTs.
A second example also related to genotoxicity and cancer. One other hallmark of cancer is the
ability of cancer cells to invade other tissues and metastasize [174, 175]. Activation of TGFβ through the
SMAD signaling pathway is linked to the epithelial-mesenchymal transition of alveolar epithelial cells to
a cell phenotype that is capable of tissue invasion and metastasis [187-189]. The current study highlighted
increased production of TBFβ following CNT/F exposure. TGFβ is also linked to increased collagen-1
deposition and pulmonary fibrosis [116, 186]. These findings suggest that inflammation, pathology
(fibrosis), and genotoxicity are heavily related.
A third example is the relationship between inflammation and extra-pulmonary translocation. Two
key mechanisms of translocation have been identified in the current study: macrophage dependent and
macrophage independent translocation. Macrophages are an inflammatory cell that plays a role in the
clearance of foreign material in the body. In an attempt to clear CNT/F from the lung, macrophages
transport particles to other tissues including the lymph nodes and spleen where the particles then are
transferred to resident cells of the respective tissues resulting in particle accumulation in extra-pulmonary
tissues where they have the potential to induce adverse systemic effects.

5.6. Contributions of Computational Modeling
The inclusion of computational modeling was essential to elevate the conclusions of this study and
apply quantitative analysis where merely descriptive conclusions would have been previously drawn.
These outcomes together conclude that the parameters of nominal diameter, nominal length, and particle
agglomeration are the primary divers of toxicity outcomes induced by MWCNT/CNF exposure, and the
inclusion of tubes within key size subpopulations can result in more potent genotoxicity, inflammation,
histopathology, and extrapulmonary translocation. While not all materials induced the same outcomes, all
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materials induced significant lung injury and possible systemic effects. The physicochemical
characteristics of MWCNT/CNF are often interconnected and dependent upon one another. While all
characteristics may influence toxicity outcomes, only a few have been identified in this study to be the
major contributors impacting the toxicity outcomes. A schematic illustrating this concept can be found in
Figure 1.
One key finding in this study was the pertinence of sub populations of particle sizes. The presence
of materials greater than 15 µm length and 50 nm in diameter result in more potent and severe effects,
even when this population is a minor component of the total particle population. The segregation of these
subpopulations using histograms was essential to understanding the outcomes of this study, and due to the
lack of this data presented in previously published toxicity assessments, data mining may be a minimally
successful endeavor.
Furthermore, particle agglomeration was a notable driver for toxicity outcomes, particularly
histopathology outcomes strictly dependent upon regional deposition in the lung. In this study,
terminology to describe agglomeration as either “spherical” or “bundled” was created as there is no current
standard verbiage to describe differences in CNT agglomeration. For comparisons between multiple
studies in the future, shared language and standardized definitions for agglomeration are needed.

5.7. Impact and Significance on Safety Recommendations
As the 2020-2024 Report of the Advisory Group to Recommended Priorities for the IARC
Monographs has recommended MWCNT as a high priority to be ready for evaluation within five years
[37], studies investigating these materials in a wholly inclusive and expansive study is necessary. In this
study, it was found that all MWCNT/CNF were genotoxic. While there were differences in the extent and
potency between materials, all materials can be assumed to present notable risk that can translate to risk
in human exposures. Of note, many of the toxicity outcomes were induced by materials of the low dose,
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which is the dose noted to be most relevant of the REL established by NIOSH. These findings would
suggest that the REL may be insufficient as a guideline for protecting facility employees, especially with
considering that mouse modeling systems compared to rat models are less sensitive therefore amplifying
the importance of adverse effects noted at the lower dose of the current study. Due to the safety factors
within the calculations for establishing the REL, often a factor of 10, differences between particles noted
int eh current study do not have enough variability between them to warrant specific RELs, one for the
broad class as a whole will be sufficient. Additionally, one major limitation to changing the REL is the
limit of detection of CNT/F. Currently, the lower limit of detection in air sampling methods is just below
the current REL, making a shift to a more restrictive exposure limit unenforceable until advancements in
air sampling techniques and technologies advance [57].
Recently, CNTs were added to the “Substitute It Now” (SIN) list in the European union, a list of
materials that are designated to be banned once a safer substitute can be identified [196]. However, this
designation has been disputed due to the unclear evidence that all CNTs are equally toxic, therefore
promoting the desire to ban some, but not all CNTs [197]. Proper understanding of the toxicities of this
broad class of materials as a whole and the possibilities of designing safer materials is crucial for the future
of the CNT industry and the potential applications for these materials.

5.8. Future Directions
The in vitro modeling with BEAS-2B human epithelial cells in the current study were useful as a
screening tool for genotoxicity but cannot be used to complete a full assessment of the carcinogenic
potential of these materials. Future studies will include an in vivo counterpart in mice to assess tumor
promotion, progression, and carcinogenic risk induced by these same materials due to the limited nature
of carcinogenicity and genotoxicity assessments using only in vitro modeling. Additionally, using more
advanced cell culture systems such as air-liquid interface and other three-dimensional co-culture systems
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may be useful to overcome the limitations of using only human fibroblast cells in monoculture for
assessing changes such as pulmonary fibrosis. The application of cutting-edge techniques may improve
the relationships elucidated through modeling and may improve the usefulness of in vitro systems in
assessing nanotoxicological outcomes.
This study emphasized the importance of modeling methodology and the necessity of inclusion of
the most accurate parameters for effective predictions. Future goals and projects will further refine this
modeling system and its prediction capabilities. This model may eventually expand to include other
carbonaceous nanomaterials of various sizes, dimensions, and characteristics. Additionally, once a
functional model has been accepted, software applications for future on-site industry applications and for
safety-by-design may become possible. While human epidemiology studies are limited by the latency of
time in the industry, efficiently pairing in vitro, in vivo, and in silico modeling in conjunction with human
studies will enhance conclusions for future safety and risk assessments. Mechanism discovery as to why
some materials induce certain outcomes and the variances in the potency of these outcomes may also be
necessary in future studies.

5.9. Conclusions
This study was a comprehensive toxicity assessment of MWCNTs and CNFs produced in U.S.
facilities. Completion of this study resulted in the creation of an accurate safety profile for seven
MWCNTs and two CNFs, and as per the originally stated hypothesis, was able to elucidate that while all
materials in this family can be toxic, the toxicity outcomes induced are dependent upon physicochemical
characteristics, importantly materials comprised of singlets and well dispersed fibers with notable
subpopulations of tubes with larger nominal diameters and lengths have a greater likelihood of inducing
greater and more persistent inflammation, histopathology changes in the bronchi and bronchioles
including pulmonary fibrosis. Materials with subpopulations of lengths within a moderate length and
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diameter have an increased likelihood of extra-pulmonary translocation to tissues such as the liver, though
size may not be a critical determinant of the likelihood of a particle to induce genotoxicity. Overall,
identification of these critical parameters is important to understanding the risks of human adverse health
effects, for the future of industry safety practices, and the design of new, safer nanomaterials.

231

CHAPTER 5 FIGURES

Figure 5.1. Schematic of the physicochemical characteristics, the four major toxicity outcomes, and the
relationships between them.
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